Use: Labeled indications
- AUGMENTIN is indicated for the treatment of infections in adults and pediatric patients, due to susceptible isolates of the designated bacteria in the conditions listed below: Lower Respiratory Tract Infections - caused…
Full indications and usage US FDA label
1 INDICATIONS AND USAGE AUGMENTIN is indicated for the treatment of infections in adults and pediatric patients, due to susceptible isolates of the designated bacteria in the conditions listed below: Lower Respiratory Tract Infections - caused by beta‑lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis. Acute Bacterial Otitis Media - caused by beta‑lactamase–producing isolates of H. influenzae and M. catarrhalis.
Sinusitis - caused by beta‑lactamase–producing isolates of H. influenzae and M. catarrhalis. Skin and Skin Structure Infections - caused by beta‑lactamase–producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species. Urinary Tract Infections - caused by beta‑lactamase–producing isolates of E. coli, Klebsiella species, and Enterobacter species.
AUGMENTIN is a combination of amoxicillin, a penicillin-class antibacterial and clavulanate potassium, a beta‑lactamase inhibitor indicated for treatment of the following infections in adults and pediatric patients: (1) Lower respiratory tract infections Acute bacterial otitis media Sinusitis Skin and skin structure infections Urinary tract infections Limitations of Use When susceptibility test results show susceptibility to amoxicillin, indicating no beta-lactamase production, AUGMENTIN should not be used. (1) Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
(1) Limitations of Use When susceptibility test results show susceptibility to amoxicillin, indicating no beta-lactamase production, AUGMENTIN should not be used. Usage To reduce the development of drug‑resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Contraindications
- Serious hypersensitivity (anaphylaxis, Stevens-Johnson syndrome) to amoxicillin-clavulanate or other beta-lactams
- Previous cholestatic jaundice or hepatic dysfunction with amoxicillin-clavulanate
Contraindications (US label) US FDA label
4 CONTRAINDICATIONS History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AUGMENTIN or to other beta‑lactams (e.g., penicillins or cephalosporins). (4.1) History of cholestatic jaundice/hepatic dysfunction associated with AUGMENTIN. (4.2) 4.1 Serious Hypersensitivity Reactions AUGMENTIN is contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin, clavulanate or to other beta‑lactam antibacterial drugs (e.g., penicillins and cephalosporins). 4.2 Cholestatic Jaundice/Hepatic Dysfunction AUGMENTIN is contraindicated in patients with a previous history of cholestatic jaundice/hepatic dysfunction associated with AUGMENTIN.
Dosing: Adult
- Oral: severe infections and respiratory infections: 875 mg every 12 hours or 500 mg every 8 hours (amoxicillin component)
- Oral: less severe infections: 500 mg every 12 hours or 250 mg every 8 hours
- Oral: GFR below 30 mL/min: Do not use 875 mg; 250–500 mg every 12 hours (GFR 10–30) or every 24 hours (below 10)
- Administration: Take at the start of a meal
- IV co-amoxiclav (PH vials): Not covered by the US label; no IV dose given here.
- Adults and Pediatric Patients greater than 40 kg: 500 or 875 mg every 12 hours or 250 or 500 mg every 8 hours, based on the amoxicillin component. (2.2, 2.3)
- Pediatric patients aged 12 weeks (3 months) and older: 25 to 45 mg/kg/day every 12 hours or 20 to 40 mg/kg/day every 8 hours, up to the adult dose. (2.3)
- Neonates and infants less than 12 weeks of age: 30 mg/kg/day divided every 12 hours, based on the amoxicillin component. Use of the 125 mg/5 mL oral suspension is recommended. (2.3)
2.1 Important Administration Instructions
2.1 Important Administration Instructions AUGMENTIN may be taken without regard to meals; however, absorption of clavulanate potassium is enhanced when AUGMENTIN is administered at the start of a meal. To minimize the potential for gastrointestinal intolerance, AUGMENTIN should be taken at the start of a meal.
2.2 Adult Patients
2.2 Adult Patients See dosing regimens of AUGMENTIN (based on the amoxicillin component) provided in Table 1 below. Table 1. Dosing Regimens of AUGMENTIN in Adult Patients TYPE OF INFECTION DOSING REGIMEN OF Amoxicillin and Clavulanate Potassium Severe infections and infections of the respiratory tract one 875 mg tablet a of AUGMENTIN every 12 hours or one 500 mg tablet b,c of AUGMENTIN every 8 hours Less severe infections one 500 mg tablet b,c of AUGMENTIN every 12 hours or one 250 mg tablet d of AUGMENTIN every 8 hours a Adults who have difficulty swallowing may be given the AUGMENTIN 200 mg/28.5 mg per 5 mL suspension or the AUGMENTIN 400 mg/57 mg per 5 mL suspension may be used in place of the 875 mg/125 mg tablet. b Adults who have difficulty swallowing may be given the AUGMENTIN 125 mg/31.25 mg per 5 mL or AUGMENTIN 250 mg/62.5 mg per 5 mL suspension in place of the 500 mg/125 mg tablet. c Two AUGMENTIN 250 mg/125 mg tablets are NOT substitutable with one 500 mg/125 mg AUGMENTIN tablet [see Dosage and Administration (2.6)]. d AUGMENTIN 250 mg/125 mg tablet is NOT substitutable with AUGMENTIN 250 mg/62.5 mg chewable tablet [see Dosage and Administration (2.6)]
2.3 Pediatric Patients
2.3 Pediatric Patients Based on the amoxicillin component, AUGMENTIN should be dosed as follows: Neonates and Infants Aged less than 12 weeks (less than 3 months): See dosing regimens of AUGMENTIN provided in Table 2 below. Table 2: Dosing Regimens of AUGMENTIN in Neonates and Infants Aged Less than 12 Weeks (Less than 3 Months) PATIENT POPULATION DOSING REGIMEN AUGMENTIN 125 mg/31.25 mg per 5 mL for oral suspension a Neonates and Infants aged less than 12 weeks (less than 3 months) 30 mg/kg/day every 12 hours a Experience with the AUGMENTIN 200 mg/28.5 mg per 5 mL formulation in this age group is limited, and thus, use of the AUGMENTIN 125 mg/31.25 mg per 5 mL for oral suspension is recommended.
Patients Aged 12 weeks (3 months) and Older and Weighing Less than 40 kg: See dosing regimens provided in Table 3 below. The every 12 hour regimen is recommended as it is associated with significantly less diarrhea [see Clinical Studies (14.2)]. The Amoxicillin and Clavulanate Potassium 200 mg/28.5 mg per 5 mL and Amoxicillin and Clavulanate Potassium 400 mg/57 mg per 5 mL) for oral suspension and Amoxicillin and Clavulanate Potassium 200 mg/28.5 mg and Amoxicillin and Clavulanate Potassium 400 mg/57 mg chewable tablets contain aspartame and should not be used by phenylketonurics. [see Warnings and Precautions (5.8)].
Table 3: Dosing in Patients Aged 12 Weeks (3 Months) and Older and Weighing Less than 40 kg Table Patients Weighing 40 kg or More: Pediatric patients weighing 40 kg or more should be dosed according to adult recommendations. The 250 mg/125 mg tablet of AUGMENTIN should NOT be used until the child weighs at least 40 kg, due to the different amoxicillin to clavulanic acid ratios in the 250 mg/125 mg tablet of AUGMENTIN versus the 250 mg/62.5 mg chewable tablet of AUGMENTIN.
2.4 Patients with Renal Impairment
2.4 Patients with Renal Impairment Patients with impaired renal function do not generally require a reduction in dose unless the impairment is severe. Renal impairment patients with a glomerular filtration rate (GFR) of less than 30 mL/min should NOT receive the 875 mg dose (based on the amoxicillin component) of AUGMENTIN.
See dosing regimens in patients with severe renal impairment provided in Table 4. Table 4. Dosing Regimens of AUGMENTIN in Patients with Severe Renal Impairment Patients with Renal Impairment Dosing Regimen GFR 10 mL/min to 30 mL/min 500 mg or 250 mg every 12 hours, depending on the severity of the infection GFR less than 10 mL/min 500 mg or 250 mg every 24 hours, depending on severity of the infection Hemodialysis 500 mg or 250 mg every 24 hours, depending on severity of the infection Administer an additional dose both during and at the end of dialysis
2.5 Directions for Mixing
2.5 Directions for Mixing Amoxicillin and Clavulanate Potassium for Oral Suspension Prepare AUGMENTIN for oral suspension at time of dispensing as follows: Tap bottle until all powder flows freely. Measure a total (see Table 5 below for total amount of water for reconstitution) OF WATER. Add approximately 2/3 of the water to the powder.
Replace cap and shake VIGOROUSLY. Add remaining water. Replace cap and shake VIGOROUSLY. Table 5: Amount of Water for Mixing AUGMENTIN for Oral Suspension Strength of AUGMENTIN Oral Suspension Bottle Size Amount of Water for Reconstitution Contents of Each Teaspoonful (5 mL) 125 mg/31.25 mg per 5 mL 75 mL 100 mL 150 mL 67 mL 90 mL 134 mL 125 mg of amoxicillin and 31.25 mg of clavulanic acid as the potassium salt 250 mg/62.5 mg per 5 mL 75 mL 100 mL 150 mL 65 mL 87 mL 130 mL 250 mg of amoxicillin and 62.5 mg of clavulanic acid as the potassium salt Shake oral suspension well before using.
Reconstituted suspension must be stored under refrigeration and discarded after 10 days. Some color change is normal during dosing period.
2.6 Switching between Dosage Forms and between Strengths
2.6 Switching between Dosage Forms and between Strengths AUGMENTIN 250 mg/125 mg Tablet is NOT Substitutable with AUGMENTIN 250 mg/62.5 mg Chewable Tablet The 250 mg/125 mg tablet of AUGMENTIN and the 250 mg/62.5 mg chewable tablet of AUGMENTIN should NOT be substituted for each other and the 250 mg/125 mg tablet of AUGMENTIN should NOT be used in pediatric patients weighing less than 40 kg [see Dosage and Administration (2.3)]. The 250 mg tablet of AUGMENTIN and the 250 mg chewable tablet of AUGMENTIN do not contain the same amount of clavulanic acid.
The 250 mg tablet of AUGMENTIN contains 125 mg of clavulanic acid whereas the 250 mg chewable tablet of AUGMENTIN contains 62.5 mg of clavulanic acid. Two AUGMENTIN 250 mg/125 mg Tablets are NOT Substitutable with One 500 mg/125 mg AUGMENTIN Tablet Two 250 mg/125 mg tablets of AUGMENTIN should NOT be substituted for one 500 mg/125 mg tablet of AUGMENTIN.
Since both the 250 mg and 500 mg tablets of AUGMNTIN contain the same amount of clavulanic acid (125 mg, as the potassium salt), two 250 mg tablets of AUGMENTIN are not equivalent to one 500 mg tablet of AUGMENTIN.
Dosing: Altered kidney function
Both components are excreted in urine (amoxicillin 50% to 70%, clavulanate 25% to 40% unchanged in 6 hours). The US label needs no dose change unless kidney impairment is severe: below a GFR of 30 mL/min do not use the 875 mg tablet, give 250 or 500 mg every 12 hours (GFR 10–30) or every 24 hours (below 10), and give extra doses during and after hemodialysis. These are oral doses; IV co-amoxiclav is not covered by the US label.
Kidney function measure: Label states GFR in mL/min (not indexed); cut-offs 30 and 10. Shown in the CrCl band rows.
Show full dosing details
- CrCl ≥60 mL/min
- Oral: no dose change (label).
- CrCl 30–59 mL/min
- Oral: no dose change; the label reduces dose only below GFR 30 (label).
- CrCl 15–29 mL/min
- Oral: GFR 10–30: 500 mg or 250 mg (amoxicillin component) every 12 hours by severity; do not use the 875 mg tablet (label). IV co-amoxiclav (for example 1.2 g vials): not covered by the US label, and no EU/UK SmPC is in the database yet; no IV kidney dose is given here. Specialist input.
- CrCl <15 mL/min (not on dialysis)
- Oral: GFR 10–14: 500 mg or 250 mg (amoxicillin component) every 12 hours. GFR below 10: 500 mg or 250 mg (amoxicillin component) every 24 hours by severity. No 875 mg tablet (label). IV co-amoxiclav (for example 1.2 g vials): not covered by the US label, and no EU/UK SmPC is in the database yet; no IV kidney dose is given here. Specialist input.
- Hemodialysis (intermittent)
- Oral: 500 mg or 250 mg (amoxicillin component) every 24 hours by severity, plus an additional dose both during and at the end of dialysis (label). IV co-amoxiclav (for example 1.2 g vials): not covered by the US label, and no EU/UK SmPC is in the database yet; no IV kidney dose is given here. Specialist input.
- Peritoneal dialysis
- Oral and IV: no peritoneal dialysis dosing in label. Specialist input.
- CRRT
- Not in label; the cited CRRT review (Li 2020) gives no regimen for this drug. Specialist input.
- Dialyzable? Yes: may be removed by hemodialysis (label). Low protein binding (amoxicillin about 18%, clavulanate about 25%).
- Monitoring Kidney function for dose; liver tests in hepatic impairment; rash; diarrhea (CDAD); INR with oral anticoagulants (label). Keep fluid intake up at high doses (crystalluria with overdose).
Children (kidney dosing)
Show full dosing details
- eGFR ≥60
- Usual pediatric dose (label).
- eGFR 30–59
- No pediatric kidney dosing in label (the GFR table is not age-specific). Specialist input.
- eGFR 15–29
- No pediatric kidney dosing in label (the GFR table is not age-specific). Specialist input.
- eGFR <15 (not on dialysis)
- No pediatric kidney dosing in label (the GFR table is not age-specific). Specialist input.
- Hemodialysis (intermittent)
- No pediatric kidney dosing in label (the GFR table is not age-specific). Specialist input.
- Peritoneal dialysis
- No pediatric kidney dosing in label (the GFR table is not age-specific). Specialist input.
- CRRT
- No pediatric kidney dosing in label (the GFR table is not age-specific). Specialist input.
Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.
renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.
US label text: Renal impairment US FDA label
2.4 Patients with Renal Impairment Patients with impaired renal function do not generally require a reduction in dose unless the impairment is severe. Renal impairment patients with a glomerular filtration rate (GFR) of less than 30 mL/min should NOT receive the 875 mg dose (based on the amoxicillin component) of AUGMENTIN.
See dosing regimens in patients with severe renal impairment provided in Table 4. Table 4. Dosing Regimens of AUGMENTIN in Patients with Severe Renal Impairment Patients with Renal Impairment Dosing Regimen GFR 10 mL/min to 30 mL/min 500 mg or 250 mg every 12 hours, depending on the severity of the infection GFR less than 10 mL/min 500 mg or 250 mg every 24 hours, depending on severity of the infection Hemodialysis 500 mg or 250 mg every 24 hours, depending on severity of the infection Administer an additional dose both during and at the end of dialysis
8.6 Renal Impairment Amoxicillin is primarily eliminated by the kidney and dosage adjustment is usually required in patients with severe renal impairment (GFR less than 30 mL/min). See Patients with Renal Impairment [see Dosage and Administration (2.4)] for specific recommendations in patients with renal impairment.
Dosing: Pediatric
- Approved ages
- All ages, including neonates (label).
- Usual dose
- Under 12 weeks: 30 mg/kg/day divided every 12 hours, using the 125 mg/5 mL suspension (label). 3 months and older, under 40 kg: 25 to 45 mg/kg/day divided every 12 hours, or 20 to 40 mg/kg/day divided every 8 hours (amoxicillin component); 40 kg or more: adult dose (label).
- Maximum dose
- Adult dose (label).
Kidney dosing in children: see Dosing: Altered kidney function.
renalcarematters.com, reviewedPediatric use (US label) US FDA label
8.4 Pediatric Use The safety and effectiveness of AUGMENTIN for Oral Suspension and Chewable Tablets have been established in pediatric patients. Use of AUGMENTIN in pediatric patients is supported by evidence from studies of AUGMENTIN Tablets in adults with additional data from a study of AUGMENTIN for Oral Suspension in pediatric patients aged 2 months to 12 years with acute otitis media [see Clinical Studies (14.2)].
Because of incompletely developed renal function in neonates and young infants, the elimination of amoxicillin may be delayed; clavulanate elimination is unaltered in this age group. Dosing of Amoxicillin and Clavulanate Potassium should be modified in pediatric patients aged less than 12 weeks (less than 3 months) [see Dosage and Administration (2.3)].
Dosing: Older adult
Geriatric use (US label) US FDA label
8.5 Geriatric Use Of the 3,119 patients in an analysis of clinical studies of AUGMENTIN, 32% were greater than or equal to 65 years old, and 14% were greater than or equal to 75 years old. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
This drug is known to be substantially excreted by the kidney, and the risk of adverse reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.
Administration
2.1 Important Administration Instructions AUGMENTIN may be taken without regard to meals; however, absorption of clavulanate potassium is enhanced when AUGMENTIN is administered at the start of a meal. To minimize the potential for gastrointestinal intolerance, AUGMENTIN should be taken at the start of a meal.
US FDA labelDosage forms
Philippines
- Film-coated tablet: 1 g, 125 mg, 250 mg Clavulanic Acid (as Clavulanate Potassium) 125 mg, 250 mg/125 mg, 375 mg, 500 mg ..125 mg, 500 mg Clavulanic Acid (as Clavulanate Potassium) 125 mg, 500 mg Clavulanic Acid (as Potassium Clavulanate) ................125 mg, 500 mg/125 mg, 625 mg, …
- Powder for suspension: 125 mg/31.25 mg, 125 mg/31.25 mg per 5 mL, 125 mg/31.25 mg/5 mL, 156.25 mg per 5 mL, 156.25 mg/5 mL, 200 mg/28.5 mg, 200 mg/28.5 mg per 5 mL, 228.5 mg per 5 mL, 228.5 mg/5 mL, 228.50 mg per 5 mL, …
- Powder for oral suspension: 5 mL contains: Amoxicillin (as trihydrate) 200 mg Clavulanic acid (as Potassium clavulanate) 28.50 mg, 5 mL of reconstituted suspension contains: Amoxicillin (as trihydrate)-250 mg Clavulanic Acid (as Potassium Clavulanate) -62.5 mg, 156.25 mg per 5 mL, 156.25 mg per 5 mL FORMULATION: Each 5 mL contains: Amoxicillin (as trihydrate) 125 mg equivalent to 131.25 mg Clavulanic Acid (as potassium clavulanate) 31.25 mg equivalent to 33.75 mg, 156.25 mg/5 mL, 156.25 mg/5 mL FORMULATION: Each 5 mL contains: Amoxicillin (as trihydrate)…………………………………....125 mg Clavulanic acid (as potassium clavulanate) ………..................31.25 mg, 200 mg/28.5 mg per 5 mL, 228.5 mg, 228.5 mg/5 mL, 228.50 mg./5 mL, …
- Powder for injection: 1 g Clavulanic acid (as Potassium Clavulanate) ... 200 mg, 1 g/200 mg, 1.2 g, 20 mL Powder for Injection (IV) contains: Amoxicillin (as sodium)..... .1 g Clavulanic Acid (as Potassium Clavulanate)......200 mg, 200 mg, 500 mg/100 mg, 600 mg
- Tablet: 1 g, 250 mg/125 mg, 375 mg, 500 mg/125 mg, 625 mg
- Dispersible tablet: 228.5 mg, 312.5 mg
- Powder for solution for injection: 1 g/200 mg, 1.2 g
- Sterile powder for injection: 1 g/200 mg, 500 mg/100 mg
- Per vial powder for injection: 1 g/200 mg
- Powder for iv injection: 1.2 g
and 4 more forms; see the products table.
Registered products in the Philippines
704 products registered with the Food and Drug Administration (FDA) Philippines list Amoxicillin + Clavulanic acid as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Co - Amoxiclav (6 products). Products registered under these spellings are included in the table and marked.
All registered products704
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Acce-ClavCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Accesspoint International Trading Inc.Importer: Greencore Pharma Inc. | DRP-6810-06 | Feb 7, 2032 | |
AceclavCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE Plastic Bottle with measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Pharmahealth EnterprisesTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-6757-04 | Apr 28, 2029 | |
AceclavCo-Amoxiclav (see reverse for formulation) | 625 mg Film-Coated TabletAlu/Alu Foil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Pharmahealth EnterprisesTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-7048-01 | Aug 30, 2028 | |
AclavCo-Amoxiclav | 1.2 g Powder For Solution For Injection (I.V.)Type I Borosilicate, Clear Transparent Glass Vial With Butyl Rubber Stopper And Aluminum-Plastic Cap (Box of 1's) | Rx | North China Pharmaceutical Co., Ltd.China | AGlobal Care, Inc. | DRP-8105 | Mar 3, 2032 | |
Aclav-625Co-amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | M.K. Pharma Pvt. Ltd.India | Aglobal Care, Inc. | DR-XY47501 | Nov 22, 2026 | |
Airoclav 1.2Co-Amoxiclav | 1 g/200 mg Powder for Injection (IV)USP Type III Glass Vial (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | Speed Cure PharmaImporter: Ambica International Corporation | DRP-4466-04 | May 23, 2028 | |
AlclavCo-Amoxiclav | 642.9mg/5mL Powder For SuspensionTranslucent round mouth HDPE bottle x 80 mL with white Polypropylene screw cap (Box of 1’s) | Rx | Alkem Laboratories LimitedIndia | Alkem Laboratories Corporation | DRP-12320 | Jul 13, 2027 | |
Alclav DS 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 30 mL and 70 mL | Rx | Giyaan Pharma Private LimitedIndia | Alkem Laboratories CorporationImporter: Ambica International Corporation | DRP-5966-08 | Jan 27, 2030 | |
Alclav KidsCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension70 mL (net content) white round HDPE bottle with white HDPE cap and 15 mL capacity measuring cup (Box of 1's) | Rx | Medopharm Private LimitedIndia | Alkem Laboratories CorporationImporter: Aglobal Care, Inc.Trader: Prime Pharmaceuticals Pvt. Ltd. | DRP-11334-03 | Mar 2, 2027 | |
Alclav NeoCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14’s) | Rx | Giyaan Pharma Private LimitedIndia | Alkem Laboratories CorporationImporter: Ambica International Corporation | DRP-5343-04 | Jun 17, 2029 | |
Alclav NeoCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's and 21's) | Rx | Giyaan Pharma Private LimitedIndia | Alkem Laboratories CorporationImporter: AGlobal Care, Inc.Trader: Prime Pharmaceuticals Ltd. | DRP-11728-01 | Oct 29, 2031 | |
AltoclavCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Strip Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Wecare Pharma Corp.Trader: Gamot Philippines, Inc. | DRP-7246-01 | Nov 13, 2029 | |
AltoclavCo-Amoxiclav | 156.25 mg per 5 mLPowder for SuspensionHDPE Plastic Bottle with LDPE Tamper Proof Cap and 20 mL - Capacity PP Plastic Measuring Cap x 60mL | Rx | Lloyd Laboratories, Inc.Philippines | Wecare Pharma Corp.Trader: Gamot Philippines, Inc. | DRP-293-06 | Sep 11, 2031 | |
AltoclavCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic Bottle) with LDPE Tamper Proof Cap & 20 mL Capacity (PP) Plastic Measuring Cap (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Wecare Pharma Corp.Trader: Gamot Philippines, Inc. | DRP-294-09 | Sep 11, 2031 | |
AltoclavCo-Amoxiclav | 400 mg/57 mg per 5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Wecare Pharma Corp.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-06 | Jan 21, 2030 | |
AltoclavCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Wecare Pharma Corp.Trader: Gamot Philippines, Inc. | DRP-615-13 | Apr 2, 2027 | |
AltoclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Strip Packs x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Wecare Pharma Corp.Trader: Gamot Philippines, Inc. | DRP-7485-02 | Jul 4, 2030 | |
AltocomCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL Box of 1's | Rx | Giyaan Pharma Private LimitedIndia | Altomed Pharmaceuticals, Inc.Importer: Ambica International Corporation | DRP-5966-04 | Jan 27, 2030 | |
AltovoxCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Foil Strip Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DRP-7246 | Nov 13, 2029 | |
AltovoxCo-Amoxiclav | 125 mg/31.25 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle with LDPE Tamper Proof Cap and 20 mL - Capacity PP Plastic Measuring Cap x 60mL Not Applicable | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, IncTrader: Gamot Philippines, Inc. | DRP-293-04 | Aug 27, 2031 | |
AltovoxCo-Amoxiclav | 250 mg / 62.5 mg per 5 mL Powder for Oral Suspension60 mL HDPE Bottle with LDPE tamper-proof cap and 20 mL-capacity PP measuring cap (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DRP-294-04 | Aug 26, 2031 | |
AltovoxCo-Amoxiclav | 400 mg/57 mg per 5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-07 | Jan 21, 2030 | |
AltovoxCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionHDPE Plastic Bottle x 70 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DR-XY36189 | Jul 27, 2029 | |
AltovoxCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DRP-615-03 | Apr 2, 2027 | |
AltovoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Strip Packs x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DRP-7485-03 | Jul 4, 2030 | |
Amac-CLCo-Amoxiclav | 1 g/200 mg Powder for Injection (I.V.)USP Type III Clear Glass Vial (Box of 1’s) | Rx | Inject Care Parenterals Pvt. Ltd.India | Suhitas Pharmaceuticals, Inc.Trader: Mac Heal Laboratories, Ltd. | DRP-3205 | Aug 23, 2031 | |
AmamclaCo-amoxiclav | 1.2 g Powder for Injection (IV)USP Type I Glass Vial (Box of 1's) | Rx | Gnana Life Sciences Pvt. Ltd.India | Ambica International Corporation | DRP-3620 | Feb 18, 2028 | |
AmamclaAmoxicillin (as sodium) + Potassium clavulanate (as clavulanic acid) | 500 mg/100 mg Powder for Injection (IV)10 mL USP Type I Glass Vial x 1's in a box | Rx | Gnana Life Sciences Pvt. Ltd.India | Ambica International Corporation | DRP-6052 | Mar 11, 2030 | |
AmbiclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's) | Rx | Stallion Laboratories Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-3087-06 | Jun 27, 2029 | |
AmixloCo-Amoxiclav | 312.5 mg/ 5 mL Powder for Oral Suspension (see reverse for formulation)White HDPE Bottle with measuring cup x 100 mL (Box of 1's) | Rx | Medopharm Private LimitedIndia | Amediqo Phils., Inc.Importer: Medethix, Inc. | DRP-11106-01 | Feb 3, 2027 | |
AmixloCo-Amoxiclav | 312.5mg/ 5mL Powder for Oral Suspension (see reverse for formulation)White HDPE Bottle with measuring cup x 60 mL (Box of 1’s) (Box of 1's) | Rx | Medopharm Private LimitedIndia | Amediqo Phil., Inc.Importer: Medethix, Inc. | DRP-11106-02 | Feb 3, 2027 | |
AmixloCo-Amoxiclav | 457mg/5mL Power for Oral SuspensionHDPE Plastic bottle with 15mL measuring cup x 70mL (Box of 1's) | Rx | Medopharm Private LimitedIndia | Amediqo Phils., Inc.Importer: Medethix, Inc. | DRP-9380-01 | Feb 7, 2032 | |
AmoclavCo-amoxiclav | 1 g Film-coated TabletAlu-Alu Blister Pack x 5's (Box of 10's) | Rx | Bilim Ilaç Sanayi ve Ticaret Anonim ŞirketiTurkey | UNILAB, Inc. | DRP-1059 | Aug 7, 2031 | |
AmoclavCo-Amoxiclav | 1 g/200 mg Powder for Injection (I.V.)USP Type III Glass Vial x 1’s (Box of 1’s) | Rx | Inject Care Parenterals Pvt. Ltd.India | Unilab, Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4466-05 | Aug 19, 2032 | |
AmoclavCo-Amoxiclav | 156.25 mg per 5 mL Powder for Oral SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | UNILAB, Inc.Importer: Sandoz Philippines Corporation | DRP-1613-02 | Nov 12, 2027 | |
AmoclavCo-Amoxiclav | 228.5 mg per 5 mL Powder for Suspension125 mL Amber Glass Bottle x 70 mL (Box of 1's) | Rx | Bilim Ilac San Ve Tic A.S.Turkey | UNILAB, Inc. | DR-XY33485 | Jun 15, 2027 | |
AmoclavCo-Amoxiclav | 312.5 mg per 5 mL Powder for Oral SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | Unilab, Inc.Importer: Sandoz Philippines Corporation | DRP-1614-04 | Nov 11, 2027 | |
AmoclavCo-Amoxiclav | 457 mg per 5 mL Powder for Suspension125 mL Amber Bottle x 70 mL (Box of 1's); 100 mL Amber Bottle x 35 mL (Box of 1's) | Rx | Bilim Ilac San Ve Tic A.S.Turkey | UNILAB, Inc. | DRP-11607 | Jun 15, 2027 | |
AmoclavCo-Amoxiclav | 500 mg/ 100 mg Powder for Injection15 mL USP Type III colorless vial | Rx | Inject Care Parenterals Pvt. Ltd.India | UNILAB, Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-3746-01 | Aug 15, 2027 | |
AmoclavCo-amoxiclav | 625 mg Film-coated TabletAlu/Alu Blister Pack x 5's (Box of 15's) | Rx | Bilim Pharmaceuticals A.S.Turkey | UNILAB, Inc. | DRP-1056 | Aug 7, 2031 | |
Amoclavex 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 14’s) | Rx | Yeluri Formulations Pvt Ltd.India | GA2 Pharmaceutical, IncImporter: Medinova Pharmaceutical, Inc. | DRP-11805-15 | May 5, 2027 | |
AmoclavinCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cap x 70 mL (Box of 1’s) | Rx | Giyaan Pharma Private LimitedIndia | Euroasia Pharmaceuticals, Inc.Importer: AMB HK Enterprises Inc. | DRP-11087-11 | Feb 3, 2027 | |
AmoclavinCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 14’s with Aluminum Pouch) | Rx | Baroque Pharmaceuticals Pvt. Ltd.India | Euroasia Pharmaceuticals, Inc.Importer: AMB HK Enterprises, Inc. | DRP-15030-02 | Mar 21, 2029 | |
AmoClav®Co-Amoxiclav | 600mg/42.9 mg per 5 mL Powder For Oral Suspension (Raspberry Flavor)125 mL Type III Amber Glass Bottle Sealed with Opaque White HDPE Cap and Measuring Spoon x 100mL (net content) (Box of 1's) | Rx | Bilim Ilaç Sanayi Ve Ticaret Anonim ŞirketiTurkey | UNILAB, Inc. | DRP-14714 | Dec 4, 2028 | |
AmocledCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Sapphire Lifesciences Pvt. Ltd.India | 777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc. | DRP-4131-01 | Dec 7, 2027 | |
AmocleedCo-Amoxiclav | Powder for Suspension 156.25 mg per 5 mLBoston Round Amber Bottle x 60 mL (Box of 1’s); Boston Round Amber Bottle x 70 mL (Box of 1’s) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | 777 Red Pharma Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-4131-02 | Dec 7, 2027 | |
AMOICLAVCO-AMOXICLAV | 457 mg/5 mL POWDER FOR SUSPENSIONWHITE TRANSLUCENT HDPE PLASTIC BOTTLE WITH WHITE LDPE FLIP-TOP PLASTIC CAP X 120 mL (70 mL NET CONTENT) AND TRANSLUCENT HDPE PLASTIC MEASURING CUP (BOX OF 1's) | Rx | J.M. TOLMANN LABORATORIES, INC.Philippines | CARE FIRST TRADING | DRP-12192-07 | Sep 2, 2027 | |
AmopenilCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's and 21's); Alu/Alu Blister Pack x 10's (Box of 20's and 30's) . | Rx | Reyoung Pharmaceutical Co., Ltd.China | FSPC Pharmaceuticals, Inc | DRP-14462 | Sep 8, 2028 | |
AmoxilabCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Reyoung Pharmaceutical Co.,Ltd.China | 777 Red Pharma Inc.Importer: Philgen Pharmaceuticals Inc. | DRP-1028-05 | Apr 16, 2031 | |
AmoxinexCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Triple Tact Import & Export Corp.Importer: Greencore Pharma Inc. | DRP-6810-16 | Feb 7, 2032 | |
AmoxirifeCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Stallion Laboratories Pvt. Ltd.India | Rifemedica CorporationImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5407-08 | Jul 30, 2029 | |
AmoxitreneCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Aisec Farma CorporationImporter: Ambica International Corporation | DRP-5966-03 | Jan 27, 2030 | |
AmoxiveeCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Euro-Care Products PhilippinesImporter: Greencore Pharma, Inc. | DRP-6810-02 | Aug 26, 2031 | |
AnloxiclavCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Pharmaxicare Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-16 | Oct 7, 2028 | |
Arclav-625Co-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 10's Packed in One Alu-Alu Pouch (Box of 30's) | Rx | Yeluri Formulations Pvt. Ltd.India | Cassandras Care Pharmaceutical DistributorImporter: Orange Biotec Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6095-05 | Feb 7, 2037 | |
ArmalanicCo-Amoxiclav | Each 20 mL Powder for Injection (IV) contains: Amoxicillin (as sodium)..... .1g Clavulanic Acid (as Potassium Clavulanate)......200 mg Powder for Injection (IV)20 mL-capacity USP type II glass vial with rubber stopper and alu-plastic flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Pharmaessence Inc. | DRP-17019 | Sep 5, 2030 | |
Asiclav-625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s with Aluminum pouch Box of 14’s | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | AMB HK Enterprises Inc. | DRP-8498 | Oct 18, 2029 | |
AsyclavCo-Amoxiclav | 457 mg/5 mL Powder For Oral SuspensionWhite Translucent HDPE plastic bottle with white LDPE Flip-top Plastic Cap x 120 mL (70 mL net content) and translucent HDPE plastic measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | TGIF Pharmaceutical Trading Inc. | DRP-12192-01 | Sep 2, 2027 | |
AsyclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 14’s) | Rx | Yeluri Formulations Pvt Ltd.India | TGIF Pharmaceutical Trading Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11805-13 | May 5, 2027 | |
AtadarCo-Amoxiclav | Each 5 mL contains: Amoxicillin (as trihydrate) 200 mg Clavulanic acid (as Potassium clavulanate) 28.50 mg Powder for Oral SuspensionAmber glass bottle x 50 mL with orange child resistant PE cap (Box of 1's) | Rx | Shin Poong Pharmaceutical Co., Ltd.Korea | Phil Shinpoong Pharma, Inc. | DRP-17406 | Dec 11, 2030 | |
AtadarCo-Amoxiclav | Formulation: Each film-coated tablet contains: Amoxicillin (as trihydrate) Clavulanic acid....... 500 mg ..125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 12's) | Rx | Shin Poong Pharm. Co., Ltd.Korea | Phil. Shinpoong Pharma Inc. | DRP-3575 | Feb 13, 2030 | |
AugetCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 2's (Box of 10's and 14's) | Rx | Sandoz GmbHAustria | Getz Pharma (Phils.), Inc.Importer: Sandoz Philippines Corporation | DRP-1612-02 | Aug 3, 2028 | |
AugetCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 4's (Box of 100's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | Getz Pharma (Phils.), Inc.Importer: Sandoz Philippines Corporation | DRP-1291-03 | Nov 14, 2027 | |
AugetCo-Amoxiclav | 625 mg Film-Coated TabletAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | Getz Pharma (Phils.), Inc.Importer: Sandoz Philippines Corporation | DRP-1614-02 | Nov 11, 2027 | |
AugimoxCo-Amoxiclav | 400 mg/57 mg/5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | D.B. Manix International, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-16 | Jan 21, 2030 | |
Augmeed 228.5 DSCo-Amoxiclav | 228.5 mg/5 mL Powder for Oral SuspensionHDPE Plastic Bottle with 15 mL Measuring Cup x 70 mL and 100 mL (Box of 1's) | Rx | Medopharm Private LimitedIndia | I.E. Medica, Inc.Importer: Medethix, Inc. | DRP-8883 | May 28, 2029 | |
Augmeed 312.5Co-Amoxiclav | Formulation: Each 5 mL of reconstituted suspension contains: Amoxicillin (as trihydrate)-250 mg Clavulanic Acid (as Potassium Clavulanate) -62.5 mg Powder For Oral SuspensionWhite HDPE Bottle with measuring cup x 100mL | Rx | Medopharm Private LimitedIndia | I.E. Medica, Inc.Importer: MedEthix, Inc. | DRP-11106 | Feb 3, 2027 | |
Augmeed 457Co-Amoxiclav | 457mg/5mL Powder for Oral SuspensionHDPE plastic bottle with 15mL measuring cup x 70mL (Box of 1's) | Rx | Medopharm Private LimitedIndia | Meedpharma Medical Supplies & Equipment DistributorImporter: MedEthix, Inc. | DRP-9380 | Dec 16, 2030 | |
AugmentinCo-Amoxiclav (See Reverse For Formulation) | 1 g TabletTropical Blister Foil Box of 14's | Rx | SmithKline Beecham Ltd T\A SmithKline Beecham PharmaceuticalsUnited Kingdom | Importer: GlaxoSmithKline Philippines, Inc. | DRP-8405 | Jul 20, 2027 | |
AugmentinCo-Amoxiclav | 156.25 mg/5 mL Powder for Oral SuspensionClear Glass Bottle x 60 mL (Box of 1's) | Rx | Glaxo Wellcome Production-MayenneFrance | Importer: GlaxoSmithKline Philippines, Inc. | DRP-6476 | Apr 30, 2028 | |
AugmentinCo-Amoxiclav | 228.5 mg per 5 mL Powder For SuspensionType III Clear Colorless Glass Bottle with a HDPE Child Resitant Cap with an induction seal x 70 mL (Box of 1's) | Rx | SmithKline Beecham Ltd. T/A SmithKline Beecham PharmaceuticalsUnited Kingdom | Importer: GlaxoSmithKline Philippines, Inc. | DR-XY24085 | Nov 28, 2027 | |
AugmentinCo-Amoxiclav | 375 mg TabletFoil-wrapped, Blister Pack x 10's (Box of 30's) | Rx | SmithKline Beecham Ltd T\A SmithKline Beecham PharmaceuticalsUnited Kingdom | Importer: GlaxoSmithKline Philippines, Inc. | DR-XY34001 | Dec 4, 2027 | |
AugmentinCo-Amoxiclav | 400 mg/57 mg Powder For Oral SuspensionType III Clear Colorless Glass Bottle with a HDPE Child Resitant Cap with an induction seal (Box of 1's) x 35 mL and 70 mL | Rx | Glaxo Wellcome ProductionFrance | GlaxoSmithKline Philippines, Inc.Trader: N/A | DRP-6477 | Dec 5, 2027 | |
AugmentinCo-amoxiclav | 625 mg TabletAluminum/PVC/PVDC Blister pack inside a desiccated aluminum/laminated pouch x7's (Box of 14's); Aluminum/PVC/PVDC Blister pack inside a desiccated aluminum/laminated pouch x7's (Box of 21's); Aluminum/PVC/PVDC Blister pack inside a desiccated aluminum/laminated pouch x10's (Box of 30's) | Rx | SmithKline Beecham Ltd T\A SmithKline Beecham PharmaceuticalsUnited Kingdom | Importer: GlaxoSmithKline Philippines, Inc. | DRP-6438 | Apr 10, 2028 | |
Augmentin DSCo-Amoxiclav | 312.5 mg/5 mL Powder for Oral SuspensionType III Clear Glass Bottle Sealed with HDPE Child-Resistant Cap and Induction Seal x 60 mL with Plastic Spoon (Box of 1’s) | Rx | Glaxo Wellcome ProductionFrance | GlaxoSmithKline Philippines, Inc.Trader: N/A | DRP-6471 | Oct 19, 2028 | |
Augmentin ESCo-Amoxiclav | 600 mg/42.9 mg per 5 mL Powder for SuspensionClear Glass Bottle x 50 mL and 100 mL | Rx | Glaxo Wellcome ProductionFrance | Importer: GlaxoSmithKline Philippines, Inc. | DR-XY32295 | Sep 2, 2028 | |
Augmin-125Co-Amoxiclav | 125 mg/31.25 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle with LDPE Tamper Proof Cap and 20 mL - Capacity PP Plastic Measuring Cap x 60mL | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Gamot Philippines, Inc. | DRP-293 | Sep 12, 2031 | |
Augmin-250Co-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic Bottle) with LDPE Tamper Proof Cap & 20 mL Capacity (PP) Plastic Measuring Cap (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Basic Pharmaceutical CorporationTrader: Gamot Philippines, Inc. | DRP-294 | Sep 6, 2030 | |
Augmin-457Co-Amoxiclav | 400 mg/57 mg per 5 mL Powder for Oral Suspension70 mL in 120 ml HDPE Plastic Bottle with cap and measuring cup | Rx | Lloyd Laboratories, Inc.Philippines | Basic Pharmaceutical CorporationTrader: Metz Pharmaceuticals, Inc. | DRP-7086-15 | Jan 21, 2030 | |
Augmin-625Co-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's Box of 18's | Rx | Stallion Laboratories Pvt. Ltd.India | Basic Pharmaceutical CorporationImporter: Ambica International Corporation | DRP-3087-16 | Jun 27, 2029 | |
Augmin-625Co-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Basic Pharmaceutical CorporationTrader: Gamot Philippines, Inc. | DRP-615-20 | Apr 2, 2027 | |
AumoxCo-Amoxiclav | 156.25 mg per 5 mL Powder for Oral SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | TGP Pharma Inc.Importer: Sandoz Philippines Corporation | DRP-1613-01 | Nov 12, 2027 | |
AumoxCo-Amoxiclav | 312.5 mg per 5 mL powder for Oral SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | TGP Pharma, Inc.Importer: Sandoz Philippines Corporation | DRP-1614-01 | Nov 11, 2027 | |
AviclavCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic Bottle) with LDPE Tamper Proof Cap & 20 mL Capacity (PP) Plastic Measuring Cap (Box of 1's) | Rx | Lloyd Laboratories, Inc.Bulacan | Westfield Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DRP-294-08 | Sep 6, 2031 | |
AxalavCo-Amoxiclav | 1.2 g Powder for Injection (I.V.)20 mL Capacity USP Type I Tubular Glass Vial with. Grey Butyl Rubber Stopper and Purple (Box of 1's) | Rx | UNI MEDICOLABS INC.India | Greencore Pharma Inc. | DRP-14530 | Oct 3, 2028 | |
AxalavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 6's); Alu/Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Greencore Pharma Inc. | DRP-6810 | Aug 26, 2031 | |
Axalav 457Co-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension100 mL HDPE bottle (Box of 1's) | Rx | Uni MedicolabsIndia | Greencore Pharma Inc. | DRP-16384 | Feb 27, 2030 | |
AxiclavCo-Amoxiclav | 1 g Film-Coated Tablet (see reverse for formulation)Alu/Alu Blister Pack x 6's (Box of 6's and 12's) | Rx | Medopharm Private LimitedIndia | MedEthix, Inc. | DRP-7046 | May 22, 2031 | |
AxiclavCo-amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 6's); Alu/Alu Blister Pack x 6's (Box of 12's) | Rx | Medopharm Pvt. Ltd.India | MedEthix, Inc. | DRP-10090 | May 22, 2028 | |
BacticoxCo-Amoxiclav | 228.5 mg/5 mL Powder for Oral Suspension (Orange Flavor)HDPE Bottle Sealed with Plastic Plug and Cap x 70 mL + 10 mL Measuring Cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-15210-03 | May 28, 2029 | |
Bacticox 125Co-Amoxiclav | 156.25 mg/5 mL Powder for Oral Suspension70 mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1’s) | Rx | Yeluri Formulations Pvt Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-12924-02 | Nov 22, 2027 | |
Bacticox 250Co-Amoxiclav | 312.5 mg/5 mL Powder for Oral Suspension70 mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1’s) | Rx | Yeluri Formulations Pvt Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-12921-03 | Oct 28, 2027 | |
Bacticox 375Co-Amoxiclav | 375 mg Film-Coated TabletAlu/Alu Blister Packs x 7’s (Box of 2 blister packs x 7 tablets) | Rx | Yeluri Formulations Pvt Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-12930-02 | Nov 3, 2027 | |
625 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s [Box of 14's] | Rx | Yeluri Formulations Pvt Ltd.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-11805-06 | May 5, 2027 | ||
BactivCo-Amoxiclav | 1 g/200 mg Sterile Powder for Injection (IV)Sterilized 20 mL Type III Clear Glass Vial with Sterilized Rubber Stopper and Aluminum Seal 1 Vial/Box | Rx | YSS Laboratories Co., Inc.Philippines | Trader: The Cathay Drug Co., Inc. | DRP-390 | Jan 6, 2031 | |
BactivCo-Amoxiclav | 457 mg per 5 mL Powder for Oral Suspension70 mL Amber Glass Bottle with Plastic Syringe (Box of 1's) | Rx | LEK PHARMACEUTICALS D.D.Slovenia | THE CATHAY DRUG CO., INC.Importer: SANDOZ PHILIPPINES CORPORATION | DRP-2274-03 | Jul 18, 2028 | |
BactivCo-Amoxiclav | 457 mg/ 5 mL Powder for Oral SuspensionType III Amber Glass Bottle with screw cap + measuring syringe (Box of 1 - 70 mL capacity x 60 mL net content) (Box of 1's) | Rx | Sandoz GmbHAustria | The Cathay Drug Co., Inc.Importer: Sandoz Philippines CorporationTrader: Hexal AG (a Sandoz Company) | DRP-15113-01 | May 2, 2029 | |
BactivCo-Amoxiclav | 457 mg/ 5 mL Powder for Oral SuspensionHDPE Plastic Bottle with 15 mL Measuring cup x 70 mL (Box of 1's) | Rx | Medopharm Private LimitedIndia | The Cathay Drug Co., Inc.Importer: MedEthix, Inc. | DRP-9380-03 | Dec 16, 2030 | |
BactivCo-Amoxiclav | 500 mg/100 mg Sterile Powder for Injection (IV)Sterilized 10 mL Type III Clear Glass Vial with Sterilized Rubber Stopper and Aluminum Seal (1 Vial/Box) | Rx | YSS Laboratories Co., Inc.Philippines | Trader: The Cathay Drug Co., Inc. | DRP-389 | Jan 6, 2031 | |
Bactiv 1gCo-Amoxiclav | 875 mg/125 mg Film Coated TabletAlu-Alu Blister Pack x 5’s (Box of 15’s) | Rx | Aurobindo Pharma LimitedIndia | The Cathay Drug Co., Inc. | DR-XY39755 | Jul 13, 2031 | |
Bactiv 625Co-Amoxiclav | 500mg/125mg FilmCoated TabletAlu/Alu Blister Pack x 5’s (Box of 15’s) | Rx | Aurobindo Pharma LimitedIndia | The Cathay Drug Co., Inc. | DR-XY39756 | Jul 13, 2031 | |
BactoclavCo-Amoxiclav | 500 mg/125 mg TabletAluminum Strip Foil x 6's Box of 48's; Aluminum Strip Foil x 14's (Box as Compliance Pack) | Rx | Micro Labs LimitedIndia | Zuellig Pharma CorporationImporter: OEP Philippines, Inc. | DRP-14435 | Jan 25, 2029 | |
BioclavidCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 2's (Box of 10's and 14's) | Rx | Sandoz GmbHAustria | Sandoz Philippines Corporation | DRP-1612 | Aug 3, 2028 | |
BioclavidCo-Amoxiclav | 1.2 g Powder for Injection (IV)Type II Colorless Glass Vial (Box of 1's) | Rx | Sandoz GmbH (Organisationseinheit/ Business Unit Anit-Infectives FDF (AI-FDF Kundl)Austria | Importer: Sandoz Philippines Corporation | DRP-5048 | Jun 23, 2029 | |
BioclavidCo-Amoxiclav | 156.25 mg per 5 mL Powder for Oral SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | Importer: Sandoz Philippines Corporation | DRP-1613 | Nov 12, 2027 | |
BioclavidCo-Amoxiclav | 375 mg Film-Coated TabletFoil Strip x 4's (Box of 48's and 100's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | Importer: Sandoz Philippines Corporation | DRP-1371 | Mar 7, 2028 | |
BioclavidCo-Amoxiclav | 457 mg per 5 mL Powder for Oral Suspension70 mL Amber Glass Bottle with Plastic Syringe (Box of 1's) | Rx | Lek Pharmaceuticals D.D.Slovenia | Importer: Sandoz Philippines Corporation | DRP-2274 | Jul 18, 2028 | |
BioclavidCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension70 mL Amber Glass Bottle with Plastic Syringe | Rx | Sandoz GmbHAustria | Sandoz Philippines Corporation.Trader: Hexal AG (a Sandoz Company) | DRP-15113 | May 2, 2029 | |
BioclavidCo-Amoxiclav | 500 mg/100 mg Powder for Injection (IV)USP Type II Glass Vial Closed with Rubber Stopper and Flip-off Crimpseal x 20 mL (Box of 1's) | Rx | Sandoz GmbHAustria | Importer: Sandoz Philippines Corporation | DRP-5077 | Nov 11, 2029 | |
BioclavidCo-Amoxiclav | 625 mg Film-Coated TabletFoil Strip x 4's (Box of 100's and 40's); Foil Strip x 3's (Box of 15's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | Importer: Sandoz Philippines Corporation | DRP-1291 | Nov 14, 2027 | |
Bioclavid ForteCo-Amoxiclav | 312.5 mg per 5 mL Powder for Oral SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | Importer: Sandoz Philippines Corporation | DRP-1614 | Nov 11, 2027 | |
BluemoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Bluecore Philippines Inc.Importer: Greencore Pharma Inc. | DRP-6810-12 | Jan 23, 2032 | |
BQMOXCo-Amoxiclav | 457 mg/5 mL Powder For SuspensionAmber glass bottle with polypropylene cap and measuring cup x 70 mL (Box of 1's) | Rx | Baroque Pharmaceuticals Pvt. Ltd.India | AMB HK Enterprises Inc. | DRP-18534 | Jul 28, 2031 | |
Bravoks-625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's in a complex film aluminum pouch (Box of 14's) | Rx | Giyaan Pharma Pvt. Ltd.India | AMB HK Enterprises Inc.Importer: PhilRx Pharma Inc. | DRP-4771-01 | Oct 2, 2028 | |
Care ClavCo-Amoxiclav | 1.2 g Powder for Injection (IV)20 mL (net content) USP Type I glass vial with bromobutyl rubber stopper and aluminum seal, and white flip-off cap (Box of 30's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Suhitas Pharmaceuticals Inc. | DRP-16479 | Mar 25, 2030 | |
CassaclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | Cassandras Care Pharmaceutical DistributorImporter: Medinova Pharmaceutical Inc. | DRP-11805-03 | May 5, 2027 | |
Cassaclav - 312Co-Amoxiclav | 312.5 mg/5 mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1’s) | Rx | Yeluri Formulations Pvt Ltd.India | Cassandras Care Pharmaceutical DistributorImporter: Medinova Pharmaceutical Inc. | DRP-12921-08 | Oct 28, 2027 | |
Cassaclav-457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL (Box of 1’s) | Rx | Giyaan Pharma Private LimitedIndia | Cassandras Care Pharmaceutical DistributorImporter: Ambica International Corporation | DRP-5966-29 | Jan 27, 2030 | |
CassanoxiclavCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Cassandras Care Pharmaceutical DistributorImporter: Ambica International Corporation | DRP-5966-13 | Jan 27, 2030 | |
Cassanoxiclav-ARCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 6's ; Alu/Alu Blister Pack x 7's Box of 6's and Box of 21's | Rx | Uni MedicolabsIndia | Cassandras Care Pharmaceutical DistributorImporter: Greencore Pharma Inc. | DRP-6810-08 | Feb 8, 2032 | |
CavumoxCo-Amoxiclav | 1 g Film-coated tabletAlu/Alu Blister Pack x 3's Box of 15's | Rx | SIAM BHEASACH CO., LTD.Thailand | MG PRIME PHARMACEUTICAL INC.Importer: ATLANTIC PHARMACEUTICALS INC. | DR-XY34843 | Jan 20, 2029 | |
CavumoxCo-Amoxiclav | 1.2 g Powder for Injection (I.V.)USP Type I Clear Glass Vial (Box of 1's) | Rx | Siam Bheasach Co., Ltd.Thailand | MG Prime Pharmaceutical, Inc.Importer: Atlantic Pharmaceuticals, Inc. | DR-XY44173 | Feb 16, 2030 | |
CavumoxCo-Amoxiclav | 625 mg Film-coated TabletAlu/Alu Blister Pack x 3's (Box of 15's) | Rx | SIAM BHEASACH CO., LTD.Thailand | MG PRIME PHARMACEUTICAL INC.Importer: ATLANTIC PHARMACEUTICALS INC. | DR-XY34842 | Jan 20, 2029 | |
ClabizaCo-Amoxiclav | 1.2g Powder for Injection (IV)Type II Clear and colorless glass vial Box of 10's | Rx | Laboratorio Reig Jofre S.A.Spain | Penta Labs Australia (Philippines) | DRP-5861 | Jun 1, 2031 | |
ClamovidCo-Amoxiclav | 125 mg/31.25 mg/5 mL Powder for SuspensionType III Amber Glass Bottle with Plastic Measuring Spoon x 100 mL Box of 1's | Rx | Bilim PharmaceuticalsTurkey | Hovid Inc.Trader: Hovid Bhd. | DR-XY30772 | May 23, 2030 | |
ClamovidCo-Amoxiclav | 500 mg/125 mg TabletAlu/Alu Blister pack x 5's (Box of 15's) | Rx | Bilim PharmaceuticalsTurkey | Hovid Inc. | DR-XY30767 | May 18, 2030 | |
ClamoxidCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Giyaan Pharma Private LimitedIndia | Altomed Pharmaceuticals, Inc.Importer: Ambica International Corporation | DRP-5343-06 | Jun 17, 2029 | |
ClamoxidCo-Amoxiclav | 875 mg/ 125 mg Film-Coated TabletAlu-Alu Foil Strip x 8’s (Box of 8’s) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I – Solid Oral Dosage Facility)India | Altomed Pharmaceuticals, Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4230-01 | Feb 14, 2028 | |
Clamoxmed 125Co-Amoxiclav | 156.25 mg/5 mL Powder for Oral Suspension70 mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1’s) | Rx | Yeluri Formulations Pvt. Ltd.India | Skymed Pharma DistributorImporter: Medinova Pharmaceutical Inc. | DRP-13800-05 | Nov 22, 2027 | |
Clamoxmed 250Co-Amoxiclav | 312.5 mg/5 mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1’s) | Rx | Yeluri Formulations Pvt Ltd.India | Skymed Pharma DistributorImporter: Medinova Pharmaceutical Inc. | DRP-12921-07 | Oct 28, 2027 | |
Clamoxmed 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) [Box of 14's] | Rx | Yeluri Formulations Pvt Ltd.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-11805-07 | May 5, 2027 | |
ClamoxtabCo-Amoxiclav | 625 mg Film-Coated Tablet (See reverse for formulation)Alu-Alu Blister Pack x 10’s Box of 10’s | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Red Drug Pharmaceutical Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4135-02 | Dec 12, 2027 | |
Clanav 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber Glass Bottle x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Rexmed Pharmaceutical SalesImporter: Ambica International Corporation | DRP-5966-16 | Jan 27, 2030 | |
Clavaxie 312.5 DTCo-Amoxiclav | 312.5 mg Dispersible TabletAluminum foil strip x 10's (Box of 10's) | Rx | Medopharm Private LimitedIndia | MedEthix, Inc. | DRP-9472 | Jan 13, 2031 | |
Clavaxie-DTCo-amoxiclav | 228.5 mg Dispersible TabletAluminum Foil Strip pack of 10's (Box of 30's) | Rx | Medopharm Private LimitedIndia | MedEthix, Inc. | DRP-8335 | Aug 15, 2029 | |
ClavcoCo-Amoxiclav | 457 mg/ 5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cup x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | FSPC Pharmaceuticals Inc.Importer: AMB HK Enterprises Inc. | DRP-11087-01 | Feb 3, 2027 | |
ClaventinCo-Amoxiclav | 625 mg TabletAluminum Foil Strip x 10 Tablets (Box of 30's) | Rx | Pt. Dankos FarmaIndonesia | Lakeside Pharmaceuticals Phil., Inc.Trader: PT. Kalbe Farma Tbk | DR-XY28822 | Jul 28, 2028 | |
ClaverobCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Stallion Laboratories Pvt. Ltd.India | RSG Pharma TradingImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5407-06 | Jul 30, 2029 | |
ClavexinCo-Amoxiclav | 125 mg/31.25 mg per 5 ml Powder for SuspensionHDPE Plastic Bottle w/ LDPE Tamper Proof Cap and 20 mL - Capacity PP Plastic Measuring Cap x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | D.B. Manix International, Inc.Trader: Gamot Philippines, Inc. | DRP-293-03 | Sep 11, 2031 | |
ClavexinCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic Bottle) with LDPE Tamper Proof Cap & 20 mL Capacity (PP) Plastic Measuring Cap (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | D.B. Manix International, Inc.Trader: Gamot Philippines, Inc. | DRP-294-03 | Aug 26, 2031 | |
ClavfirstCo-Amoxiclav | 457 mg per 5 mL Powder for SuspensionHDPE Bottle x 70 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Firstmed Theraconcept Inc. | DRP-6306 | Jan 26, 2030 | |
Clavibact 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | GA2 Pharmaceutical, Inc.Importer: Medinova Pharmaceutical, Inc. | DRP-11805-16 | May 5, 2027 | |
ClavicCo-Amoxiclav | 125 mg/ 31.25 mg per 5 mL Powder for suspensionHDPE Plastic Bottle x 60 mL Box of 1's | Rx | Lloyd Laboratories, Inc.Philippines | Vitalink Health Products, Inc.Trader: Aldril Pharmaceuticals, Inc. | DRP-941-01 | Apr 1, 2028 | |
ClavicCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionPlastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Vitalink Health Products, Inc.Trader: Aldril Pharmaceuticals, Inc. | DRP-942-02 | Dec 18, 2027 | |
ClavicCo-Amoxiclav | 400 mg/57 mg/5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-01 | Jan 21, 2030 | |
ClavicCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 60's) | Rx | Lloyd Laboratories, Inc.Philippines | Vitalink Health Products, Inc. | DRP-3603-03 | Feb 24, 2029 | |
ClavicinCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | CELOGEN PHARMA PVT. LTD.India | HEALTHWINDS MEDICAL TRADING CORP.Importer: PHARMASTAR INT'L TRADING CORP. | DRP-7156-01 | May 19, 2029 | |
ClavifrontCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's Box of 14's | Rx | Stallion Laboratories Pvt. Ltd.India | Frontida Pharmaceutical IncorporatedImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5407-09 | Jul 30, 2029 | |
ClavimargeCo-Amoxiclav | 457 mg/5 mL Powder for Oral SuspensionHDPE plastic bottle with 15 mL measuring cup x 70 mL (Box of 1's) | Rx | Medopharm Private LimitedIndia | Vitalife Pharma & Medical Supply Inc.Importer: Medethix, Inc. | DRP-9380-02 | Nov 24, 2031 | |
ClavimargeCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Reyoung Pharmaceutical Co., Ltd.256100 P.R. China | Vitalife Pharma and Medical Supply Inc.Importer: Philgen Pharmaceuticals Inc. | DRP-1028-07 | Mar 12, 2031 | |
ClavimoxCo-amoxiclav | 1.2 g Powder for Injection (IM/IV)USP Type I Clear Colorless Glass Vial with Yellow Flip-Off Seal (Box of 1's) | Rx | Swiss Parenterals Pvt. Ltd.India | Endure Medical, Inc. | DR-XY35687 | Apr 16, 2029 | |
ClavinCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE Plastic Bottle with measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Vincare PharmaTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-6757-03 | Apr 28, 2029 | |
ClavinCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Foil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Vincare PharmaTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-7048-02 | Aug 30, 2028 | |
ClavinyxCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's) | Rx | Stallion Laboratories Pvt. Ltd.India | GX International, Inc.Importer: Ambica International Corporation | DRP-3087-08 | Jun 27, 2029 | |
ClavipedCo-Amoxiclav | 457 mg / 5 mL Powder for Suspension70 mL Amber Bottle with aluminumcap and measuring cup (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Pediawell Pharma Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-14019-07 | Jun 6, 2028 | |
ClavisarCo-Amoxiclav | 1 g/200 mg Powder for Injection (IV)USP Type I Clear Glass Vial x 10 mL (Box of 1's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Geofman Pharmaceuticals Subic, Inc.Importer: Sahar International Trading, Inc. | DRP-6801-01 | Sep 13, 2028 | |
ClavisarCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack of 6's (Alu pouch x 12's); Alu-Alu Blister Pack of 7's (Box of 14's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co. Ltdhebei Province China | Geofman Pharmaceuticals Subic Inc.Importer: Sahar International Trading Inc | DRP-2645-01 | Jun 18, 2031 | |
Clavistan-625Co-Amoxiclav | 625 mg Film-Coated TabletIndividually Boxed Alu/Alu Blister Pack x 10's (Box of 50's) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-2159 | Jun 22, 2029 | |
ClavixoCo-Amoxiclav | Formulation: Each vial contains: Amoxicillin (as sodium) lg Clavulanic acid 200 mg Powder for Injection (IV)20 mL Type I Clear Glass Vial Sealed with Gray Bromobutyl Rubber Stopper and Blue Aluminum Flip- Off Seal Cap x 1's 20 mL Sterile Water for Injection in Clear Glass Ampoule (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | FSPC Pharmaceuticals, Inc. | DRP-14238 | Aug 2, 2028 | |
Clavmarck (Denied BNC Control number: D-49525)Co-Amoxiclav | 457.5 mg per 5 mL Powder for Suspension75 mL (35 mL net content) and 130 mL (70 mL net content) Round Amber Glass Bottle sealed with white PP cap (Box of 1's) | Rx | Techno Drugs Ltd.Bangladesh | Promarck Pharma and Medical Supplies TradingImporter: Bridgemark Marketing | DRP-4201-0 | Nov 11, 2029 | |
Clavmari-1200Co-Amoxiclav | 1.2 g Powder for Injection (IV)20 mL Glass Vial with Rubber Stopper and Aluminum Flip-off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-10975 | Dec 28, 2031 | |
Clavmari-600Co-Amoxiclav | 600 mg Powder for Injection (IV)10 mL Glass Vial with Rubber Stopper and Aluminum Flip-off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-10976 | Dec 28, 2031 | |
ClavMaxCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Dreamax IncorporatedImporter: Suhitas Pharmaceuticals Inc. | DRP-1077-13 | Oct 7, 2028 | |
ClavmedCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE Plastic Bottle with measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Vamsler Phils. Inc.Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-6757-01 | Apr 28, 2029 | |
ClavmedCo-Amoxiclav | 457 mg/5 mL Powder for Suspension70 mL net content in 120 mL HDPE Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DRP-8313 | Jan 27, 2030 | |
ClavmentinCo-Amoxiclav | 1.2g Powder for Injection (I.V)USP Type II Clear Glass Vial x 1.2g (Box of 1's and 10's) | Rx | 2 World LaboratoriesIndia | 2 World Traders Subic Inc. | DR-XY38434 | Aug 25, 2030 | |
ClavmetzCo-Amoxiclav | 400 mg/57 mg /5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with Cap and Measuring Cup | Rx | Lloyd Laboratories, Inc.Philippines | Gamot Philippines, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-04 | Jan 21, 2030 | |
ClavmexCo-Amoxiclav | 312.5 mg per 5 mL Powder for Oral Suspension (see reverse for formulation)HDPE White Plastic Bottle x 60 mL Box of 1's | Rx | Lloyd Laboratories, Inc.Philippines | Gold Life Distribution Phils. Inc.Trader: Euro-Health Care Exponents, Inc. | DR-XY32936 | Aug 22, 2027 | |
ClavmoxCo-Amoxiclav | 500 mg/ 125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DRP-615-19 | Apr 2, 2027 | |
ClavmoxwelCo-Amoxiclav | 875 mg/125 mg Film-Coated TabletAlu/Alu Foil Strip x 8's (Box of 8's) | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4230 | Feb 14, 2028 | |
Clavmoxwel-156.25Co-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle x 30 mL, 60 mL and 100 mL (Box of 1's) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility)India | Diafarm, Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4231 | Feb 14, 2028 | |
Clavmoxwel-375Co-Amoxiclav | 375 mg Film-Coated Tablet (see reverse for formulation)Alu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)India | Diafarm Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4134 | Dec 7, 2027 | |
Clavmoxwel-625Co-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 10’s) | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Guimhealth Pharmaceutical Distributor & DrugstoreImporter: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4135 | Dec 12, 2027 | |
ClavobacCo-Amoxiclav | 228.5 mg/5 mL Powder for Suspension70 mL (net content) in 120 mL HDPE Bottle | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Transcend Phils., Inc. | DRP-7628 | Jan 27, 2030 | |
ClavocureCo-Amoxiclav | 625 mg Film-Coated TabletAlu / Alu Blister Pack x 7’s [Box of 14’s] | Rx | Yeluri Formulations Pvt. Ltd.India | New Seammed Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11805-12 | May 5, 2027 | |
ClavogenCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension (see reverse for formulation)70 mL (net content) white round HDPE bottle with white HDPE cap and 15 mL capacity measuring cup (Box of 1's) | Rx | Medopharm Private LimitedIndia | Genace Pharma DistributorImporter: Aglobal Care, Inc.Trader: Prime Phamaceuticals Pvt. Ltd. | DRP-11334-01 | Mar 2, 2027 | |
Clavogen-625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's and 21's) | Rx | Giyaan Pharma Pvt. Ltd.India | Genace Pharma DistributorImporter: AGlobal Care, Inc.Trader: Prime Pharmaceuticals Ltd. | DRP-11728-02 | Oct 29, 2031 | |
ClavolinkCo-Amoxiclav | 400 mg/57 mg/5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Vitalink Health Products, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-13 | Jan 21, 2030 | |
ClavomaxCo-amoxiclav | 600 mg Powder for Injection (IM/IV)USP Type I clear glass vial (Box of 10's) | Rx | Harbin Pharmaceutical Group Co. Ltd. General Pharm. FactoryChina | Endure Medical, Inc. | DRP-1428 | Jul 24, 2028 | |
ClavomexCo-Amoxiclav | 457 mg/5 mL Powder for Oral SuspensionWhite Translucent HDPE plastic bottle with white LDPE Flip-top Plastic cap x 120 mL (70 mL net content) and translucent HDPE plastic measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | CHMI Pharma, Inc. | DRP-12192-02 | Sep 2, 2027 | |
Clavomoxyl 125Co-Amoxiclav | 156.25 mg / 5 mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1’s) | Rx | Yelluri Formulations Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-13800-04 | Nov 22, 2027 | |
Clavomoxyl 228Co-Amoxiclav | 228.5 mg/5 mL Powder for Oral Suspension (Orange Flavor)HDPE Bottle Sealed with Plastic Plug and Cap x 70 mL + 10 mL Measuring Cup (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-15210-04 | May 28, 2029 | |
Clavomoxyl 250Co-Amoxiclav | 312.5 mg/5 mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1’s) | Rx | Yeluri Formulations Pvt. Ltd.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-12921-06 | Oct 28, 2027 | |
Clavomoxyl 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 14’s) | Rx | Yeluri Formulations Pvt Ltd.India | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-11805-11 | May 5, 2027 | |
ClavopharmCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber Glass Bottle x 70 mL | Rx | Giyaan Pharma Private LimitedIndia | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-5966-22 | Jan 27, 2030 | |
CLAVOPPEXCO-AMOXICLAV | 457 MG PER 5 ML POWDER FOR SUSPENSIONHDPE PLASTIC BOTTLE X 70 ML (BOX OF 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | APPEX MD'S PHARMACEUTICALS INC. | DRP-6174-08 | Dec 15, 2029 | |
Clavoranex 457Co-Amoxiclav | 457mg/5mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Bottle with Plastic Plug and Screw Cap + 10 mL Measuring Cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Regimed Pharmaceutical DistributorImporter: Medinova Pharmaceutical, Inc. | DRP-17475-01 | Jan 7, 2031 | |
ClavorilzCo-Amoxiclav | 250 mg/ 62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic) Bottle with LDPE Tamper Proof Cap & 20 mL Capacity PP (Plastic) Measuring Cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Marilz Pharmaceuticals CorporationTrader: Gamot Philippines, Inc. | DRP-294-11 | Aug 26, 2031 | |
ClavorilzCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Marilz Pharmaceuticals CorporationTrader: Gamot Philippines, Inc. | DRP-615-14 | Apr 2, 2027 | |
ClavoxelCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Innogen Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-10904-05 | Dec 17, 2031 | |
ClavoxelCo-Amoxiclav | 125 mg / 31.25 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-15102 | Apr 1, 2028 | |
ClavoxelCo-Amoxiclav | 125 mg/31.25 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DR-XY28469 | Apr 1, 2028 | |
ClavoxelCo-Amoxiclav | 250 mg/ 125 mg Film-Coated TabletFoil Strip x 8's (Box of 24's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-15103 | Dec 18, 2027 | |
ClavoxelCo-Amoxiclav | 250 mg/125 mg Film-Coated TabletFoil Strip x 8's (Box of 24's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DR-XY28164 | Dec 18, 2027 | |
ClavoxelCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionLDPE Plastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DR-XY28161 | Dec 18, 2027 | |
ClavoxelCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionLDPE Plastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-15124 | Dec 18, 2027 | |
ClavoxelCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-5563 | Jan 28, 2028 | |
Clavoxel-BIDCo-Amoxiclav | 228.5 mg per 5 mL Powder for Suspension120 mL White Opaque HDPE bottle x 70 mL (net content) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DR-XY36099 | Jul 1, 2029 | |
Clavoxel-BIDCo-Amoxiclav | 457 mg per 5 mL Powder for Suspension120 mL HDPE Bottle x 70 mL with Measuring Cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DR-XY41086 | Jul 26, 2027 | |
Clavoxel-BIDCo-Amoxiclav | 457 mg per 5 mL Powder for Suspension120 mL HDPE Bottle x 70 mL with Measuring Cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-12822 | Jul 26, 2027 | |
Clavoxsea 1000Co-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister pack x 7's (Box of 2 Alu pouches x 7 tablets) | Rx | Yeluri Formulations Pvt. Ltd.India | Seapharma International, Inc. | DRP-14523 | Jun 2, 2027 | |
Clavoxsea 228.5Co-Amoxiclav | 228.5 mg Powder For Oral SuspensionHDPE bottle with PP screw cap x 100 mL + measuring cup (Box of l’s) | Rx | Yeluri Formulations Pvt. Ltd.India | Seapharma International, Inc. | DRP-12099 | Jun 10, 2027 | |
Clavoxsea 375Co-Amoxiclav | Formulation: Each Tablet contains Amoxicillin (as trihydrate) 250 mg Clavulanic Acid (as Clavulanate Potassium) 125 mg Film-Coated TabletAlu/Alu Blister pack x 7's (Box of 2 Alu pouches x 7 tablets) | Rx | Yeluri Formulations Pvt. Ltd.India | Seapharma International, Inc. | DRP-12018 | May 31, 2027 | |
Clavoxsea 457Co-Amoxiclav | 457 mg Powder for Oral SuspensionHDPE bottle x 100 mL with PP screw cap + measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Seapharma International, Inc. | DRP-12100 | Jun 10, 2027 | |
Clavoxsea 625Co-Amoxiclav | Formulation: (CPR at the back) Each Tablet contains Amoxicillin (as trihydrate) 500 mg Clavulanic Acid (as Clavulanate Potassium) 125 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 2 Alu pouches x 7 tablets) | Rx | Yeluri Formulations Pvt. Ltd.India | Seapharma International, Inc. | DRP-12017 | May 31, 2027 | |
ClavoxsurCo-Amoxiclav | 1g/200mg Powder for Injection (IM/IV)Type II Glass Vial with Butyl Rubber Stopper and Aluminum Flip-off Cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Pharma-Surrey International, Inc. | DRP-10894 | Dec 14, 2031 | |
ClavoxtinCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | 228 Pharma TradingImporter: Ambica International Corporation | DRP-5966-02 | Jan 27, 2030 | |
ClavoxtinCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Stallion Laboratories Pvt. Ltd.India | 228 Pharma TradingImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5407-02 | Jul 30, 2029 | |
ClavquestCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxcillin + 62.5 mg Clavulanic Acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Health-Quest Pharma And Medical Supplies TradingImporter: Suhitas Pharmaceuticals Inc. | DRP-1092-15 | Oct 14, 2028 | |
ClavquestCo-Amoxiclav | 457 mg / 5 mL Powder for Suspension70 mL Amber Bottle with aluminum cap and measuring cup (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Health-Quest Pharma and Medical Supplies TradingImporter: Suhitas Pharmaceuticals Inc. | DRP-14019-08 | Jun 6, 2028 | |
ClavquestCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Health-Quest Pharma and Medical Supplies TradingImporter: Suhitas Pharmaceuticals Inc. | DRP-1077-24 | Oct 7, 2028 | |
ClavronCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 6's); Alu/Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Ellebasy Medicale TradingImporter: Greencore Pharma Inc. | DRP-6810-03 | Feb 1, 2032 | |
Clavsave-457Co-Amoxiclav | 457 mg / 5mL Powder for Oral Suspension70 mL (net content) white round HDPE bottle with white HDPE cap and 15 mL capacity measuring cup (Box of 1 ’s) | Rx | Medopharm Private LimitedIndia | Savelink Pharma and Trading Co.,Importer: Aglobal Care Inc.Trader: Prime Pharmaceuticals Pvt. Ltd. | DRP-11334-06 | Mar 2, 2027 | |
ClavsefCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic Bottle) with LDPE Tamper Proof Cap & 20 mL Capacity (PP) Plastic Measuring Cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Euro-Health Care Exponents, Inc.Trader: Gamot Philippines, Inc | DRP-294-12 | Sep 11, 2031 | |
ClavsefCo-Amoxiclav | 400 mg/57 mg/5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Euro-Health Care Exponents, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-08 | Jan 21, 2030 | |
ClavsinCo-Amoxiclav | 125 mg/31.25 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle with LDPE Tamper Proof Cap and 20 mL - Capacity PP Plastic Measuring Cap x 60mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | TGP Pharma Inc.Trader: Gamot Philippines, Inc. | DRP-293-01 | Aug 27, 2031 | |
ClavsinCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic ) Bottle with LDPE Tamper Proof Cap & 20 mL Capacity PP ( Plastic ) Measuring Cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | TGP Pharma Inc.Trader: Gamot Philippines, Inc. | DRP-294-01 | Aug 26, 2031 | |
ClavsinCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | TGP Pharma, Inc.Trader: Gamot Philippines, Inc. | DRP-615 | Apr 2, 2027 | |
Clavtri 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's Box of 14's | Rx | Giyaan Pharma Private LimitedIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-5357-03 | Jun 20, 2029 | |
ClavubacCo-Amoxiclav | 457 mg/5 mL Powder for Oral SuspensionWhite Translucent HDPE plastic bottle with white LDPE Flip-top Plastic Cap x 120 mL (70 mL net content) and translucent HDPE plastic measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | — | DRP-12192 | Sep 2, 2027 | |
ClavuclavCo-Amoxiclav | 1 g/200 mg Powder for Injection (IV)USP Type III Glass Vial (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | Labmate Pharma Inc.Importer: Ambica International Corporation | DRP-4466-01 | May 23, 2028 | |
ClavuclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's) | Rx | Stallion Laboratories Pvt. Ltd.India | Labmate Pharma Inc.Importer: Ambica International Corporation | DRP-3087-11 | Jun 27, 2029 | |
ClavugenCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11805-02 | May 5, 2027 | |
Clavugen-375Co-Amoxiclav | 375 mg Film-Coated TabletAlu/Alu Blister Packs x 7's (Box of 2 Blister Packs x 7 Tablets) | Rx | Yeluri Formulations Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-12930-01 | Nov 5, 2027 | |
ClavulifeCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s); Alu/Alu Blister Pack 2 x 7’s (Box of 14's); Alu/Alu Blister Pack 3 x 7’s (Box of 21’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Life and Health Source Pharmaceutical Distribution Co.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-28 | Oct 7, 2028 | |
Clavulife 125Co-Amoxiclav | 156.25 mg/5mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | Life And Health Source Pharmaceutical Distribution Co.Importer: Medinova Pharmaceutical Inc. | DRP-13800-02 | Nov 22, 2027 | |
Clavulife 250Co-Amoxiclav | 312.5 mg / 5 mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | Life and Health Source Pharmaceutical Distribution Co.Importer: Medinova Pharmaceutical Inc. | DRP-12921-04 | Oct 28, 2027 | |
Clavulife 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Yeluri Formulations Pvt Ltd.India | Life And Health Source Pharmaceutical Distribution Co.Importer: Medinova Pharmaceutical Inc. | DRP-11805-08 | May 5, 2027 | |
ClavunolCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 10's Packed in One Alu-Alu Pouch (Box of 30's) | Rx | Yeluri Formulations Pvt. Ltd.India | Largen Med Inc.Importer: Orange Biotec Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6095-06 | Feb 7, 2030 | |
ClavustanCo-Amoxiclav | 457 mg/5 mL Powder for Oral SuspensionWhite Translucent HDPE plastic bottle with white LDPE Flip-top Plastic Cap x 120 mL (70 mL net content) and translucent HDPE plastic measuring cup (Box of 1’s) | Rx | J.M. Tolmann Laboratories,Inc.Philippines | Westfield Pharmaceuticals, Inc. | DRP-12192-05 | Sep 2, 2027 | |
ClavutecCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack of 7's (Box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | Greentech Life Sciences Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11805-05 | May 5, 2027 | |
ClavuxelCo-Amoxiclav | 228.50 mg per 5 mL Powder for Suspension (see reverse for formulation)White Round Opaque HDPE Plastic Bottle x 70 mL with measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY42810 (For Export Only) | Oct 14, 2028 | |
ClavuxelCo-Amoxiclav | 457 mg per 5 mL Powder for Suspension (see reverse for formulation)HDPE Plastic Bottle x 70 mL with LDPE cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY44328 (For Export Only) | Mar 13, 2030 | |
CLAVWELLCo-Amoxiclav | 457 MG PER 5 ML POWDER FOR SUSPENSIONHDPE PLASTIC BOTTLE X 70 ML Box of 1's | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | CASTELLANO DRUG | DRP-6174-05 | Dec 15, 2029 | |
ClavwellCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Castellano DrugImporter: Suhitas Pharmaceuticals Inc. | DRP-1077-14 | Oct 7, 2028 | |
ClavxicureCo-Amoxiclav | 457 mg/ 5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cup x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Curecare Pharmaceutical Products DistributionImporter: AMB HK Enterprises Inc. | DRP-11087-03 | Feb 3, 2027 | |
ClavxytinCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber Glass Bottle x 70 mL Box of 1's | Rx | Giyaan Pharma Private LimitedIndia | Singtern Pharmaceuticals DistributorImporter: Ambica International Corporation | DRP-5966-12 | Jan 27, 2030 | |
ClavzivacCo-Amoxiclav | 457 mg/ 5mL Powder for SuspensionAmber glass bottle x 30 mL and 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Pharmworld IncorporatedImporter: Ambica International Corporation | DRP-5966-24 | Jan 27, 2030 | |
Clavztar CV625Co-Amoxiclav | 1.2g Powder for InjectionUSP Type III Clear Colorless Glass Vial x 20 mL Box of 1's | Rx | Celogen Pharma Pvt. LtdIndia | Healthwinds Medical Trading Corp.Importer: Pharmastar Int'l Trading Corp. | DRP-7169-01 | Mar 30, 2029 | |
ClaxicCo-Amoxiclav | 200 mg/28.5 mg per 5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Metz Pharmaceuticals, Inc. | DRP-7140 | Jan 21, 2030 | |
ClaxicCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionPlastic Bottle x 60mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Metz Pharmaceuticals, Inc.Trader: Aldril Pharmaceuticals, Inc. | DRP-942-04 | Dec 18, 2027 | |
ClaxicCo-Amoxiclav | 400 mg/57 mg/5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086 | Jan 21, 2030 | |
ClaxicCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Metz Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DRP-615-15 | Apr 2, 2027 | |
ClaxicCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 60's) | Rx | Lloyd Laboratories, Inc.Philippines | Metz Pharmaceuticals, Inc. | DRP-3603-02 | Feb 24, 2029 | |
156.25 mg/5 mL Powder for Oral Suspension100 mL-Capacity Amber Glass Bottle with White Cap and Measuring Cup (Box of 1's) | Rx | Medopharm Private LimitedIndia | Importer: Hexagon Healthcare Corporation. | DR-XY48899 | Oct 5, 2028 | ||
ClaxonCo-Amoxiclav | 228.5 mg/5 mL Powder for SuspensionWhite round HDPE plastic bottle with marking x 70 mL + 15 mL transparent measuring cup (Box of 1's) | Rx | Medopharm Private LimitedIndia | Hexagon Pharmaceuticals | DR-XY49179 | Aug 22, 2029 | |
ClaxonCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Medopharm Private LimitedIndia | Importer: Hexagon Pharmaceuticals | DR-XY49277 | Nov 15, 2029 | |
ClaxonCo-Amoxiclav | 625 mg Film-Coated tabletAlu/Alu Blister pack x 10's (Box of 20's) | Rx | Medopharm Private LimitedIndia | Importer: Hexagon PharmaceuticalsTrader: Omnicals Pharma Pvt. Ltd. | DRP-17127 | Nov 15, 2029 | |
CledomoxCo-Amoxiclav | 312.5mg/5mL Powder For Oral SuspensionWhite HDPE Bottle with measuring cup x 100 mL | Rx | Medopharm Private LimitedIndia | MedEthix, Inc. | DRP-11093 | Jan 31, 2027 | |
Cledomox 228.5 DSCo-Amoxiclav | 228.5mg/5 mL Powder for Oral SuspensionHDPE plastic bottle with 15 mL measuring cup x 70 mL and 100 mL Box of 1's | Rx | Medopharm Private LimitedIndia | MedEthix, Inc. | DRP-8884 | May 28, 2029 | |
Cledomox 457 DSCo-Amoxiclav | 457 mg/5 mL Powder for Oral SuspensionHDPE plastic bottle with 15mL measuring cup x 70 mL (Box of 1's) | Rx | Medopharm Private LimitedIndia | MedEthix, Inc. | DRP-9381 | Dec 16, 2030 | |
ClovimaxCo-Amoxiclav | 156.25 mg per 5 mL (see reverse) Powder for SuspensionPlastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DRP-2622 | Dec 18, 2027 | |
ClovimaxCo-Amoxiclav | 312.5 mg per 5 mL Powder for SuspensionPlastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DRP-3844 | Aug 4, 2029 | |
ClovimaxCo-Amoxiclav | 457 mg per 5 mL Powder for SuspensionPlastic Bottle x 70 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DRP-3730 | Jul 31, 2029 | |
ClovimaxCo-Amoxiclav | 500 mg/125 mg Film-coated TabletFoil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Vamsler Phils. Incorporated | DRP-3729 | Jan 28, 2028 | |
ClovimedCo-Amoxiclav | 156.25 mg per 5 mL (see reverse) Powder for SuspensionPlastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Meedpharma Medical Supplies & Equipment DistributorTrader: Vamsler Phils. Incorporated | DRP-2622-01 | Dec 18, 2027 | |
ClovimedCo-Amoxiclav | 312.5 mg per 5 mL Powder for SuspensionPlastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Meedpharma Medical Supplies & Equipment DistributorTrader: Vamsler Phils. Incorporated | DRP-3844-01 | Aug 4, 2029 | |
ClovimedCo-Amoxiclav | 457 mg per 5 mL Powder for SuspensionPlastic Bottle x 70 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Meedpharma Medical Supplies & Equipment DistributorTrader: Vamsler Phils. Incorporated | DRP-3730-01 | Jul 31, 2029 | |
ClovintinCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's) | Rx | Stallion Laboratories Pvt. Ltd.India | Speed Cure PharmaImporter: Ambica International Corporation | DRP-3087-04 | Jun 27, 2029 | |
Clovoxclav-156.25Co-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle with LDPE Plastic Cap x 60 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation | DRP-5186-02 | Feb 26, 2029 | |
Clovoxclav-457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber Glass Bottle x 30 mL and 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Ambitech Biopharmaceuticals Inc.Importer: Ambica International Corporation | DRP-5966-21 | Jan 27, 2030 | |
Co-AmoxedCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Oral SuspensionRound Boston Amber Glass Bottle x 60 ml Box of 1's | Rx | SAPPHIRE LIFESCIENCES PVT. LTDIndia | 777 Red Pharma IncImporter: Nelpa Lifesciences, Inc. | DRP-8398-01 | May 12, 2027 | |
Co-AmoxigenCo-Amoxiclav | 125 mg / 31.25 mg Powder For SuspensionAmber Colored Glass Bottle with Measuring Cup x 100 mL (Box of 1's) | Rx | Sarthi PharmaIndia | Philgen Pharmaceuticals Inc. | DRP-18856 | Sep 15, 2031 | |
Co-AmoxigenCo-Amoxiclav | 1g Film-Coated TabletAlu-Alu Blister Pack x 7’s (Box of 14’s) | Rx | Sarthi PharmaIndia | Philgen Pharmaceuticals, Inc. | DRP-19120 | Oct 29, 2031 | |
Co-AmoxigenCo-Amoxiclav | 200 mg / 28.5 mg Powder For SuspensionAmber Colored Glass Bottle with Measuring Cup x 1100 mL (Box of 1's) | Rx | Sarthi PharmaIndia | Philgen Pharmaceuticals Inc. | DRP-18855 | Sep 15, 2031 | |
Co-AmoxigenCo-Amoxiclav | 250 mg / 62.5 mg Powder For SuspensionAmber Colored Glass Bottle with Measuring Cip x 100 mL (Box of 1's) | Rx | Sarthi PharmaIndia | Philgen Pharmaceuticals Inc. | DRP-18854 | Sep 15, 2031 | |
Co-AmoxigenCo-Amoxiclav | 375 mg Film-Coated TabletAlu-Alu Blister Pack x 7’s (Box of 14’s) | Rx | Sarthi PharmaIndia | Philgen Pharmaceuticals, Inc. | DRP-19118 | Oct 29, 2031 | |
Co-AmoxigenCo-Amoxiclav | 400 mg / 57 mg Powder For SuspensionAmber Colored Glass Bottle with Measuring Cup x 100 mL (Box of 1's) | Rx | Sarthi PharmaIndia | Philgen Pharmaceuticals Inc. | DRP-18853 | Sep 15, 2031 | |
Co-AmoxigenCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 7’s (Box of 14’s) | Rx | Sarthi PharmaIndia | Philgen Pharmaceuticals, Inc. | DRP-19119 | Oct 29, 2031 | |
Co-Amoxillen 125Co-Amoxiclav | 156.25 mg/5 mL FORMULATION: Each 5 mL contains: Amoxicillin (as trihydrate)…………………………………....125 mg Clavulanic acid (as potassium clavulanate) ………..................31.25 mg Powder For Oral SuspensionAmber glass bottle with HDPE cap x 60 mL (Box of 1’s) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc. | DRP-18877 | Sep 16, 2032 | |
Co-Amoxillen 250Co-Amoxiclav | 312.5 mg/5 mL Powder For Oral SuspensionAmber glass bottle with HDPE cap x 60 mL (Box of 1's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc. | DRP-18876 | Sep 16, 2032 | |
Co-Amoxillen 457Co-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc. | DRP-17633 | Feb 10, 2031 | |
Co-Amoxillen 625Co-Amoxiclav | 625 mg Film-Coated Tablet | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc. | DRP-17632 | Feb 10, 2031 | |
Co-Amoxisaph 375Co-Amoxiclav | 375mg Film-Coated TabletAlu/Alu Blister Pack x 7's and 10's (Box of 14's and 20's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Ollen Pharma Trading, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-12256 | Jul 5, 2027 | |
Co-Amoxisaph 375Co-Amoxiclav | 375mg Film-Coated TabletAlu/Alu Blister pack of 7's (Box 14's) Alu/alu Blister Pack x 10's (Box of 20's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14260 | Aug 7, 2028 | |
Co-Amoxisaph 457Co-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension70 mL Boston Round Amber Glass Bottle (Box of 1's) | Rx | Sapphire Lifesciences Pvt. Ltd.India | Nelpa Lifesciences, Inc.Trader: Aaron Healthcare and Export Pvt. Ltd. | DRP-12744 | Sep 30, 2027 | |
Co-Amoxisaph 457Co-Amoxiclav | 457 mg/5 mL Powder for Suspension60 mL-capacity (35 mL net content) and 120 mL- capacity (70 mL net content) Amber glass bottle with blue ROPP cap + measuring cup (Box of 1's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Nelpa Lifesciences, Inc. | DRP-16522 | May 15, 2030 | |
Co-Amoxisaph 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's in an Aluminum pouch (Box of 14's); Alu/Alu Blister Pack x 10's in an Aluminum pouch (Box of 30's) | Rx | Sapphire Lifesciences Pvt. Ltd.India | Nelpa Lifesciences, Inc. | DRP-10548 | Oct 14, 2031 | |
Co-Amoxisaph-125Co-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | Rx | SAPPHIRE LIFESCIENCES PVT. LTDIndia | Nelpa Lifesciences, Inc. | DRP-4131 | Dec 7, 2027 | |
Co-Amoxisaph-228Co-Amoxiclav | 228.5mg/5mL Powder for Oral Suspension (French Vanilla Flavor)100mL-Capacity Round Boston Amber Bottle Sealed with HDPE Cap x 70mL (net content) with Plastic Measuring Cup (Box of 1's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Nelpa Lifesciences, Inc. | DRP-17276 | Nov 5, 2030 | |
Co-Amoxisaph-250Co-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Oral SuspensionRound Boston Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Sapphire Lifesciences Pvt. Ltd.India | Importer: Nelpa Lifesciences, Inc. | DRP-8398 | May 12, 2027 | |
Co-AmoxitreneCo-Amoxiclav | 875 mg/ 125 mg Film-Coated TabletAlu/Alu Foil Strip x 8’s (Box of 8’s) | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Aisec Farma CorporationImporter: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4230-03 | Feb 14, 2028 | |
Co-AvoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Strip Packs x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Pharma Dynamic, Inc.Trader: Gamot Philippines, Inc. | DRP-7485 | Jul 4, 2030 | |
Co-AxCo-Amoxiclav | 457mg/5mL Powder For Suspension70 mL (net content) white round HDPE bottle with white HDPE cap and 15 mL capacity measuring cup (Box of 1 ’s) | Rx | Medopharm Private LimitedIndia | Aglobal Care Inc.Importer: Aglobal Care, Inc.Trader: Prime Pharmaceuticals Pvt. Ltd. | DRP-11334 | Mar 2, 2027 | |
Co-AxCo-Amoxiclav (see reverse for formulation) | 625 mg Film-Coated TabletAluminum Foil Strip x 10's Box of 60's | Rx | SUN PHARMACEUTICAL INDUSTRIES LTD.India | ADP PHARMA CORPORATIONImporter: SUN PHARMA PHILIPPINES, INC. | DRP-1324-01 | Jun 17, 2027 | |
Co-EnzoclavCo-Amoxiclav | 457 mg/ 5 mL Powder for Oral SuspensionWhite Translucent HDPE plastic bottle with white LDPE Flip-top Plastic Cap x 120 mL (70 mL net content) and translucent HDPE plastic measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Marti-Lian Pharma Link | DRP-12192-06 | Sep 2, 2027 | |
Co-Life 312.5Co-Amoxiclav | 312.5 mg per 5 mL Powder for Oral Suspension60 mL amber glass bottle with measuring cup (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Life and Health Source Pharmaceutical Distribution Co.Importer: PhilRx Pharma Inc. | DRP-13115-02 | Dec 2, 2027 | |
Co-Life 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's in a complex film aluminum pouch (Box of 14's) | Rx | Giyaan Pharma Pvt. Ltd.India | Life and Health Source Pharmaceutical Distribution Co.Importer: PhilRx Pharma Inc. | DRP-4771-07 | Oct 2, 2028 | |
Co-Life-457Co-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cup x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Life and Health Source Pharmaceutical Distribution Co.Importer: AMB HK Enterprises Inc. | DRP-11087-09 | Feb 3, 2027 | |
CoamoximedCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic Acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Healthmed Pharmaceutical Products DistributionImporter: Suhitas Pharmaceuticals Inc. | DRP-1092-11 | Oct 14, 2028 | |
CoamoximedCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Indchemie Health Specialities Private LimitedIndia | Healthmed Pharmaceutical Products DistributionImporter: Suhitas Pharmaceuticals Inc. | DRP-1077-17 | Oct 7, 2028 | |
CoamoxivetCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Golden Caishen International Medical Supply TradingImporter: Suhitas Pharmaceuticals Inc. | DRP-1093-07 | Oct 14, 2028 | |
Cobeluxi-457Co-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension (see reverse for formulation)70 mL (net content) white round HDPE bottle with white HDPE cap and 15 mL capacity measuring cup (Box of 1's) | Rx | Medopharm Private LimitedIndia | Bellus Life Solutions, Inc.Importer: Aglobal Care, Inc.Trader: Prime Pharmaceuticals Pvt. Ltd. | DRP-11334-04 | Mar 2, 2027 | |
CobiokidsCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic Bottle) with LDPE Tamper Proof Cap & 20 mL Capacity (PP) Plastic Measuring Cap (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Nutramedica Inc.Trader: Gamot Phlippines, Inc. | DRP-294-13 | Sep 22, 2031 | |
CobiomaxCo-Amoxiclav (see reverse for formulation) | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 6’s (Box of 12’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Nutramedica Inc.Importer: Phil. Shinpoong Pharma Inc. | DRP-3575-09 | Feb 13, 2030 | |
Colav-250Co-amoxiclav | 250 mg/ 62.5 mg per 5 mL Powder for Oral SuspensionAmber glass bottle x 60 mL with induction sealing cap and measuring cup (Box of 1’s) | Rx | Giyaan Pharma Private LimitedIndia | Kaufmann Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-13682-01 | Mar 28, 2028 | |
Colav-457Co-Amoxiclav | 457 mg / 5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cup x 70 mL (Box of 1’s) | Rx | Giyaan Pharma Private LimitedIndia | Kaufmann Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-11087-07 | Feb 3, 2027 | |
CombimoxCo-Amoxiclav | 457 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle x 70 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Zeutica, Inc. | DRP-6174-09 | Dec 15, 2029 | |
ComolavCo-Amoxiclav | 228.5 mg per 5 mL Powder for Suspension70 mL net content in a 120 mL HDPE Plastic Bottle (Box of 1's) | Rx | LLOYD LABORATORIES, INC.Philippines | Trader: IVANCOR IMPORTER | DR-XY44132 | Jan 27, 2030 | |
ComolavCo-Amoxiclav | 457 mg per 5 mL Powder for Suspension70 mL in 120 mL HDPE Plastic Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Ivancor Importer | DR-XY44019 | Dec 19, 2029 | |
ComolavCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAluminum Foil Strip x 10's Box of 30's | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Ivancor Importer | DR-XY43595 | Sep 16, 2029 | |
ComoxCo-Amoxiclav | 125 mg/31.25 mg per 5 mL Powder for Suspension (Passion fruit flavor)HDPE Plastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DRP-941 | Apr 1, 2028 | |
ComoxCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionPlastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DRP-942 | Dec 18, 2027 | |
ComoxCo-Amoxiclav | 625 mg Film-Coated TabletFoil Strip x 10's (Box of 60's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DR-XY28466 | Apr 1, 2028 | |
ComoxCo-Amoxiclav | 625 mg Film-Coated TabletFoil Strip x 10s (Box of 60s) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DRP-15991 | Apr 1, 2028 | |
ComoxbetCo-Amoxiclav | 1 g Film-Coated Tablet (see reverse for formulation)Box of 1 Alu/Alu Blister Pack x 10's | Rx | Indchemie Health Specialities Private LimitedIndia | Better Option Pharmaceuticals Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-10904-02 | Dec 17, 2026 | |
ComoxbetCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1093-08 | Oct 14, 2028 | |
ComoxbetCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic Acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1092-12 | Oct 14, 2028 | |
ComoxbetCo-Amoxiclav | 457 mg/ 5 mL Powder for Suspension70 mL Amber Bottle with aluminum cap and measuring cup (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-14019-01 | Jun 6, 2028 | |
ComoxbetCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-09 | Oct 7, 2028 | |
ComoxdinCo-Amoxiclav | 625 mg Film- Coated TabletAlu-Alu blister pack x 10’s (Box of 10's and 30's) | Rx | Yeluri Formulations Private LimitedIndia | SEA-King Pharma Inc.Importer: Grovic Pharma Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6702-03 | Jan 25, 2032 | |
ComoxiCo-Amoxiclav | 156.25 mg/ 5mL Powder for SuspensionAmber Glass Bottle x 60mL and 90 mL (Box of 1's) | Rx | Macter International LtdPakistan | Sahar International Trading Inc. | DRP-7326 | Mar 28, 2031 | |
Comoxi DSCo-Amoxiclav | 312.5 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60 ml And 90mL with 30 mL Plastic Measuring Cup Box of 1's | Rx | Macter International Ltd.Pakistan | Sahar International Trading Inc | DRP-7327 | Mar 28, 2031 | |
Comoxicef-1000Co-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Medicef PharmaIndia | Aglobal Care, Inc. | DRP-17559 | Jan 26, 2031 | |
ComoxitabCo-Amoxiclav | 625 mg Film-Coated Tablet (see reverse side for unit dose formulation)Alu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Cassandras Care Pharmaceutical DistributorImporter: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4135-03 | Dec 12, 2027 | |
Comxicare 625Co-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Medcare PharmaceuticalsImporter: Suhitas Pharmaceuticals Inc. | DRP-1077-22 | Oct 7, 2028 | |
Comxicare-SCo-Amoxiclav | 457 mg/ 5mL Powder for Suspension70 mL Amber Bottle with aluminum cap and measuring cup (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Medcare PharmaceuticalsImporter: Suhitas Pharmaceuticals Inc. | DRP-14019-06 | Jun 6, 2028 | |
ComxiclaCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-10904 | Dec 17, 2031 | |
ComxiclaCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-1093 | Oct 14, 2028 | |
ComxiclaCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxcillin + 62.5 mg Clavulanic Acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-1092 | Oct 14, 2028 | |
ComxiclaCo-Amoxiclav | 457 mg/5 mL Powder For Suspension60 mL Amber Bottle | Rx | Indchemie Health Specialities Private LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-14019 | Jun 6, 2028 | |
ComxiclaCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-1077 | Oct 7, 2028 | |
ComxicuraCo-Amoxiclav | 312.5 mg per 5mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | RVM Pharma & Medical Supplies DistributionImporter: Suhitas Pharmaceuticals, Inc. | DRP-1092-17 | Oct 14, 2028 | |
ComxicuraCo-Amoxiclav | 457 mg/5mL Powder for Suspension70 mL Amber Bottle with aluminum cap and measuring cup (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | RVM Pharma & Medical Supplies DistributionImporter: Suhitas Pharmaceuticals, Inc. | DRP-14019-10 | Jun 6, 2028 | |
ComxicuraCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | RVM Pharma & Medical Supplies DistributionImporter: Suhitas Pharmaceuticals Inc. | DRP-1077-25 | Oct 7, 2028 | |
Comxired 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 30’s); Alu/Alu Blister Pack x 7’s (Box of 14’s and 21's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Roymed PharmaceuticalImporter: Ollen Pharma Trading Inc. | DRP-17632-01 | Feb 10, 2031 | |
CorxiclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's with Aluminum pouch (Box of 14's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Vispomed CorporationImporter: AMB HK Enterprises Inc. | DRP-8498-02 | Oct 18, 2029 | |
CosmoxCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's Box of 18's | Rx | Stallion Laboratories Pvt. Ltd.India | Starpharm, Inc.Importer: Ambica International Corporation | DRP-3087-01 | Jun 27, 2029 | |
Cosmox 312.5Co-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionAmber Bottle x 60 mL (Box of 1's) | Rx | Pil Pharmaceuticals Pvt. Ltd.India | Starpharm, Inc.Importer: Jf Draf Pharmaceuticals Corporation | DRP-6356-05 | Aug 17, 2031 | |
Cosmox 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL | Rx | Giyaan Pharma Private LimitedIndia | Starpharm, Inc.Importer: Ambica International Corporation | DRP-5966-01 | Jan 27, 2030 | |
CowamoxCo-Amoxiclav | 1.2 g Powder for IV Injection20 mL-Capacity USP Type II Glass Vial with Butyl Rubber Stopper and Aluminum Flip-Off Cap (Box of 1's and 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Lakeside Pharmaceuticals Phils., Inc. | DRP-13627 | Mar 23, 2028 | |
Coxatech 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's in a complex film aluminum pouch (Box of 14's) | Rx | Giyaan Pharma Pvt. Ltd.India | SNV Biotech Medicinal Products WholesalingImporter: PhilRx Pharma Inc. | DRP-4771-09 | Oct 2, 2028 | |
Coxatech 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's with Aluminum pouch (Box of 14's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | SNV Biotech Medicinal Products WholesalingImporter: AMB HK Enterprises Inc. | DRP-8498-04 | Oct 18, 2029 | |
CoxiclavCo-Amoxiclav | 400 mg/57 mg/5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with Cap and Measuring Cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | RL Pharma Enterprises, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-17 | Jan 21, 2030 | |
CoxxwellCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 30 mL and 70 mL | Rx | Giyaan Pharma Private LimitedIndia | Bansan Pharma DistributorImporter: Ambica International Corporation | DRP-5966-10 | Jan 27, 2030 | |
CozealCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionAmber Bottle x 60 mL and 100 mL (Box of 1's) | Rx | Pil Pharmaceuticals Pvt. Ltd.India | Pharmasilv TradingImporter: Jf Draf Pharmaceuticals Corp. | DRP-6356-04 | Aug 13, 2031 | |
CozealCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's) | Rx | Stallion Laboratories Pvt. Ltd.India | Pharmasilv TradingImporter: Ambica International Corporation | DRP-3087-02 | Jun 27, 2029 | |
CozealCo-Amoxiclav | 875 mg/125 mg Film-Coated TabletAlu/ Foil Strip x 7's (Box of 14's) | Rx | Pil Pharmaceuticals Pvt. Ltd.India | Pharmasilv TradingImporter: JF Draf Pharmaceuticals Corporation | DRP-6357-06 | Jul 21, 2031 | |
Cozeal 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber Glass Bottle x 30 mL and 70 mL Box of 1's | Rx | Giyaan Pharma Private LimitedIndia | Pharmasilv TradingImporter: Ambica International Corporation | DRP-5966-19 | Jan 27, 2030 | |
CurimoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/ Alu Blister Pack x 7's with Aluminum pouch (Box of 14's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-8498-05 | Oct 18, 2029 | |
DemiclavCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE Plastic Bottle with measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Transcend Phils., Inc.Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-6757-02 | Apr 28, 2029 | |
DomiclavCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Domineight Trading Corp.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-11 | Oct 7, 2028 | |
DuoclavCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Excelcare, Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1092-08 | Oct 14, 2028 | |
DuoclavCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's Box of 18's | Rx | Stallion Laboratories Pvt. Ltd.India | Excelcare, Inc.Importer: Ambica International Corporation | DRP-3087-14 | Jun 27, 2029 | |
DuoxiclavCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's Box of 14's | Rx | Giyaan Pharma Private LimitedIndia | Titanium PharmaImporter: Ambica International Corporation | DRP-5343-05 | Jun 17, 2029 | |
DuoxiclavCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 30 mL and 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Titanium PharmaImporter: Ambica International Corporation | DRP-5966-26 | Jan 27, 2030 | |
DuoxiclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Giyaan Pharma Private LimitedIndia | Titanium PharmaImporter: Ambica International Corporation | DRP-5357-02 | Jun 20, 2029 | |
EleventinCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle with LDPE Plastic Cap x 60 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Ambica International Corporation | DRP-5186 | Feb 26, 2029 | |
Eleventin 1000Co-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's Box of 14's | Rx | Giyaan Pharma Private LimitedIndia | Ambica International Corporation | DRP-5343 | Jun 17, 2029 | |
Eleventin 375Co-Amoxiclav | 375 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Giyaan Pharma Private LimitedIndia | Ambica International Corporation | DRP-5358 | Jun 20, 2029 | |
Eleventin 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 30 mL and 70 mL | Rx | Giyaan Pharma Private LimitedIndia | Ambica International Corporation | DRP-5966 | Jan 27, 2030 | |
Eleventin 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Giyaan Pharma Private LimitedIndia | RSG Pharma TradingImporter: Ambica International Corporation | DRP-5357 | Jun 20, 2029 | |
Elmox-CV 228.5Co-Amoxiclav | 228.5mg/5mL Powder for Oral SuspensionHDPE bottle with polypropylene plastic screw cap x 100 mL & 10 mL measuring cup (Box of 1’s) | Rx | Yeluri Formulations Pvt. Ltd.India | Pharma-Surrey International, Inc. | DRP-12243 | Jul 1, 2027 | |
Elmox-CV 312.5Co-Amoxiclav (see reverse for formulation) | 312.5 mg per 5 mL Powder for Oral Suspension100 mL HDPE bottle with cap and measuring cup (Box of l's) | Rx | Yeluri Formulations Pvt. Ltd.India | Pharma-Surrey International, Inc. | DRP-11245 | Feb 21, 2027 | |
Elmox-CV 375Co-Amoxiclav | 375 mg Film-Coated TabletAlu-Alu Blister Pack x 7's (Box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | Pharma-Surrey International Inc. | DRP-13381 | Apr 3, 2028 | |
Elmox-CV 457Co-Amoxiclav | 457 mg/5 mL Powder for Oral SuspensionHDPE bottle with polypropylene plastic screw cap x 100mL & 10mL measuring cup | Rx | Yeluri Formulations Pvt. Ltd.India | Pharma-Surrey International, Inc. | DRP-12194 | Jun 28, 2027 | |
Elmox-CV 625Co-Amoxiclav | 625mg Film-Coated TabletAlu-Alu Blister Pack of 2 x 7 tablets (Box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | Pharma-Surrey International, Inc. | DRP-12244 | Jul 1, 2027 | |
Endclav-375Co-Amoxiclav | 375 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 60's) | Rx | Stallion Laboratories Pvt. Ltd.India | Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5406 | Jul 30, 2029 | |
Endclav-625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's Box of 14's | Rx | Stallion Laboratories Pvt. Ltd.India | Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5407 | Jul 30, 2029 | |
EnhamoxCo-Amoxiclav | 312.5 mg per 5 mL Powder for SuspensionPlastic Bottle with measuring Cup x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Randril Internation Co., Inc. | DR-XY29391 | Feb 24, 2029 | |
EnhamoxCo-Amoxiclav | 312.5mg per 5mL Powder for SuspensionPlastic Bottle with measuring Cup x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Randril International Co., Inc. | DRP-15169 | Feb 24, 2029 | |
EnhamoxCo-Amoxiclav | 400 mg/57 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle x 70 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Randril Internation Co., Inc. | DRP-12542 | Apr 2, 2028 | |
EnhamoxCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 10's Box of 60's | Rx | Lloyd Laboratories, Inc.Philippines | Randril Internation Co., Inc. | DRP-3603 | Feb 24, 2029 | |
EnhancinCo-Amoxiclav | 1 g Film-Coated TabletFoil Strip 2 x 6 (Box of 12’s) | Rx | Sun Pharmaceutical Industries LimitedIndia | Sun Pharma Philippines, Inc. | DRP-1006 | Aug 12, 2028 | |
EnhancinCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 20's and 60's) | Rx | Sun Pharmaceutical Industries LimitedIndia | Sun Pharma Philippines, Inc. | DRP-1324 | Jun 17, 2032 | |
457mg / 5 mL Powder for Oral SuspensionWhite HDPE Bottles sealed with Plastic Cap X 70 mL + 10mL PP Measuring Cup (Box of 1's) | Rx | Baroque Pharmaceuticals Pvt. Ltd.India | Epione Lifecare Inc.Importer: Despina Pharma Inc. | DRP-15768-01 | Sep 12, 2029 | ||
EuroclavCo-Amoxiclav | 400 mg/57 mg per 5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | All-Bio Pharma, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-10 | Jan 21, 2030 | |
EuroclavCo-Amoxiclav | 875 mg/125 mg Film-Coated TabletAlu Foil Strip 7's (Box of 14's) | Rx | Pil Pharmaceuticals Ltd.India | All-Bio Pharma IncImporter: JF Draf Pharmaceuticals Corporation | DRP-6357-04 | Sep 22, 2031 | |
EurovoxCo-Amoxiclav | 1.2 g Powder for Injection (I.V.)20 mL USP Type I Clear Colorless Glass Vial (Box of 1's) | Rx | Nitin Lifesciences Pvt. Ltd.India | Euro-Health Care Exponents, Inc. | DR-XY46062 | Oct 3, 2027 | |
FlemingCo-Amoxiclav | 1 g Film-Coated TabletAlu/Clear PVC Blister Pack x 7's in aluminum pouch (Box of 14's) | Rx | Medreich LimitedIndia | Metro Drug, Inc.Importer: Paradigm Pharma (Philippines) Corporation | DR-XY46881 | Jul 2, 2030 | |
FlemingCo-Amoxiclav | 156.25mg/5mL Powder for Oral Suspension100 mL Flint Glass Bottle (Box of 1's) | Rx | Medreich LimitedIndia | Metro Drug, Inc.Importer: Paradigm Pharma (Philippines) Corporation | DR-XY46279 | Mar 8, 2028 | |
FlemingCo-Amoxiclav | 375mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's in aluminum pouch with desiccant (Box of 10 pouches) | Rx | Medreich Limited - Unit 1India | Metro Drug, Inc.Importer: Paradigm Pharma (Philippines) Corporation | DR-XY46138 | Nov 6, 2027 | |
FlemingCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's in aluminum pouch with desiccant (Box of 10 pouches) | Rx | Medreich Limited - Unit 1India | Metro Drug, Inc.Importer: Paradigm Pharma (Philippines) Corporation | DR-XY46139 | Nov 6, 2027 | |
GalexiclavCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Galenica Pharmaceuticals Inc.Trader: Gamot Philippines, Inc. | DRP-615-12 | Apr 2, 2027 | |
Genbac CVCo-Amoxiclav | 312.5 mg/5 mL Powder for Oral Suspension ( Orange Flavor)70 mL-Capacity HDPE Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-12921-01 | Oct 28, 2027 | |
GenclavCo-Amoxiclav | 156.25mg/5ml Powder for Suspension70 mL HDPE bottle with PP screw cap and 10 mL measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Generic Option Pharma Corp. | DRP-11951 | May 23, 2027 | |
GenclavCo-Amoxiclav | 1g Film-Coated TabletAlu-Alu Blister Pack X7's packed in one Alu-alu Pouch (box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | Generic Option Pharma Corp. | DRP-11908 | May 20, 2027 | |
GenclavCo-Amoxiclav | 312.5mg/5mL Powder for Suspension70 mL HDPE bottle with PP screw cap and 10 mL measuring cup (Box of l’s) | Rx | Yeluri Formulations Pvt. Ltd.India | Generic Option Pharma Corp. | DRP-11950 | May 23, 2027 | |
GenclavCo-Amoxiclav | 457mg/5mL Powder for Suspension70 mL HDPE bottle with PP screw cap and 10 mLine measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Generic Option Pharma Corp. | DRP-11949 | May 30, 2027 | |
GenclavCo-Amoxiclav | 500mg / 125mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Generics Pharmacal Phils., Inc.Trader: Gamot Philippines , Inc. | DRP-615-18 | Apr 2, 2027 | |
GenclavCo-Amoxiclav | 625mg Film-Coated TabletAlu-alu blister pack of 10's packed in one Alu-alu pouch (box of 20's) | Rx | Yeluri Formulations Pvt. Ltd.India | Generic Option Pharma Corp. | DRP-11909 | May 20, 2027 | |
Genclav CVCo-Amoxiclav | 156.25 mg/5 mL Powder for Oral Suspension (Orange Flavor)70mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10mL Measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-13800-01 | Nov 22, 2027 | |
GenoxiclavCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Generics Pharmacal Phils., Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-15 | Oct 7, 2028 | |
GeoxiclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Giyaan Pharma Private LimitedIndia | GPC Geo Pharma CorporationImporter: Ambica International Corporation | DRP-5357-01 | Jun 20, 2029 | |
GiclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | Gijun Trading Inc.Importer: Medinova Pharmaceutical Inc. | DRP-11805-01 | May 5, 2027 | |
Giclav-457Co-Amoxiclav | 457 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle x 70mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Gijun Trading Inc. | DRP-6174-10 | Dec 15, 2029 | |
GlobantinCo-Amoxiclav | 1.2 g Powder for Injection (I.V)Individually boxed clear glass vial with yellow flip-off seal (Box of 10's) | Rx | Zhuhai United Laboratories (Zhongshan) Company LimitedChina | GLOBAL PHARMATRADE | DR-XY35524 | Mar 3, 2029 | |
GlobantinCo-Amoxiclav | 600 mg Powder for Injection (IV)Individually boxed USP Type II glass vial with rubber stopper and pale-yellow flip-off seal (Box of 10's) | Rx | Zhuhai United Laboratories (Zhongshan) Co., Ltd.China | GLOBAL PHARMATRADE | DR-XY35891 | May 25, 2029 | |
GloclavCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Giyaan Pharma Private LimitedIndia | Ellebasy Medicale Group Inc.Importer: Ambica International Corporation | DRP-5343-07 | Jun 17, 2029 | |
GloclavCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle with LDPE plastic cap x 60 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-5186-01 | Feb 26, 2029 | |
GloclavCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 30 mL and 70 mL | Rx | Giyaan Pharma Private LimitedIndia | Ellebasy Medicale Group Inc.Importer: Ambica International Corporation | DRP-5966-09 | Jan 27, 2030 | |
GloclavCo-Amoxiclav | 875 mg/ 125 mg Film-Coated TabletAlu/Alu Foil Strip x 8’s Box of 8’s | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Ellebasy Medical Group, Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4230-04 | Feb 14, 2028 | |
GoclavCo-Amoxiclav | 1.2 g Powder For Solution For Injection (Iv)Type I borosilicate, clear transparent glass vial with butyl rubber stopper and aluminum plastic cap (Box of 1's) | Rx | North China Pharmaceutical Co., Ltd.China | Applied Pharmaceutical Distribution IncImporter: Aglobal Care, Inc. | DRP-8105-01 | Mar 3, 2027 | |
Goclav 228Co-Amoxiclav | 228.5 mg / 5 mL Powder for Oral SuspensionHDPE Bottle Sealed with Plastic Plug and Cap x 70 mL + 10 mL Measuring Cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Applied Pharmaceutical Distribution Inc.Importer: Medinova Pharmaceutical Inc. | DRP-15210-01 | May 28, 2029 | |
Goclav-125Co-Amoxiclav | 156.25 mg/5 mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | Applied Pharmaceutical Distribution Inc.Importer: Medinova Pharmaceutical Inc. | DRP-12924-01 | Nov 22, 2027 | |
Goclav-250Co-Amoxiclav | 312.5 mg / 5 mL Powder for Oral Suspension (Orange Flavor)70 mL - Capacity HDPE Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | Applied Pharmaceutical Distribution Inc.Importer: Medinova Pharmaceutical Inc. | DRP-12921-02 | Oct 28, 2027 | |
Goclav-625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | Applied Pharmaceutical Distribution IncImporter: Medinova Pharmaceutical Inc. | DRP-11805-04 | May 5, 2027 | |
GomoxCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's) | Rx | Stallion Laboratories Pvt. Ltd.India | Applied Pharmaceutical Distribution Inc.Importer: Ambica International Corporation | DRP-3087-09 | Jun 27, 2029 | |
Gomox 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL | Rx | Giyaan Pharma Private LimitedIndia | Applied Pharmaceutical Distribution IncImporter: Ambica International Corporation | DRP-5966-06 | Jan 27, 2030 | |
GoxiclavCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 7’s (Box of 14’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Applied Pharmaceutical Distribution, Inc.Importer: Suhitas Pharmaceuticals, Inc. | DRP-1077-27 | Oct 7, 2028 | |
GravimoxCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL Box of 1’s | Rx | Indchemie Health Specialities Private LimitedIndia | Ellebasy Medicale TradingImporter: Suhitas Pharmaceuticals Inc. | DRP-1092-05 | Oct 14, 2028 | |
GravimoxCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Ellebasy Medicale TradingImporter: Suhitas Pharmaceuticals Inc. | DRP-1077-06 | Oct 7, 2028 | |
Grovixin 625Co-Amoxiclav | 625 mg Film- Coated TabletAlu-Alu Blister Pack x 10’s (Box of 10's and 30's) | Rx | Yeluri Formulations Private LimitedIndia | Grovic Pharma Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6702 | Feb 24, 2031 | |
GuimoxCo-Amoxiclav | 400 mg/57 mg per 5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup | Rx | Lloyd Laboratories, Inc.Philippines | Foramen Products CorporationTrader: Metz Pharmaceuticals, Inc. | DRP-7086-12 | Jan 21, 2030 | |
HaiclavCo-Amoxiclav | 1.2 g Powder for Injection (I.V.)20 mL- Capacity USP Type I Tubular Glass Vial with Grey Butyl Rubber Stopper and Purple Flip-Off Seal (Box of 1's) | Rx | Uni MedicolabsIndia | Triple Tact Import & Export Corp.Importer: Greencore Pharma Inc. | DRP-14530-01 | Oct 3, 2028 | |
HaiclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Triple Tact Import & Export Corp.Importer: Greencore Pharma Inc. | DRP-6810-01 | Feb 7, 2032 | |
HarcillinCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Harlem SalesImporter: Philgen Pharmaceuticals Inc. | DRP-1028-06 | Apr 5, 2031 | |
HealclavCo-Amoxiclav | 457 mg/ 5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cup x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Healol Pharma CorporationImporter: AMB HK Enterprises Inc. | DRP-11087-05 | Feb 3, 2027 | |
HealclavCo-Amoxiclav | 457mg/ 5mL Powder for Oral SuspensionWhite Round HDPE Bottle Sealed with Cap x 70 mL (Box of 1's) | Rx | Medopharm Private LimitedIndia | Healol Pharma CorporationImporter: Synergia Health Care & Life Sciences, Inc. | DRP-17433-01 | Dec 15, 2031 | |
HI-CLAVCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Hlm Pharmaceutical Inc.Importer: Greencore Pharma Inc. | DRP-6810-09 | Feb 8, 2032 | |
HypermoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 10's in a Laminated PET/Al/PE Puch x 20's (Box of 20's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Global Pharmatrade | DR-XY45028 | Feb 2, 2031 | |
InfeclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Stallion Laboratories Pvt. Ltd.India | JJYSRINN Trading Inc.Importer: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5407-03 | Jul 30, 2029 | |
InoclavCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic Bottle) with LDPE Tamper Proof Cap & 20 mL Capacity (PP) Plastic Measuring Cap (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Eadriex Pharmaceuticals, Phils., Inc.Trader: Gamot Philippines, Inc. | DRP-294-06 | Sep 6, 2035 | |
InoclavCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Eadriex Pharmaceuticals Phils., Inc.Trader: Gamot Philippines, Inc. | DRP-615-08 | Apr 2, 2027 | |
InovoxCo-Amoxiclav | 156.25 mg per 5 mL Powder for Suspension (see reverse for formulation)60 mL in 120 mL HDPE Plastic Bottle with measuring Cup, in a Box | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-6793 | Feb 21, 2028 | |
InovoxCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE Plastic Bottle with measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Quad-Gen PharmaceuticalsTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-6757 | Apr 28, 2029 | |
InovoxCo-Amoxiclav | 457 mg per 5 mL Powder for Oral Suspension70 mL in 120 mL HPDE Plastic Bottle with cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Eadriex Pharmaceuticals Phils., Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-02 | Jan 21, 2030 | |
InovoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Foil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-7048 | Aug 30, 2028 | |
IzzobrexCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Stallion Laboratories Pvt. Ltd.India | Dynasty PharmaceuticalsImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5407-01 | Jul 30, 2029 | |
Izzobrex 457Co-Amoxiclav | 457 mg/5 mL Powder For Suspension120 mL-capacity (70 mL net content) Amber gass bottle with white HDPE cap + measuring cup (Box of 1's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Dynasty PharmaceuticalsImporter: Nelpa Lifesciences, Inc. | DRP-16522-01 | Jun 15, 2031 | |
J-MoxCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE Plastic Bottle with Measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Jazmark PharmaceuticalTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-6757-05 | Apr 28, 2029 | |
J-MoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's in a complex film aluminum pouch (Box of 14's) | Rx | Giyaan Pharma Pvt. Ltd.India | Jazmark PharmaceuticalImporter: PhilRx Pharma Inc. | DRP-4771-08 | Oct 2, 2028 | |
JamoxiCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's Box of 14's | Rx | Giyaan Pharma Private LimitedIndia | Jazmark PhamaceuticalImporter: Ambica International Corporation | DRP-5343-02 | Jun 17, 2029 | |
JamoxiCo-Amoxiclav | 457.5 mg per 5 mL Powder for Suspension75 mL (35 mL net content) and 130 mL (70 mL net content) Round Amber Glass Bottle sealed with white PP cap (Box of 1's) | Rx | Techno Drugs Ltd.Bangladesh | Jazmark PharmaceuticalImporter: Bridgemark Marketing | DRP-4201-02 | Nov 11, 2029 | |
JanclavCo-Amoxiclav | 625 mgAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Jjysrinn Trading Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-05 | Oct 7, 2028 | |
Janclav 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | JJYSRINN Trading Inc.Importer: Ambica International Corporation | DRP-5966-14 | Jan 27, 2030 | |
JazimoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Jazmark PharmaceuticalImporter: Greencore Pharma, Inc. | DRP-6810-07 | Aug 26, 2031 | |
KiddymoxCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 30 mL and 70 mL | Rx | Giyaan Pharma Private LimitedIndia | JWK Enterprises, Inc.Importer: Ambica International Corporation | DRP-5966-25 | Jan 27, 2030 | |
KlamoxCo-Amoxiclav | 457mg per 5mL Powder For SuspensionHDPE Plastic Bottle x 70mL (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | — | DRP-6174 | Dec 15, 2029 | |
KlavelCo-Amoxiclav | 1.2 g Powder for Solution for Injection (IV)Type I borosilicate, clear transparent glass vial with butyl rubber stopper and aluminum plastic cap Box of 1's | Rx | North China Pharmaceutical Co., Ltd.China | Bellus Life Solutions, Inc.Importer: Aglobal Care, Inc. | DRP-8105-02 | Mar 3, 2027 | |
KlavicCo-Amoxiclav | 1g/200mg Powder for Injection (IV)USP Type III Clear Glass Vial with gray flip-off seal (Box of 10's) | Rx | Karnataka Antibiotics & Pharmaceuticals LimitedIndia | Phil. Pharmawealth, Inc. | DR-XY31440 | Jan 19, 2031 | |
KlavicCo-amoxiclav | 228.5 mg per 5 mL Powder for Suspension100 mL USP Type I amber glass bottle (Box of 1's) | Rx | Swiss Parenterals Pvt. Ltd.India | Endure Medical, Inc. | DR-XY42977 | Nov 18, 2028 | |
KlavicCo-Amoxiclav | 500 mg/100 mg Powder for Injection (I.V.)USP Type III Clear Glass Vial (Box of 10's) (Box of 10's) | Rx | Karnataka Antibiotics & Pharmaceuticals LimitedIndia | Phil. Pharmawealth, Inc. | DR-XY31211 | Oct 26, 2030 | |
KlaviranCo-Amoxiclav | 1g Film-Coated TabletAlu/Alu Blister Pack x 7's in Aluminum Pouch (Box of 14's) | Rx | Giyaan Pharma Private Limited.India | AMB HK Enterprises, Inc.Importer: AMB HK Enterprises Inc. | DRP-15183 | May 21, 2029 | |
Klaviran DSCo-amoxiclav | 156.25 mg per 5 mL FORMULATION: Each 5 mL contains: Amoxicillin (as trihydrate) 125 mg equivalent to 131.25 mg Clavulanic Acid (as potassium clavulanate) 31.25 mg equivalent to 33.75 mg Powder for Oral SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Amb Hk Enterprises Inc.Importer: AMB HK Enterprises Inc. | DRP-15181 | May 21, 2029 | |
KmoxilinCo-Amoxiclav | 625 mg Tablet2 PVDC/Alu Blister Pack x 10’s in Aluminum Sachet Box of 100’s | Rx | CHONG KUN DANG PHARMACEUTICAL CORP.Republic of Korea | Yunimedika Philippines, Inc.Importer: UNIMEX, INC. | DRP-2491 | Jun 22, 2027 | |
Koact 1.2Co-Amoxiclav | 1 g/200 mg Powder for Solution for Injection (IV)30 mL USP Type I Tubular Vial (Box of 1's) | Rx | Aurobindo Pharma Limited (Unit XII)India | Medethix, Inc. | DRP-11714 | Aug 19, 2031 | |
Kosiklav 228.5Co-Amoxiclav | (see reverse for formulation) 228.5 mg Powder for Oral SuspensionHDPE bottle with screw cap x 70 mL (Box of 1’s) | Rx | Chiros PharmaIndia | Ambicare Pharmaceuticals Inc.Trader: Neomi Pharmaceuticals Pvt. Ltd. | DRP-18620 | Aug 11, 2031 | |
KOSIMOX-1.2Co-Amoxiclav | 1.2 g Powder For Injection (Iv)12 mL-Capacity Usp Type II Moulded Soda Lime Clear Glass Vial With Halogenated Butyl Rubber Stopper And Yellow Alu-Plastic Flip-Off Cap (Box of 1's) | Rx | Zhuhai United Laboratories (Zhongshan) Co., Ltd.China | Aglobal Care, Inc. | DRP-9747 | Jul 29, 2031 | |
LactamoxCo-Amoxiclav | 125 mg/31.25 mg per 5 mL Powder for Suspension (see reverse for formulation)HDPE Plastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Totalcare Pharma Inc.Trader: Aldril Pharmaceuticals, Inc. | DRP-941-02 | Apr 1, 2028 | |
LactamoxCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension (see reverse for formulation)Plastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Totalcare Pharma Inc.Trader: Aldril Pharmaceuticals, Inc. | DRP-942-03 | Dec 18, 2027 | |
LactamoxCo-Amoxiclav | 457mg/5mL Powder For Suspension120 mL-capacity (70 mL-net content) white translucent HDPE bottle with white translucent LDPE flip-top cap and translucent PP measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Totalcare Pharma, Inc | DRP-14790 | Jan 5, 2029 | |
LactamoxCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 60's) | Rx | Lloyd Laboratories, Inc.Philippines | Totalcare Pharma Inc. | DRP-3603-01 | Feb 24, 2029 | |
Lewiclav 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Flamingo Pharmaceuticals Ltd.India | Lewison Pharmaceuticals CorporationImporter: Hexagon Pharmaceuticals | DRP-2159-02 | Jun 22, 2029 | |
LezclavCo-Amoxiclav | 875 mg/ 125 mg Film-Coated TabletAlu-Alu Foil Strip x 8’s (Box of 8’s) | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Guimhealth Pharmaceutical Distributor & DrugstoreImporter: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4230-02 | Feb 14, 2028 | |
Lezclav 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber Glass Bottle x 30 mL and 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Guimhealth Pharmaceutical Distributor & DrugstoreImporter: Ambica International Corporation | DRP-5966-17 | Jan 27, 2030 | |
Lezclav 625Co-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's) | Rx | Stallion Laboratories Pvt. Ltd.India | Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Ambica International Corporation | DRP-3087-13 | Jun 27, 2029 | |
LimoclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Trumed PharmaceuticalsImporter: Greencore Pharma Inc. | DRP-6810-13 | Aug 26, 2031 | |
LoxCo-Amoxiclav | 625 mg Tablet2 PVDC/Alu Blister Pack x 10’s in Aluminum Sachet Box of 100’s | Rx | Chong Kun Dang Pharmaceutical Corp.Republic of Korea | D&G PharmaImporter: Unimex, Inc. | DRP-2491-01 | Jun 22, 2027 | |
MabiclavCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Indchemie Health Specialities Private LimitedIndia | Medconcern Drugs And General Merchandise Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-18 | Oct 7, 2028 | |
MaediclavCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 3's Box of 21's | Rx | Ipca LaboratoriesIndia | Maed Pharma CorporationImporter: Blue Global (FZE) | DRP-3774-06 | Jul 20, 2028 | |
MaxClavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 6's ; Alu/Alu Blister Pack x 7's (Box of 6's and Box of 21's) | Rx | Uni MedicolabsIndia | Dreamax IncorporatedImporter: Greencore Pharma Inc. | DRP-6810-04 | Feb 8, 2032 | |
Maxclav 1.2Co-Amoxiclav | 1.2 g Powder For Injection (IV)20 mL-capacity USP Type II clear and colorless glass vial enclosed with gray butyl rubber stopper and aluminum seal with blue flip-off plastic cap with blue (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Incorporated | DRP-13891 | May 11, 2028 | |
MaxlavcoCo-Amoxiclav | 375 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 60's) | Rx | Stallion Laboratories Pvt. Ltd.India | Diafarm Inc.Importer: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5406-01 | Jul 30, 2029 | |
Maxlavco 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Diafarm Inc.Importer: Ambica International Corporation | DRP-5966-07 | Jan 27, 2030 | |
Maxlavco 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's Box of 14's | Rx | — | Diafarm Inc.Importer: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5407-04 | Jul 30, 2029 | |
MedavoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's in a complex film aluminum pouch (Box of 14's) | Rx | Giyaan Pharma Pvt. Ltd.India | Quad-Gen PharmaceuticalsImporter: PhilRx Pharma Inc. | DRP-4771-02 | Oct 2, 2028 | |
Medavox 457Co-Amoxiclav | 457 mg/ 5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cup x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Quad-Gen PharmaceuticalsImporter: AMB HK Enterprises Inc. | DRP-11087-6 | Feb 3, 2027 | |
MediclavCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Foil Strip Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Gamot Philippines, Inc. | DRP-7246-02 | Nov 13, 2029 | |
MediclavCo-Amoxiclav | 156.25 mg per 5 mL Powder for Suspension60 mL HDPE Plastic Bottle w/ LDPE Tamper Proof Cap and 20 mL - Capacity PP Plastic Measuring Cap | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Gamot Philippines, Inc. | DRP-293-05 | Sep 11, 2031 | |
MediclavCo-Amoxiclav | 250 mg/ 62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic ) Bottle with LDPE Tamper Proof Cap & 20 mL Capacity PP (Plastic) Measuring Cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Gamot Philippines, Inc. | DRP-294-05 | Aug 26, 2031 | |
MediclavCo-Amoxiclav | 457 mg per 5 mL Powder for SuspensionHDPE Bottle x 70 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Gamot Philippines, Inc. | DR-XY35404 | Feb 4, 2029 | |
MediclavCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with Cap and Measuring Cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-05 | Jan 21, 2030 | |
MediclavCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Gamot Philippines, Inc. | DRP-615-07 | Apr 2, 2027 | |
MedxiclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Gdmed Pharma DistributorImporter: Greencore Pharma Inc. | DRP-6810-15 | Feb 2, 2032 | |
MegaclavCo-Amoxiclav | 125 mg/31.25 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle x 60 mL with measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-4616 | Oct 28, 2030 | |
MegaclavCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionHDPE Bottle x 60 mL with Measuring Cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Westfield Pharmaceuticals, Inc. | DRP-3704 | Oct 21, 2031 | |
MegaclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Strip Packs x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Westfield Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DRP-7485-01 | Sep 11, 2031 | |
312.5 mg per 5 mL Powder For Oral Suspension60 mL amber glass bottle with measuring cup (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | AMB HK Enterprises Inc. | DRP-13115 | Dec 2, 2027 | ||
MixclavCo-Amoxiclav | 250mg / 62.5 mg Per 5ml Powder for SuspensionAmber Bottle x 60mL and 100mL (Box of 1's) | Rx | Pil Pharmaceuticals Limited - IndiaIndia | JF Draf Pharmaceuticals Corporation | DRP-6356 | Oct 2, 2030 | |
MixclavCo-Amoxiclav | 625 mg TabletAlu-Strip Foil Pack x 6's (Box of 24's) | Rx | PIL Pharmaceuticals LimitedIndia | JF Draf Pharmaceuticals Corporation | DRP-5108 | Nov 19, 2028 | |
MixclavCo-Amoxiclav | 875 mg/125 mg Film-Coated TabletAlu Foil Strip x 7's (Box of 14's) | Rx | Pil Pharmaceuticals Ltd.India | Jf Draf Pharmaceuticals Corporation | DRP-6357 | Oct 2, 2030 | |
MoclaphilCo-Amoxiclav | 625 mg TabletsAlu/Alu Strip x 7's in aluminum pouch (Box of 14's) | Rx | Baroque Pharmaceuticals Pvt. Ltd.India | AMB HK Enterprises Inc. | DRP-18514 | Jul 27, 2031 | |
Monamox-CL 625Co-Amoxiclav | 500 mg / 125 mg Film Coated TabletAlu/Alu Blister pack x 6's (Box of 6's and 30's) | Rx | Zee Laboratories LimitedIndia | Eon Pharmatek Inc. | DR-XY42806 | Aug 30, 2028 | |
Monamox-CL 625Co-Amoxiclav | 625 mg Film-Coated Tablet (see reverse for formulation)Alu/Alu Blister pack x 6’s (Box of 6's, 10's, and 30's) | Rx | Zee Laboratories LimitedIndia | Eon Pharmatek Inc. | DRP-15574 | Aug 30, 2028 | |
MoxCV 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Clear PVC-PVDC Blister Pack x 10's (Box of 10's) | Rx | Sun Pharma Laboratories Ltd.India | Sun Pharma Philippines, Inc. | DRP-14076 | Jun 14, 2028 | |
Moxgen-457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 30 mL and 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Quad-Gen PharmaceuticalsImporter: Ambica International Corporation | DRP-5966-11 | Jan 27, 2030 | |
MoxibacCO-AMOXICLAV | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 10's and 30's) | Rx | Yeluri Formulations Private LimitedIndia | Central West Medicale Inc.Importer: Grovic Pharma Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6702-05 | Nov 19, 2031 | |
Moxibac 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 30 mL and 70 mL | Rx | Giyaan Pharma Private LimitedIndia | Central West Medicale Inc.Importer: Ambica International Corporation | DRP-5966-28 | Jan 30, 2030 | |
MoxibamCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 10's Packed in One Alu-Alu Pouch (Box of 20's) | Rx | Yeluri Formulations Pvt. Ltd.India | Boon Pharma CorpImporter: Orange Biotec Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6095-07 | Feb 7, 2030 | |
MoxibamCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Boon Pharma Corp.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-23 | Oct 7, 2028 | |
Moxibam 312.5Co-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic Acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Boon Pharma Corp.Importer: Suhitas Pharmaceuticals Inc. | DRP-1092-18 | Oct 14, 2028 | |
Moxibam 457Co-Amoxiclav | 457 mg/5 mL Powder for Suspension70 mL Amber Bottle with an aluminum cap and measuring cup (Box of 1’s) | Rx | Indchemie Health Specialties Private LimitedIndia | Boon Pharma CorpImporter: Sunitas Pharmaceuticals, Inc. | DRP-14019-11 | Jun 6, 2028 | |
MoxikingCo-Amoxiclav | 625 mg Tablet2 PVDC/Alu Blister Pack x 10’s in Aluminum Sachet (Box of 100’s) | Rx | Chong Kun Dang Pharmaceutical Corp.Republic of Korea | Pharma King DistributorImporter: Unimex, Inc. | DRP-2491-02 | Jun 22, 2027 | |
MoxilivCo-Amoxiclav | 1 g Film Coated TabletAlu-Alu Strip x 10's (Box of 20's) | Rx | Kopran LimitedIndia | Triple Tact Import & Export Corp. | DRP-17957 | Apr 15, 2031 | |
MoxilivCo-Amoxiclav | 625 mg Film Coated TabletAlu/Alu Blister Pack x 7's (Box of 21's) | Rx | Kopran LimitedIndia | Triple Tact Import & Export Corp. | DRP-17958 | Apr 16, 2031 | |
Moxinova CVCo-Amoxiclav | 156.25 mg/5 mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Bottle with Induction seal and closed with Cap and 10 mL measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | Medinova Pharmaceutical, Inc. | DRP-13800 | Mar 21, 2029 | |
Moxinova CVCo-Amoxiclav | 156.25 mg/5mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | Medinova Pharmaceutical Inc. | DRP-12924 | Nov 22, 2027 | |
Moxinova CVCo-Amoxiclav | 228.5 mg/5 mL Powder for Oral Suspension (Orange Flavor)HDPE Bottle Sealed with Plastic Plug and Cap x 70 mL | Rx | Yeluri Formulations Pvt. Ltd.India | Medinova Pharmaceutical Inc. | DRP-15210 | May 28, 2029 | |
Moxinova CVCo-Amoxiclav | 312.5 mg/5 mL Powder for Oral Suspension (Orange Flavor)70 mL-Capacity HDPE Bottle with Induction seal and closed with cap and 10 mL measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | Medinova Pharmaceutical Inc. | DRP-12921 | Mar 21, 2029 | |
Moxinova CVCo-Amoxiclav | 375mg Film-Coated TabletAlu/Alu Blister Packs x 7's (Box of 2 blister packs x 7 Tablets) | Rx | Yeluri Formulations Pvt Ltd.India | Medinova Pharmaceutical Inc. | DRP-12930 | Nov 3, 2027 | |
Moxinova CVCo-Amoxiclav | Formulation Each film-coated tablet contains: Amoxicillin (as Trihydrate) .......... 500 mg Clavulanic Acid (as Potassium Clavulanate) ................125 mg Film coated TabletAlu/Alu Blister Pack x 7's [Box of 14's] | Rx | Yeluri Formulations Pvt. Ltd.India | Medinova Pharmaceutical Inc. | DRP-11805 | May 5, 2027 | |
Moxinova CV 457Co-Amoxiclav | 457mg/5mL Powder for Oral Suspension (Orange Flavor)70mL-Capacity HDPE Bottle with Plastic Plug and Screw Cap + 10mL Measuring Cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Medinova Pharmaceutical Inc. | DRP-17475 | Jan 7, 2031 | |
MoxseaCo-Amoxiclav | 625 mg Film- Coated TabletAlu-Alu blister pack x 10’s (Box of 10's and 30's) | Rx | Yeluri Formulations Private LimitedIndia | Multigro Healthcare Inc.Importer: Grovic Pharma Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6702-02 | Feb 3, 2032 | |
Myclav-1000Co-Amoxiclav | 1 g Film-Coated TabletFoil Strip x 2's (Box of 14's) | Rx | Ipca Laboratories LimitedIndia | Healol Pharma CorporationImporter: Blue Global (FZE) | DRP-3773-04 | Jul 6, 2031 | |
Myclav-375Co-Amoxiclav | 250/125 mg Film-Coated TabletAlu/Alu Foil Strip x 6's (Box of 60's) | Rx | Unichem Laboratories Ltd.India | Healol Pharma Corporation | DR-XY35642 | Aug 13, 2029 | |
Myclav-625Co-Amoxiclav | 500mg/125mg Film-Coated TabletAlu/Alu Foil Strip Individually Boxed by 10's (Box) of 100's and 200's) | Rx | Unichem Laboratories Limited.India | Healol Pharma Corporation. | DRP-3371 | Dec 21, 2028 | |
NahaltinCo-Amoxiclav | 1 g/200 mg Powder for Injection (IV)USP Type I Clear Glass Vial x 10 mL (Box of 1's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co.,China | Sahar International Trading, Inc. | DRP-6801 | Sep 13, 2028 | |
NahaltinCo-Amoxiclav | 375 mg TabletAlu/Alu Foil Pack x 6's (Box of 12's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Amson PharmaceuticalsImporter: Sahar International Trading, Inc. | DR-XY38701 | Oct 25, 2027 | |
NahaltinCo-Amoxiclav | 500 mg/100 mg Powder for Injection (IV)10 mL USP Type I Clear Glass Vial (Box of 1's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Sahar International Trading Inc. | DRP-6799 | Sep 13, 2028 | |
NahaltinCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack of 6's (Alu Pouch x 12's) and 7's (Box of 14's) | Rx | CSPC Zhoungnuo Pharmaceutical (Shijiazhuang) Co. LtdProvince of China | Sahar International Trading, Inc. | DRP-2645 | Jun 16, 2031 | |
NahaltinCo-Amoxiclav | 875 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's enclosed in Aluminum Foil Pouch (Box of 12's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co. Ltd.China | Sahar International Trading Inc. | DR-XY41161 | Sep 20, 2027 | |
NatravoxCo-amoxiclav | 1 g Film-coated TabletAlu/Alu Blister Pack x 6's (Box of 48's) | Rx | Medopharm Private LimitedIndia | Natrapharm Inc.Importer: MedEthix, Inc. | DRP-7046-03 | May 22, 2031 | |
NatravoxCo-Amoxiclav | 1.2 g Powder for Injection (IV)Clear, Colorless, USP Type I Glass vial (Box of 1’s) | Rx | Samjin Pharmaceutical Co., Ltd.Republic of Korea | Natrapharm Inc. | DR-XY31387 | Jan 13, 2031 | |
NatravoxCo-amoxiclav | 125 mg/31.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: NATRAPHARM, INC. | DR-XY34785 | Aug 12, 2028 | |
NatravoxCo-amoxiclav | 228.5 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 70mL (Box of 1's) | Rx | Lloyd Laboratories, IncPhilippines | Trader: Natrapharm Inc | DR-XY34776 | Aug 11, 2028 | |
NatravoxCo-Amoxiclav | 312.5 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Natrapharm Inc. | DR-XY34778 | Aug 11, 2028 | |
NatravoxCo-amoxiclav | 375mg Film-coated tabletBlister Pack x 8's in aluminum pouch Box of 48's | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Natrapharm, Inc. | DR-XY28251 | Jan 27, 2028 | |
NatravoxCo-Amoxiclav | 457 mg per 5mL Powder for SuspensionAmber Glass Bottle x 35 mL (Box of 1's); Amber Glass Bottle x 70 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Natrapharm Inc. | DR-XY34777 | Aug 11, 2028 | |
NatravoxCo-Amoxiclav | 500 mg/100 mg Powder for Injection (IV)Clear, Colorless, USP Type I Glass vial (Box of 1’s) | Rx | Samjin Pharmaceutical Co., Ltd.Republic of Korea | Natrapharm Inc. | DR-XY31388 | Jan 16, 2031 | |
NatravoxCo-amoxiclav | 500 mg/125mg Film-coated TabletBlister Pack x 8's in Aluminum Pouch (Box of 40's) | Rx | Llody Laboratories, Inc.Philippines | Trader: Natrapharm, Inc. | DR-XY28249 | Jan 27, 2028 | |
NatravoxCo-Amoxiclav | 625mg Film-coated TabletAlu/Alu Blister Pack x 6's (Box of 48's) | Rx | Medopharm Private LimitedIndia | Natrapharm Inc.Importer: Medethix, Inc. | DRP-10090-02 | May 22, 2028 | |
NatravoxCo-Amoxiclav | 642.9 mg/5 mL Powder for Oral SuspensionType III Amber Glass bottle with measuring cup x 50 mL (Box of 1's); Type III Amber Glass bottle with measuring cup x 70 mL (Box of 1's); Type III Amber Glass bottle with measuring cup x 100 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Natrapharm,Inc. | DR-XY36416 | Aug 4, 2029 | |
NeomoxclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu / Alu Blister Pack x 7’s (Box of 14’s) | Rx | Giyaan Pharma Private LimitedIndia | Neodrugs Pharma and Medical Supplies DistributionImporter: Ambica International Corporation | DRP-5357-08 | Jun 20, 2029 | |
NoneCo-Amoxiclav | 1 g Film-Coated TabletFoil Strip 2 x 6 (Box of 12's) | Rx | Sun Pharmaceuticals Industries LImitedIndia | Ritemed Phils., Inc.Importer: Sun Pharma Philippines, Inc. | DRP-1006-04 | Aug 12, 2028 | |
NoneCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Giyaan Pharma Private LimitedIndia | TGP Pharma Inc.Importer: Ambica International Corporation | DRP-5343-03 | Jun 17, 2029 | |
NoneCo-Amoxiclav | 1 g Film-coated TabletAlu/Alu Blister Pack x 6's (Box of 12's) | Rx | Medopharm Private LimitedIndia | Patriot Pharmaceuticals CorporationImporter: MedEthix, Inc. | DRP-7046-02 | May 26, 2031 | |
NoneCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Strip Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Foramen Products CorporationTrader: Gamot Philippines, Inc. | DRP-7246-03 | Nov 13, 2029 | |
NoneCo-Amoxiclav | 1 g/200 mg per vial Powder for Injection (IV)USP Type III Glass Vial (Box of 1's) | Rx | Stallion Laboratories Pvt. Ltd.India | MMG-FED PharmaImporter: Ambica International Corporation | DRP-4466-02 | May 23, 2028 | |
NoneCo-Amoxiclav | 156.25 mg per 5 mL Powder for Oral Suspension (see reverse for formulation)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-15181-01 | May 21, 2029 | |
NoneCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-7924-01 | Mar 2, 2028 | |
NoneCo-Amoxiclav | 200mg/28.5mg per 5mL Powder for SuspensionAmber glass bottle x 60mL Box of 1's | Rx | Drugmaker's Laboratories, Inc.Philippines | TGP Pharma Inc. | DRP-5549-01 | Sep 20, 2027 | |
NoneCo-Amoxiclav | 228.5 mg Dispersible TabletAluminum foil strip pack of 10's (Box of 30's) | Rx | Medopharm Private LimitedIndia | Medethix, Inc. | DRP-8336 | Aug 15, 2029 | |
NoneCo-Amoxiclav | 228.5 mg/5 mL Powder for Oral SuspensionAmber glass bottle x 70 mL with HDPE screw cap and Polypropylene measuring cup (Box of 1's) | Rx | Sparsh Bio-Tech Pvt., Ltd.India | Khriz Pharma Trading, Inc. | DRP-12224 | Jun 30, 2027 | |
NoneCo-Amoxiclav | 228.5 mg/5 mL Powder for Oral Suspension (Orange Flavor)HDPE Bottle Sealed with Plastic Plug and Cap x 70 mL + 10 mL Measuring Cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Qualifirst Health Inc.Importer: Medinova Pharmaceutical Inc. | DRP-15210-05 | May 28, 2029 | |
NoneCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL Box of 1’s | Rx | Indchemie Health Specialities Private LimitedIndia | Actimed, Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1092-07 | Oct 14, 2028 | |
NoneCo-Amoxiclav | 312.5 mg Dispersible TabletAluminum foil strip x 10's (Box of 10's) | Rx | Medopharm Private LimitedIndia | Medethix, Inc. | DRP-9473 | Jan 13, 2031 | |
NoneCo-Amoxiclav | 312.5 mg per 5 mL Powder for Oral Suspension60 mL amber glass bottle with measuring cup (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Cyden Medicale Trading Inc.Importer: AMB HK Enterprises Inc. | DRP-13115-01 | Dec 2, 2027 | |
NoneCo-Amoxiclav | 457 mg per 5 mL Powder for Oral Suspension70 mL Amber Glass Bottle with Plastic Syringe (Box of 1's) | Rx | Lek Pharmaceuticals d.d.Slovenia | TGP PHARMA INC.Importer: Sandoz Philippines Corporation | DRP-2274-04 | Jul 18, 2028 | |
NoneCo-Amoxiclav | 457 mg/ 5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cup x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Qualifirst Health Inc.Importer: AMB HK Enterprises Inc. | DRP-11087-10 | Feb 3, 2027 | |
NoneCo-Amoxiclav | 457 mg/5 mL Powder for Oral SuspensionWhite Translucent HDPE plastic bottle with white LDPE Flip-top Plastic Cap x 120 mL (70 mL net content) and translucent HDPE plastic measuring cup (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Watsons Personal Care Stores (Philippines), Inc. | DRP-12192-03 | Sep 2, 2027 | |
NoneCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cup x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Cyden Medicale Trading Inc.Importer: AMB HK Enteprises Inc. | DRP-11087-08 | Feb 3, 2027 | |
NoneCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber Glass Bottle x 30 mL and 70 mL | Rx | Giyaan Pharma Private LimitedIndia | Tri-Eve Pharmaceutical MarketingImporter: Ambica International Corporation | DRP-5966-18 | Mar 2, 2037 | |
NoneCo-Amoxiclav | 500 mg / 125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's) | Rx | Stallion Laboratories Pvt. Ltd.India | South Star DrugImporter: Ambica International Corporation | DRP-3087-19 | Jun 27, 2029 | |
NoneCo-Amoxiclav | 500 mg/ 125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's) | Rx | Stallion Laboratories Pvt. Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-3087-17 | Jun 27, 2029 | |
NoneCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 60's) | Rx | Stallion Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-3087-18 | Jun 27, 2029 | |
NoneCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | St. Joseph DrugstoreTrader: Innogen Pharmaceuticals, Inc. | DRP-5563-01 | Jan 28, 2028 | |
NoneCo-Amoxiclav | 500 mg/125 mg FIlm-Coated TabletAluminum Foil Strip x 10's (Box of 20's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | Trader: FIRSTMED THERACONCEPT INC. | DRP-6173 | Dec 4, 2029 | |
NoneCo-Amoxiclav | 625 mg Film - Coated TabletAlu/Clear PVC-PVDC Blister Pack x 10's (Box of 10's) | Rx | Sun Pharmaceutical Industries LimitedIndia | Ritemed Phils., Inc.Importer: Sun Pharma Philippines, Inc. | DRP-14076-01 | Jun 14, 2028 | |
NoneCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Strip Pack x 10 (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Dyna Drug Corporation | DR-XY43932 | Dec 2, 2029 | |
NoneCo-Amoxiclav | 625 mg Film-Coated TabletFoil Strip x 4's (Box of 100's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | Watsons Personal Care Stores (Philippines), Inc.Importer: Sandoz Philippines Corporation | DRP-1291-02 | Nov 14, 2027 | |
NoneCo-Amoxiclav | 625 mg Film-Coated TabletFoil Strip x 3's (Box of 15's) | Rx | Sandoz GmbH (Organisationseinheit Techops)Austria | Ritemed Phils., Inc.Importer: Sandoz Philippines Corporation | DRP-1291-05 | Nov 14, 2027 | |
NoneCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 3's (Box of 21's) | Rx | Ipca LaboratoriesIndia | Actimed, Inc.Importer: Blue Global (FZE) | DRP-3774-02 | Jul 20, 2028 | |
NoneCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 3's (Box of 21's) | Rx | Ipca LaboratoriesIndia | International Pharmaceuticals, Inc.Importer: Blue Global (FZE) | DRP-3774-05 | Jul 20, 2028 | |
NoneCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s *Box of 10’s) | Rx | Akums Drugs & Pharmaceuticals Ltd.India | ATC Healthcare International Corp.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4135-01 | Dec 12, 2027 | |
NoneCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14’s) | Rx | Giyaan Pharma Private LimitedIndia | Reta DrugImporter: Ambica International Corporation | DRP-5357-05 | Jun 20, 2029 | |
NoneCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's Box of 14's | Rx | Giyaan Pharma Private LimitedIndia | Airlife International Trading CorporationImporter: Ambica International Corporation | DRP-5357-06 | Jun 20, 2029 | |
NoneCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Stallion Laboratories Pvt. Ltd.India | PharmaVital Corp.Importer: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5407-10 | Jul 30, 2029 | |
NoneCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | TGP Pharma, Inc.Importer: Greencore Pharma, Inc. | DRP-6810-11 | Feb 7, 2032 | |
NoneCo-Amoxiclav | 625 mg Film-Coated Tablet (see reverse for formulation)AluAlu Blister Pack x 10’s (Box of 10’s) | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4135-04 | Dec 12, 2027 | |
NoneCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Actimed, Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-07 | Oct 7, 2028 | |
NoneCo-Amoxiclav | 625 mg TabletAluminum/PVC/PVDC Blister pack inside a desiccated aluminum/laminated pouch Box of 30's | Rx | SmithKline Beecham Ltd T/A Smithkline Beecham PharmaceuticalsUnited Kingdom | Philusa CorporationImporter: GlaxoSmithkline Philippines, Inc. | DRP-6438-01 | Apr 10, 2028 | |
NoneCo-amoxiclav | 625mg Film-coated TabletAlu/Alu Blister Pack x 6's (Box of 12's) | Rx | Medopharm Pvt. Ltd.India | Patriot Pharmaceuticals CorporationImporter: MedEthix, Inc. | DRP-10090-01 | May 22, 2028 | |
NoneCo-Amoxiclav | 875 mg/ 125 mg Film-Coated TabletAlu/Alu Foil Strip x 8’s Box of 8’s | Rx | Akums Drugs & Pharmaceuticals Ltd.India | Tri-Eve Pharmaceutical MarketingImporter: Ambica International CorporationTrader: Unosource Pharma Ltd. | DRP-4230-05 | Feb 14, 2028 | |
OranclaCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Indchemie Health Specialities Private LimitedIndia | Orange Biotec Inc. | DRP-14940 | Feb 21, 2029 | |
OranclaCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension (Peppermint Flavor)Amber Glass Bottle x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Orange Biotec Inc.Trader: N/A | DRP-14938 | Feb 21, 2029 | |
Orancla 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Orange Biotec Inc.Trader: N/A | DRP-14939 | Feb 21, 2029 | |
OrapenCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-10 | Oct 7, 2028 | |
Orapen InjCo-Amoxiclav | 1 g/ 200 mg Powder for Injection (I.V.)Clear Glass Vial USP Type III (Box of 1’s) | Rx | Inject Care Parenterals Pvt. Ltd.India | Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Mac Heal Laboratories, Ltd. | DRP-3205-01 | Aug 23, 2031 | |
457 mg/ 5 mL Powder for Suspension60 mL and 70 mL Amber Bottle with aluminum cap and measuring cup (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-14019-03 | Jun 6, 2028 | ||
Orapen-GCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-10904-03 | Dec 17, 2031 | |
Orapen-SCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL Box of 1’s | Rx | Indchemie Health Specialities Private LimitedIndia | Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1093-06 | Oct 14, 2028 | |
Orapen-SCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Orange Biotec Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1092-10 | Oct 14, 2028 | |
OrcomoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 10's Packed in One Alu-Alu Pouch (Box of 30's) | Rx | Yeluri Formulations Pvt. Ltd.India | 999 Seth Pharmaceutical Inc.Importer: Orange Biotec Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6095-02 | Mar 2, 2031 | |
Orcomox 1Co-Amoxiclav | 1g Film Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Indchemie Health Specialities Private LimitedIndia | 999-Seth Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-10904-06 | Dec 17, 2026 | |
Orcomox 20Co-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | 999 Seth Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-26 | Oct 7, 2028 | |
Orcomox-SCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | 999 Seth Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1093-10 | Oct 14, 2028 | |
Orcomox-SCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic Acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | 999 Seth Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1092-14 | Oct 14, 2028 | |
Orcomox-SCo-Amoxiclav | 457 mg / 5 mL Powder for Suspension70 mL Amber Bottle with aluminum cap and measuring cup (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | 999 Seth Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-14019-05 | Jun 6, 2028 | |
Orconz-sCo-Amoxiclav | 228.5 mg per 5 mL Powder for Suspension100 mL-Capacity Round Boston Amber Bottle Sealed with HDPE Cap x 70 mL (net content) with Plastic Measuring Cup (Box of 1's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Roymed PharmaceuticalImporter: Nelpa Lifesciences, Inc. | DRP-17276-01 | Nov 5, 2030 | |
PaxiclavCo-Amoxiclav | 457 mg per 5 mL Powder for SuspensionPlastic Bottle x 70 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | GX International, Inc.Trader: Vamsler Phils. Incorporated | DRP-3730-03 | Jul 31, 2029 | |
PaxiclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Gx International, Inc.Importer: Greencore Pharma Inc. | DRP-6810-14 | Feb 8, 2032 | |
PearliclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's with Aluminum pouch (Box of 14's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | PNI Pharmaceutical Enterprises Inc.Importer: AMB HK Enterprises Inc. | DRP-8498-06 | Oct 18, 2029 | |
PediaclavCo-Amoxiclav (see reverse for formulation) | 312.5 mg per 5 mL Powder for Suspension (see reverse for formulation)HDPE Plastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medlink Pharma Phils., Inc. | DR-XY33625 | Jul 12, 2027 | |
PediaClavCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber Glass Bottle x 70 mL Box of 1's | Rx | Giyaan Pharma Private LimitedIndia | Medlink Pharma Phils., Inc.Importer: Ambica International Corporation | DRP-5966-23 | Jan 27, 2030 | |
PenclaCo-amoxiclav | 625 mg Film-Coated Tablet | Rx | PENMIX LTD. | ONE PHARMA CO., INC. | DRP-2465 | Apr 27, 2027 | |
Penclav 1000Co-Amoxiclav | 1g TabletAlu-Alu Blister Pack x 10's (Box of 10's and 30's) | Rx | — | A. Pendragon International Distribution OpcImporter: Khriz Pharma Trading Inc. | DRP-12235-01 | Jun 30, 2027 | |
Penclav 228.5Co-Amoxiclav | 228.5 mg/5 mL Powder for Oral SuspensionAmber glass bottle x 70 mL with HDPE screw cap and Polypropylene measuring cup (Box of 1's) | Rx | Sparsh Bio-Tech Pvt., Ltd.India | A. Pendragon International Distribution OpcImporter: Khriz Pharma Trading, Inc. | DRP-12224-01 | Jun 30, 2027 | |
Penclav 625Co-Amoxiclav | 625 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 30's) | Rx | Sparsh Bio-Tech Pvt. Ltd.India | A. Pendragon International Distribution OpcImporter: Khriz Pharma Trading, Inc. | DRP-16718-01 | Jun 29, 2028 | |
Penclav DS 312.5Co-Amoxiclav | 312.5 mg/5 mL Powder for Oral Suspension70mL Amber Colored Glass Bottle with Measuring Cup (Box of 1's) | Rx | Sparsh Bio-Tech Pvt. LtdIndia | A. Pendragon International Distribution OPCImporter: Khriz Pharma Trading Inc. | DRP-17952-01 | Jun 30, 2028 | |
Penclav ForteCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension70 mL-net content in 100 mL-capacity amber glass bottle with HDPE plastic screw cap and measuring cup (Box of 1's) | Rx | Sparsh Bio-Tech Pvt., Ltd.India | A. Pendragon International Distribution OPCImporter: Khriz Pharma Trading Inc. | DRP-17954-01 | Aug 24, 2028 | |
457 mg/5 mL Powder for Oral Suspension70 ml Amber Bottle with Induction Sealing Cap and Measuring Cup (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Amb HK Enterprises Inc.Importer: AMB HK Enterprises Inc. | DRP-14133 | Jun 29, 2028 | ||
PillclavCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's, 36's and 60's) | Rx | Stallion Laboratories Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-3087-20 | Jun 27, 2029 | |
Prevaclav 1gCo-Amoxiclav | 1 g Film-Coated TabletFoil Strip 2 x 6 (Box of 12’s) | Rx | Sun Pharmaceutical Industries LimitedIndia | Sun Pharma Philippines, Inc. | DRP-1006-03 | Aug 12, 2028 | |
Prevaclav 1gCo-Amoxiclav | 1 g Film-Coated Tablet (see reverse for formulation)Alu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Preventia Healthcare Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-10904-01 | Dec 17, 2031 | |
Prevaclav 312.5Co-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Preventia Healthcare Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1092-09 | Oct 14, 2028 | |
Prevaclav 457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Preventia Healthcare Inc.Importer: Ambica International Corporation | DRP-5966-20 | Jan 27, 2030 | |
Prevaclav 625Co-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 60's) | Rx | Sun Pharmaceutical Industries LimitedIndia | Preventia Healthcare Inc.Importer: Sun Pharma Philippines, Inc. | DRP-1324-04 | Jun 17, 2027 | |
Prevaclav 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Clear PVC-PVDC Blister Pack x 10's (Box of 10's and 100's) | Rx | Sun Pharmaceutical Industries LimitedIndia | Preventia Healthcare Inc.Importer: Sun Pharma Philippines, Inc. | DRP-14076-02 | Jun 14, 2028 | |
Prevaclav 625Co-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Preventia Healthcare Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-12 | Oct 7, 2028 | |
ProviclavCo-Amoxiclav (see reverse for formulation) | 228.50mg./5mL Powder for Oral SuspensionAmber glass bottle x 50 mL with orange child resistant PE cap (Box of 1’s) | Rx | Shin Poong Pharmaceutical Co., Ltd.Republic of Korea | Providencia Medica Inc.Importer: Phil Shinpoong Pharma, Inc. | DRP-17406-01 | Dec 11, 2030 | |
ProviclavCo-Amoxiclav (see reverse for formulation) | 625 mg Film-Coated TabletAlu / Alu Blister Pack x 6’s (Box of 12’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Providencia Medica Inc.Importer: Phil. Shinpoong Pharma Inc. | DRP-3575-08 | Feb 13, 2030 | |
Proviclav DSCo-Amoxiclav | 400 mg/57 mg per 5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Providencia Medica Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-09 | Jan 21, 2030 | |
QuadxiclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's in a Complex Film Aluminum Pouch (Box of 14's) | Rx | Giyaan Pharma Pvt. Ltd.India | Quad-Gen PharmaceuticalsImporter: PhilRx Pharma Inc. | DRP-4771-04 | Oct 2, 2028 | |
QualiclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 20's | Rx | ALKEM LABORATORIES, LTD.India | QUALIFIRST HEALTH INC. | DRP-1437 | May 28, 2027 | |
QUALICLAVCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Qualifirst Health Inc.Importer: Greencore Pharma Inc. | DRP-6810-10 | Feb 8, 2032 | |
R-VokzCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's in a Complex Film Aluminum Pouch (Box of 14's) | Rx | Giyaan Pharma Private LimitedIndia | Rkin'z PharmaImporter: PhilRx Pharma Inc. | DRP-4771-05 | Oct 2, 2028 | |
RafonexCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Reyoung Pharmaceutical Co.,Ltd.China | Philgen Pharmaceuticals Inc. | DRP-1028 | Mar 12, 2031 | |
Rafonex 625Co-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 7's in Foil Pouch (Box of 14's) | Rx | Centurion Remedies Pvt. Ltd.India | Philgen Pharmaceuticals Inc. | DRP-5348 | Feb 15, 2030 | |
RaniclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's and 21's); Alu/Alu Blister Pack x 10's (Box of 20's and 30's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-14462-01 | Sep 8, 2028 | |
RaniclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's with Aluminum pouch (Box of 14's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Philrx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-8498-01 | Oct 18, 2029 | |
Raniclav-DSCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's in Aluminum Pouch (Box of 14's) | Rx | GIYAAN PHARMA PRIVATE LIMITEDIndia | PHILRX PHARMA INC.Importer: AMB HK Enterprises Inc. | DRP-15183-01 | May 21, 2029 | |
RapiclavCo-Amoxiclav | 1 g Film-Coated TabletFoil Strip x 2's (Box of 14's) | Rx | IPCA Laboratories LimitedIndia | Blue Global (FZE) | DRP-3773 | Aug 9, 2031 | |
RapiclavCo-Amoxiclav | 250 mg/125 mg TabletFoil Strip x 3's (Box of 21's) | Rx | Ipca LaboratoriesIndia | Blue Global (FZE) | DRP-3756 | Sep 25, 2028 | |
RapiclavCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 3's (Box of 21's) | Rx | Ipca LaboratoriesIndia | Blue Global (FZE) | DRP-3774 | Jul 20, 2028 | |
RedClav 625Co-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Indchemie Health Specialities Private LimitedIndia | Redrocks Pharma and Medical Supplies DistributionImporter: Suhitas Pharmaceuticals Inc. | DRP-1077-20 | Oct 7, 2028 | |
RemoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu / Alu Blister Pack x 7's in a complex film aluminum pouch (Box of 14's) | Rx | Giyaan Pharma Pvt. Ltd.India | R.E. PharmaceuticalsImporter: PhilRx Pharma Inc. | DRP-4771- | Oct 2, 2028 | |
RemoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's in a complex film aluminum pouch (Box of 14's) | Rx | Giyaan Pharma Pvt. Ltd.India | R. E. PharmaceuticalsImporter: PhilRx Pharma Inc. | DRP-4771-10 | Oct 2, 2028 | |
RetaclavCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension (see reverse for formulation)70 mL (net content) white round HDPE bottle with white HDPE cap and 15 mL capacity measuring cup (Box of 1's) | Rx | MEDOPHARM PRIVATE LIMITEDIndia | RETA DRUGImporter: AGLOBAL CARE, INC.Trader: PRIME PHARMACEUTICALS PVT.LTD. | DRP-11334-05 | Mar 2, 2027 | |
Retaclav-RCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Reta DrugImporter: Suhitas Pharmaceuticals Inc. | DRP-10904-04 | Dec 17, 2031 | |
Retaclav-RCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Reta DrugImporter: Suhitas Pharmaceuticals Inc. | DRP-1093-09 | Oct 14, 2028 | |
Retaclav-RCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic Acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Reta DrugImporter: Suhitas Pharmaceuticals Inc. | DRP-1092-13 | Oct 14, 2028 | |
Retaclav-RCo-Amoxiclav | 457 mg / 5 mL Powder for Suspension70 mL Amber Bottle with aluminum cap and measuring cup (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Reta DrugImporter: Suhitas Pharmaceuticals Inc. | DRP-14019-04 | Jun 6, 2028 | |
Retaclav-RCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 30 mL and 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Reta DrugImporter: Ambica International Corporation | DRP-5966-27 | Jan 27, 2030 | |
Retaclav-RCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Indchemie Health Specialties Private LimitedIndia | Reta DrugImporter: Suhitas Pharmaceuticals Inc. | DRP-1077-19 | Oct 7, 2028 | |
Retavacyl 125Co-Amoxiclav | 156.25 mg/5mL Powder for Oral Suspension70 mL-Capacity HDPE Plastic Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-13800-03 | Nov 22, 2027 | |
Retavacyl 228Co-Amoxiclav | 228.5 mg / 5 mL Powder for Oral Suspension (Orange Flavor)HDPE Bottle Sealed with Plastic Plug and Cap x 70 mL + 10 mL Measuring Cup (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-15210-02 | May 28, 2029 | |
Retavacyl 250Co-Amoxiclav | 312.5 mg/5 mL Powder for Oral Suspension70 mL-Capacity HDPE Bottle with Plastic Plug and closed with Cap and 10 mL measuring cup. (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-12921-05 | Oct 28, 2027 | |
Retavacyl 375Co-Amoxiclav | 375 mg Film-Coated TabletAlu/Alu Blister Packs x 7’s (Box of 2 blister packs x 7 tablets) | Rx | Yeluri Formulations Pvt Ltd.India | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-12930-03 | Nov 3, 2027 | |
Retavacyl 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's. (Box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-11805-10 | May 5, 2027 | |
RicoxinCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu blister pack x 7's (Box of 14's with aluminum pouch) | Rx | Baroque Pharmaceuticals Pvt. Ltd.India | AMB HK Enterprises Inc. | DRP-15030 | Mar 21, 2029 | |
Rinaclav 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14’s and 21’s); Alu/Alu Blister Pack x 10's (Box of 20’s and 30’s) | Rx | Reyoung Pharmaceutical Co., Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-14462-02 | Sep 8, 2028 | |
RocklavCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 10's Packed in One Alu-Alu Pouch (Box of 30's) | Rx | Yeluri Formulations Pvt. Ltd.India | Redrocks Pharma and Medical Supplies DistributionImporter: Orange Biotec Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6095-04 | Feb 7, 2037 | |
RoclavCo-Amoxiclav | 312.5 mg (equivalent to 250 mg Amoxicillin + 62.5 mg Clavulanic Acid) per 5 mL Powder for SuspensionAmber Glass Bottle x 60 ml (Box of 1’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Redrocks Pharma and Medical Supplies DistributionImporter: Suhitas Pharmaceuticals Inc. | DRP-1092-16 | Oct 14, 2028 | |
RoclavCo-Amoxiclav | 457 mg / 5 mL Powder for Suspension70 mL Amber Bottle with aluminum cap and measuring cup (Box of 1's) | Rx | Indchemie Health Specialities Private LimitedIndia | Redrocks Pharma and Medical Supplies DistributionImporter: Suhitas Pharmaceuticals Inc. | DRP-14019-09 | Jun 6, 2028 | |
RoxiclavCo-Amoxiclav | 125 mg/31.25 mg per 5 mL Powder of SuspensionHDPE Plastic Bottle x 60 mL with measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | 999 Seth Pharmaceutical, Inc.Trader: Westfield Pharmaceuticals, Inc. | DRP-4616-02 | Oct 10, 2031 | |
RoxiclavCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionHDPE Bottle x 60 mL with Measuring Cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Bulacan | 999 Seth Pharmaceutical, Inc.Trader: Westfield Pharmaceuticals, Inc. | DRP-3704-01 | Oct 21, 2031 | |
RoxiclavCo-Amoxiclav | 457 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle X 70 mL Box of 1'S | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | 999 SETH PHARMACEUTICAL INC. | DRP-6174-04 | Dec 15, 2029 | |
S-ClavCo-Amoxiclav | 457 mg/5 mL Powder for Oral SuspensionWhite Translucent HDPE plastic bottle with white LDPE Flip-top Plastic Cap x 120 mL (70 mL net content) and translucent HDPE plastic measuring cup (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES, INC.Philippines | STARPHARM, INC. | DRP-12192-04 | Sep 2, 2027 | |
Seaclavin 1200Co-Amoxiclav | Formulation: Each vial contains: Amoxicillin (as sodium)... 1g Clavulanic acid (as Potassium Clavulanate) ... 200 mg Powder for Injection (IM/IV)USP Type I Glass vial with grey bromo butyl rubber stopper with ring (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Bliss GVS Pharma Ltd. | DRP-11313 | Feb 24, 2027 | |
She-ClavCo-Amoxiclav | 625 mg TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Indchemie Health Specialities Private LimitedIndia | Kain's Trading Corp.Importer: Suhitas Pharmaceuticals Inc. | DRP-1077-21 | Oct 7, 2028 | |
SiclavCo-Amoxiclav | 125 mg/31.25 mg per 5 mL Powder for SuspensionAmber Glass Bottle x 60 mL (Box of 1's) | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-7924 | Mar 2, 2028 | |
SiclavCo-Amoxiclav | 200mg/28.5mg per 5mL Powder for SuspensionAmber glass bottle x 60mL Box of 1's | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-5549 | Sep 20, 2027 | |
SiclavCo-Amoxiclav | 312.5 mg per 5 mL Powder for Suspension60 mL in 120 mL Amber Glass Bottle Box of 1's | Rx | Drugmaker's Laboratories Inc.Philippines | — | DRP-5664 | May 16, 2030 | |
SolclavCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for Suspension60 mL HDPE (Plastic Bottle) with LDPE Tamper Proof Cap & 20 mL Capacity (PP) Plastic Measuring Cap | Rx | Lloyd Laboratories, Inc.Bulacan | Solvang Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DRP-294-07 | Sep 6, 2031 | |
SolclavCo-Amoxiclav | 400 mg/57 mg per 5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup | Rx | Lloyd Laboratories, Inc.Philippines | Solvang Pharmaceuticals, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-7086-03 | Jan 21, 2030 | |
SolclavCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Solvang Pharmaceuticals, Inc.Trader: Gamot Philippines, Inc. | DRP-615-06 | Apr 2, 2027 | |
SolvamoxCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionPlastic Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Solvang Pharmaceuticals, Inc.Trader: Aldril Pharmaceuticals, Inc. | DRP-942-01 | Dec 18, 2027 | |
SoonmeltCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Yung Shin Pharm. Ind. Co., Ltd.China | Yung Shin (Philippines), Inc. | DR-XY37136 | Dec 2, 2029 | |
SovlanCo-Amoxiclav | 1.2g Powder for Injection (I.V.)Clear Glass USP Type I Vial in a box (Box of 10's) | Rx | Yung Shin Pharm. Ind. Co., Ltd. - Taichung Youth Factory IIITaiwan | Yung Shin (Philippines), Inc. | DR-XY32530 | Nov 13, 2031 | |
Spotclav 625Co-Amoxiclav | 625 mg Film-coated TabletAlu/ Alu Blister Pack x 7' s (Box of 14's and 21's); Alu/ Alu Blister Pack x 10's (Box of 10's and 30's) | Rx | Sparsh Bio-Tech Pvt. Ltd.India | Khriz Pharma Trading Inc. | DRP-16718 | Jun 29, 2028 | |
Spotclav 625Co-Amoxiclav | 625mg Film-Coated TabletsAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Sparsh Bio-Tech Pvt. Ltd.India | Khriz Pharma Trading Inc. | DR-XY48788 | Jun 29, 2028 | |
Spotclav DS 312.5Co-Amoxiclav | 312.5 mg/ 5 mL Powder for Oral Suspension Powder Oral Suspension70mL Amber colored glass bottle with measuring cup (Box of 1's) | Rx | Sparsh Bio-Tech Pvt. Ltd.India | Khriz Pharma TraImporter: Khriz Pharma Trading Inc. | DR-XY48787 | Jun 30, 2028 | |
Spotclav DS 312.5Co-Amoxiclav | 312.5 mg/5 mL Powder for Oral Suspension70mL Amber Colored Glass Bottle with Measuring CUp (Box of 1's) | Rx | Sparsh Bio-Tech Pvi. LtdIndia | Khriz Pharma Trading Inc. | DRP-17952 | Jun 30, 2028 | |
Spotclav ForteCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension70 mL-net content in 100 mL-capacity amber glass bottle with HDPE plastic screw cap and measuring cup (Box of 1's) | Rx | Sparsh Bio-Tech Pvt., Ltd.India | Khriz Pharma Trading Inc. | DRP-17954 | Aug 24, 2028 | |
Spotclav ForteCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension. Antibacterial (Penicillin-Beta-lactamase Inhibitor Combination)70 mL-net content in 100 mL-capacity amber glass. bottle with HDPE plastic screw cap and measuring cup (Box of 1's) | Rx | Sparsh Bio-Tech Pvt. Ltd.India | Khriz Pharma Trading, Inc. | DR-XY48857 | Aug 24, 2028 | |
Stalmox CL-1.2Co-Amoxiclav | 1 g/200 mg Powder for Injection (IV)USP Type III Glass Vial x 1’s (Box of 1’s) | Rx | Inject Care Parenterals Pvt. Ltd.India | Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-4466 | Aug 19, 2032 | |
Stalmox-CL 625Co-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 18's) | Rx | Stallion Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-3087 | Jun 27, 2029 | |
Stalmox-CL-600Co-Amoxiclav | 500 mg/100 mg Powder for Injection15 mL USP Type III colorless vial Not Applicable | Rx | Inject Care Parenterals Pvt. Ltd.India | Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-3746 | Aug 15, 2032 | |
StarclavCo-Amoxiclav | 1.2 g Powder for Injection (I.V.)USP type III Clear Glass Vial x 20mL (Box of 1's) | Rx | Celogen Pharma Pvt. Ltd.India | Pharmastar Int'l Trading Corp. | DRP-7169 | Mar 30, 2029 | |
SucomoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 10's Packed in One Alu-Alu Pouch (Box of 30's) | Rx | Yeluri Formulations Pvt. Ltd.India | Radbuster Inc.Importer: Orange Biotec Inc.Trader: Sherrington Pharmaceuticals, Inc. | DRP-6095 | Feb 7, 2037 | |
SullivanCo-Amoxiclav | 156.25 mg per 5 mL Powder for SuspensionPlastic (HDPE) Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma Inc. | DR-XY29146 | Nov 11, 2028 | |
SullivanCo-Amoxiclav | 250 mg/62.5 mg per 5 mL Powder for SuspensionHDPE Plastoc Bottle x 60 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma Inc. | DR-XY28252 | Jan 27, 2028 | |
SullivanCo-Amoxiclav | 625 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 100's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY28464 | Mar 31, 2028 | |
SullivanCo-Amoxiclav | 875 mg/125 mg Film-Coated TabletFoil Strip x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY37414 | Jan 28, 2030 | |
Symoxyclav 457Co-Amoxiclav | 457mg/5mL Powder for Oral SuspensionWhite Round HDPE Bottle Sealed with Cap x 70mL (Box of 1's) | Rx | Medopharm Private LimitedIndia | Synergia Health Care & Life Sciences, Inc. | DRP-17433 | Dec 15, 2031 | |
Symoxyclav 625Co-Amoxiclav | 625 mg Film Coated TabletAlu/Alu Strip Foil x 7's (Box of 14's) | Rx | Medopharm Private LimitedIndia | Synergia Health Care & Life Sciences, Inc. | DRP-17432 | Dec 15, 2031 | |
SymuloxCo-amoxiclav | 250 mg/ 62.5 mg per 5 mL Powder for Oral SuspensionAmber glass bottle x 60 mL with induction sealing cap and measuring cup (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Amb Hk Enterprises Inc.Importer: AMB HK Enterprises Inc. | DRP-13682 | Mar 28, 2028 | |
TG-ClavCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionWhite Translucent HDPE plastic bottle with white LDPE Flip-top Plastic Cap x 120 mL (70 mL net content) and translucent HDPE plastic measuring cup (Box of 1's) | Rx | JM Tolmann Laboratories Inc.Metro Manila | TGIF Pharmaceutical Trading Inc. | DRP-12192-08 | Jun 28, 2027 | |
TheraclavCo-Amoxiclav | 457 mg/5 mL Powder for Oral Suspension70 mL (net content) white round HDPE bottle with white HDPE cap and 15 mL capacity measuring cup (Box of 1's) | Rx | Medopharm Private LimitedIndia | Therapevo Farmaco Pharma And Medical Supplies TradingImporter: AGlobal Care, Inc.Trader: Prime Pharmaceuticals Pvt. Ltd. | DRP-11334-07 | Mar 2, 2027 | |
Theramox 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu / Alu Blister Pack x 7's (Box of 14's) | Rx | Yeluri Formulations Pvt. Ltd.India | Therapevo Farmaco Pharma and Medical Supplies TradingImporter: Medinova Pharmaceutical Inc. | DRP-11805-14 | May 5, 2027 | |
Theramox 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 10's Packed in One Alu-Alu Pouch (Box of 20's and 30's) | Rx | Yeluri Formulations Pvt. Ltd.India | Therapevo Farmaco Pharma and Medical Supplies TradingImporter: Orange Biotec Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6095-08 | Feb 7, 2030 | |
Travoxclav-457Co-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber glass bottle x 70 mL | Rx | Giyaan Pharma Private LimitedIndia | TGP Pharma Inc.Importer: Ambica International Corporation | DRP-5966-05 | Jan 27, 2030 | |
TriaclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 21's) | Rx | Uni MedicolabsIndia | Tri Pharma Enterprises, Inc.Importer: Greencore Pharma, Inc. | DRP-6810-17 | Aug 26, 2031 | |
TrinmoxilCo-Amoxiclav | 457 mg/5 mL Powder for SuspensionAmber Glass Bottle x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Kodapharm Med Corp.Importer: Ambica International Corporation | DRP-5966-15 | Jan 27, 2030 | |
TruclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's); Individually Boxed Alu/Alu Blister Pack x 10's (Box of 50's) | Rx | Flamingo Pharmaceuticals Ltd.India | TRUMED PHARMACEUTICALSImporter: HEXAGON PHARMACEUTICALS | DRP-2159-05 | Jun 22, 2029 | |
UnbrandedCo-Amoxiclav | 156.25 mg/5 mL Powder for Suspension60 mL with translucent HDPE bottle with white plastic cap and translucent measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Dr. Zen’s Research, Inc. | DRP-16148 | Sep 30, 2031 | |
Unimox PlusCo-Amoxiclav | 500 mg/ 125 mg Film-coated TabletAlu/Alu Blister Pack x 6's (Box of 6's); Alu/Alu Blister Pack x 7's (Box of 14's) | Rx | Uni Medicolabs Inc.India | MedEthix, Inc. | DRP-6275 | Jun 5, 2028 | |
VaclopsivCo-Amoxiclav | 400 mg/57 mg per 5 mL Powder for Oral Suspension70 mL in 120 mL HDPE Plastic Bottle with cap and measuring cup | Rx | Lloyd Laboratories, Inc.Philippines | Vispomed CorporationTrader: Metz Pharmaceuticals, Inc. | DRP-7086-14 | Jan 21, 2030 | |
VaculanCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 20's) | Rx | Indchemie Health Specialities Private LimitedIndia | Helande Kidney Care Inc.Importer: Orange Biotec Inc. | DRP-14939-01 | Feb 21, 2029 | |
Valcimox DSCo-Amoxiclav | 457 mg/ 5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cup x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-11087-02 | Feb 3, 2027 | |
VamoxCo-Amoxiclav | 250 mg/ 62.5 mg per 5 mL Powder for Suspension120 mL Amber Glass Bottle (net content of 60 mL, when reconstituted); 15 mL Amber Glass Bottle as Physician's Sample (net content of 10 mL when reconstituted) | Rx | Drugmaker's Laboratories, Inc.Philippines | Trader: Terramedic, Inc. | DRP-1104 | Aug 25, 2027 | |
VamoxCo-Amoxiclav | 400 mg/ 57 mg per 5 mL Powder for Suspension70 mL (Net content) in 120 mL Amber Bottle (Box of 1's) | Rx | Drugmaker's Laboratories, Inc..Philippines | Trader: Terramedic, Inc. | DR-XY37205 | Dec 22, 2026 | |
VapclosivCo-Amoxiclav | 625 mg Film-Coated TabletAlu/ Alu Blister Pack x 7's in a Complex Film Aluminum Pouch (Box of 14's) | Rx | Giyaan Pharma Pvt. Ltd.India | Vispomed EnterprisesImporter: PhilRx Pharma Inc. | DRP-4771-03 | Oct 2, 2028 | |
VexiclavCo-Amoxiclav | 1.2 g Powder for Injection (see reverse for formulation)USP Type I Glass Vial x 25mL (Box of 10's) | Rx | NORTH CHINA PHARMACEUTICAL CO. LTD.China | SANNOVEX PHARMACEUTICAL DISTRIBUTORImporter: SANNOVEX PHARMACUTICAL DISTRIBUTOR | DR-XY40739 | Jun 25, 2027 | |
ViamoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7’s (Box of 14’s with aluminum pouch) | Rx | Baroque Pharmaceuticals Pvt. Ltd.India | Bell-Kenz Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-15030-01 | Mar 21, 2029 | |
VispoclavCo-Amoxiclav | 500 mg/125 mg Film-Coated TabletAlu/Alu Blister Pack x 6's Box of 18's | Rx | Stallion Laboratories Pvt. Ltd.India | Jvzea Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-3087-10 | Jun 27, 2029 | |
VoxiclavCo-Amoxiclav | 457 mg/ 5 mL Powder for Oral Suspension (Raspberry Flavor)Amber glass bottle with white HDPE screw cap and transparent measuring cup x 70 mL (Box of 1's) | Rx | Giyaan Pharma Private LimitedIndia | Bio Erixx Pharma DistributionImporter: AMB HK Enterprises Inc. | DRP-11087-04 | Feb 3, 2027 | |
Wellmox 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Stallion Laboratories Pvt. Ltd.India | Sanoviz Pharmaceutical Products TradingImporter: Ambica International CorporationTrader: Endurance Healthcare Pvt. Ltd. | DRP-5407-07 | Jul 30, 2029 | |
WESCLAVCo-Amoxiclav | 457 mg per 5 ml Powder For SuspensionHDPE PLASTIC BOTTLE X 70 ML (BOX OF 1'S) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | MEDIRICH PHARMA DISTRIBUTION CORP. | DRP-6174-02 | Dec 15, 2029 | |
WesclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack x 10's Packed in One Alu-Alu Pouch (Box of 30's) | Rx | Yeluri Formulations Pvt. Ltd.India | Medirich Pharma Distribution Corp.Importer: Orange Biotec Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-6095-09 | Feb 7, 2030 | |
WestaCo-Amoxiclav | 457 mg per 5 mL Powder for SuspensionHDPE Plastic Bottle x 70 mL (Box of 1's) | Rx | J.M. Tolmann Laboratories Inc.J.M. Tolmann Laboratories Inc.Philippines | Westpoint Pharma Inc. | DRP-6174-03 | Dec 15, 2029 | |
Westa 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Giyaan Pharma Private LimitedIndia | Westpoint Pharma Inc.Importer: Ambica International Corporation | DRP-5357-07 | Jun 20, 2029 | |
WilgiclavCo-Amoxiclav | 1 g Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Giyaan Pharma Private LimitedIndia | Ezmeds Pharma Co.Importer: Ambica International Corporation | DRP-5343-01 | Jun 17, 2029 | |
XeubactinCo-Amoxiclav | 500 mg/100 mg Powder for Injection (IV)Type II Colorless Glass Mould Vial with Gray Bromobutyl Rubber Stopper and Blue Aluminum Plastic Cap x 1's (Box of 1's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | Ambicare Pharmaceuticals Inc. | DRP-11178 | Feb 10, 2032 | |
XiclavCo-Amoxiclav | 457.5 mg per 5 mL Powder for Suspension75 mL (35 mL net content) and 130 mL (70 mL net content) Round Amber Glass Bottle sealed with white PP cap (Box of 1's) | Rx | Techno Drugs Ltd.Bangladesh | Bridgemark Marketing | DRP-4201 | Nov 11, 2029 | |
Xinclav 1000Co-Amoxiclav | 1000 mg Film-Coated TabletAlu/Alu Blister Pack x 5's (Box of 15's) | Rx | Aurobindo Pharma Limited (Unit XII)India | S.M.H.P. Marketing & Consultancy | DR-XY47642 | Dec 29, 2026 | |
Xinclav 1000Co-Amoxiclav | 1000mg Film-Coated TabletAlu/alu blister pack x 5's (Box of 15's) | Rx | Aurobindo Pharma Limited (Unit XII)India | S.M.H.P. Marketing & Consultancy | DRP-12355 | Dec 29, 2026 | |
Xinclav 625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 5's (Box of 15's) | Rx | Aurobindo Pharma Limited (Unit XII)India | S.M.H.P. Marketing & Consultancy | DR-XY47641 | Dec 29, 2026 | |
Xinclav 625Co-Amoxiclav | 625mg Film-Coated TabletAlu/Alu blister pack x 5's (Box of 15's) | Rx | Aurobindo Pharma Limited (Unit XII)India | S.M.H.P. Marketing & Consultancy | DRP-12354 | Dec 29, 2026 | |
Xiocare-625Co-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's and 21's) | Rx | Giyaan Pharma Private LimitedIndia | Bellus Life Solutions, Inc.Importer: AGlobal Care, Inc.Trader: Prime Pharmaceuticals Ltd. | DRP-11728-03 | Oct 29, 2031 | |
XovaxCo-amoxiclav | 625 mg Film Coated TabletAlu/Alu Blister Pack x 6's (Box of 6's); Alu/Alu Blister Pack x 7's (Box of 14's) | Rx | Uni Medicolabs Inc.India | All-Bio Pharma, Inc.Importer: Medethix, Inc. | DRP-6275-02 | Jun 5, 2028 | |
XyveemoxCo-Amoxiclav | 625 mg Film-Coated TabletAlu-Alu Blister Pack of 6's (Alu Pouch x 12's) and 7's (Box of 14's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Amson PharmaceuticalsImporter: Sahar International Trading Inc. | DRP-2645-02 | Jun 18, 2036 | |
ZebeclavCo-Amoxiclav | 625 mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Yeluri Formulations Pvt Ltd.India | Zebe TradingImporter: Medinova Pharmaceutical Inc. | DRP-11805-09 | May 5, 2027 | |
(no brand name)Co-Amoxiclav | 1 g Film-Coated TabletAlu-Alu Blister Pack x 2's (Box of 10's and 14's) | Rx | Sandoz GmbHAustria | Ritemed Phils., Inc.Importer: Sandoz Philippines Corporation | DRP-1612-03 | Aug 3, 2028 | |
(no brand name)Co-Amoxiclav | 1 g Film-Coated TabletAlu-Alu Blister Pack x 2's (Box of 10's and 14's) | Rx | Sandoz GmbHAustria | TGP Pharma Inc.Importer: Sandoz Philippines Corporation | DRP-1612-04 | Aug 3, 2028 | |
(no brand name)Co-Amoxiclav | 1 g TabletAlu-Alu Blister Pack x 10's (Box of 10's) | Rx | Sparsh Bio-Tech Pvt., Ltd.India | Khriz Pharma Trading, Inc. | DRP-12235 | Jun 30, 2027 | |
(no brand name)Co-Amoxiclav | 156.25 mg per 5 mL Powder for Oral Suspension100 mL Type III Amber Bottle with Polyethylene Cap and Spoon Measure (Box of 1's) | Rx | Bilim Ilaç Sanayi ve Ticaret Anonim ŞirketiTurkey | Onesource Pharma Solutions, Inc. | DRP-13936 | May 18, 2028 | |
(no brand name)Co-Amoxiclav | 1g Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's)Alu/alu Blister Pack x 10's (Box of 30's) | Rx | Bueno Salud Care (India) Pvt. Ltd.India | Ollen Pharma Trading Inc. | DRP-14195 | Aug 7, 2028 | |
(no brand name)Co-Amoxiclav | 312.5 mg per 5 mL Powder For Oral Suspension100 mL Type III Amber Bottle with Polyethylene Cap and Spoon Measure (Box of 1's) | Rx | Bilim Ilaç Sanayi ve Ticaret Anonim ŞirketiTurkey | Onesource Pharma Solutions, Inc. | DRP-13886 | May 18, 2028 | |
(no brand name)Co-Amoxiclav | 312.5 mg/5 mL Powder For Suspension60 mL (net content) white translucent HDPE bottle with white translucent LDPE flip-top cap and translucent PP measuring cup (box of 1 bottle) | Rx | Lloyd Laboratories, Inc.Philippines | — | DRP-11718 | Apr 21, 2027 | |
(no brand name)Co-Amoxiclav | 375mg Film-Coated TabletAlu/Alu Blister Pack x 7's (Box of 14's) Alu/alu Blister Pack x 10's (Box of 20's) | Rx | Sunlovis Pharmaceuticals LLP.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-14259 | Aug 7, 2028 | |
(no brand name)Co-Amoxiclav | 457 mg per 5 mL Powder for Oral Suspension120 mL capacity (70 mL net content) white translucent HDPE bottle with white translucent LDPE flip-top cap and translucent PP measuring cup (box of 1 bottle) | Rx | Lloyd Laboratories, Inc.Philippines | — | DRP-11719 | Apr 21, 2027 | |
(no brand name)Co-Amoxiclav | 457mg/5mL Powder For Suspension120 mL-capacity (70 mL-net content) white translucent HDPE bottle with white translucent LDPE flip-top cap and translucent PP measuring cup (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: D.B Manix International, Inc | DRP-14789 | Jan 5, 2029 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
United States (label)
Dosage forms and strengths (US label) US FDA label
3 DOSAGE FORMS AND STRENGTHS Augmentin for Oral Suspension, USP: 125 mg/31.25 mg per 5 mL: Banana-flavored powder for oral suspension (each 5 mL of reconstituted suspension contains 125 mg of amoxicillin as the trihydrate and 31.25 mg of clavulanic acid as the potassium salt). 250 mg/62.5 mg per 5 mL: Orange-flavored powder for oral suspension (each 5 mL of reconstituted suspension contains 250 mg of amoxicillin as the trihydrate and 62.5 mg of clavulanic acid as the potassium salt). For Oral Suspension: 125 mg/31.25 mg per 5 mL, 250 mg/62.5 mg per 5 mL (3)
Warnings/Precautions
- Serious (including fatal) hypersensitivity reactions: Discontinue AUGMENTIN if a reaction occurs. (5.1)
- Severe Cutaneous Adverse Reactions (SCAR): Monitor closely. Discontinue if rash progresses. (5.2)
- Drug-induced enterocolitis syndrome (DIES) has been reported with use of Amoxicillin, A componet of Augmentin. If this occures, discontinue AUGMENIN and institute appropriate therapy (5.3)
- Hepatic dysfunction and cholestatic jaundice: Discontinue if signs/symptoms of hepatitis occur. Monitor liver function tests in patients with hepatic impairment. (5.4)
- Clostridioides difficile -associated diarrhea (CDAD): Evaluate patients if diarrhea occurs. (5.5)
- Patients with mononucleosis who receive AUGMENTIN develop skin rash. Avoid AUGMENTIN use in these patients. (
5.6 Overgrowth
5.6 Overgrowth: The possibility of superinfections with fungal or bacterial pathogens should be considered during therapy. (5.7)
5.1 Hypersensitivity Reactions
5.1 Hypersensitivity Reactions Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving beta-lactam antibacterials, including AUGMENTIN. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and/or a history of sensitivity to multiple allergens.
Before initiating therapy with AUGMENTIN, careful inquiry should be made regarding previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens. If an allergic reaction occurs, AUGMENTIN should be discontinued, and appropriate therapy instituted.
5.2 Severe Cutaneous Adverse Reactions
5.2 Severe Cutaneous Adverse Reactions AUGMENTIN may cause severe cutaneous adverse reactions (SCAR), such as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP). If patients develop a skin rash, they should be monitored closely, and AUGMENTIN discontinued if lesions progress.
5.3 Drug-Induced Enterocolitis Syndrome (DIES)
5.3 Drug-Induced Enterocolitis Syndrome (DIES) Drug-induced enterocolitis syndrome (DIES) has been reported with use of amoxicillin, a componet of AUGMENTIN [see Adverse Reactions (6.2)], with most cases occurring in pediatric patients < 18 years of age. DIES is a non IgE mediated hypersensitivity reaction characterized by protracted vomiting occuring 1 to 4 hours after drug ingestion in the absence of skin or respiratory symptoms.
DIES may be associated with pallor, lethargy, hypotension, shock, diarrhea within 24 hours of ingesting amoxicillin, and leukocytosis with neutrophilia. If DIES occurs, discontinue AUGMENTIN and institute appropriate therapy.
5.4 Hepatic Dysfunction
5.4 Hepatic Dysfunction Hepatic dysfunction, including hepatitis and cholestatic jaundice has been associated with the use of AUGMENTIN. Hepatic toxicity is usually reversible; however, deaths have been reported. Hepatic function should be monitored at regular intervals in patients with hepatic impairment.
5.5 Clostridioides difficile Associated Diarrhea (CDAD)
5.5 Clostridioides difficile Associated Diarrhea (CDAD) Clostridioides difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including AUGMENTIN, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.
C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin-producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibacterial use.
Careful medical history is necessary since CDAD has been reported to occur over 2 months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibacterial use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.
5.6 Skin Rash in Patients with Mononucleosis
5.6 Skin Rash in Patients with Mononucleosis A high percentage of patients with mononucleosis who receive amoxicillin develop an erythematous skin rash. Thus, AUGMENTIN should not be administered to patients with mononucleosis.
5.7 Potential for Microbial Overgrowth
5.7 Potential for Microbial Overgrowth The possibility of superinfections with fungal or bacterial pathogens should be considered during therapy. If superinfection occurs, amoxicillin and clavulanate potassium should be discontinued and appropriate therapy instituted.
5.8 Phenylketonurics
5.8 Phenylketonurics AUGMENTIN Chewable tablets and AUGMENTIN for Oral Suspension contain aspartame which contains phenylalanine. Each 200 mg chewable tablet of AUGMENTIN contains 2.1 mg phenylalanine; each 400 mg chewable tablet contains 4.2 mg phenylalanine; each 5 mL of either the 200 mg/5 mL or 400 mg/5 mL oral suspension contains 7 mg phenylalanine.
The other formulations of AUGMENTIN do not contain phenylalanine.
5.9 Development of Drug-Resistant Bacteria Prescribing
5.9 Development of Drug-Resistant Bacteria Prescribing AUGMENTIN in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug‑resistant bacteria.
Drug interactions
| Drug or class | Severity | Effect | What to do |
|---|---|---|---|
| Probenecid | Avoid | Blocks tubular secretion; higher and longer drug levels (label). | Coadministration not recommended. |
| Warfarin and other oral anticoagulants | Adjust or monitor | Prolonged prothrombin time / higher INR reported (label). | Monitor INR. |
| Allopurinol | Minor | More skin rash with ampicillin-class drugs (label). | Usually no action; counsel. |
| Oral contraceptives | Minor | May reduce contraceptive efficacy (label). | Counsel on backup contraception. |
Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.
renalcarematters.com, reviewed- Co‑administration with probenecid is not recommended. (7.1)
- Concomitant use of AUGMENTIN and oral anticoagulants may increase the prolongation of prothrombin time. (7.2)
- Co-administration with allopurinol increases the risk of rash. (7.3)
- AUGMENTIN may reduce efficacy of oral contraceptives. (7.4)
7.1 Probenecid
7.1 Probenecid Probenecid decreases the renal tubular secretion of amoxicillin but does not delay renal excretion of clavulanic acid. Concurrent use with AUGMENTIN may result in increased and prolonged blood concentrations of amoxicillin. Co-administration of probenecid is not recommended.
7.2 Oral Anticoagulants
7.2 Oral Anticoagulants Abnormal prolongation of prothrombin time (increased international normalized ratio [INR]) has been reported in patients receiving amoxicillin and oral anticoagulants. Appropriate monitoring should be undertaken when anticoagulants are prescribed concurrently with AUGMENTIN. Adjustments in the dose of oral anticoagulants may be necessary to maintain the desired level of anticoagulation.
7.3 Allopurinol
7.3 Allopurinol The concurrent administration of allopurinol and amoxicillin increases the incidence of rashes in patients receiving both drugs as compared to patients receiving amoxicillin alone. It is not known whether this potentiation of amoxicillin rashes is due to allopurinol or the hyperuricemia present in these patients.
7.4 Oral Contraceptives
7.4 Oral Contraceptives AUGMENTIN may affect intestinal flora, leading to lower estrogen reabsorption and reduced efficacy of combined oral estrogen/progesterone contraceptives.
7.5 Effects on Laboratory Tests
7.5 Effects on Laboratory Tests High urine concentrations of amoxicillin may result in false-positive reactions when testing for the presence of glucose in urine using CLINITEST ®, Benedict's Solution, or Fehling's Solution. Since this effect may also occur with AUGMENTIN, it is recommended that glucose tests based on enzymatic glucose oxidase reactions be used.
Following administration of amoxicillin to pregnant women, a transient decrease in plasma concentration of total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol has been noted.
Adverse reactions
Common
- Diarrhea or loose stools (9%)
- Nausea, rash and urticaria, vomiting, vaginitis
Serious
- Anaphylaxis; severe cutaneous adverse reactions
- Drug-induced enterocolitis syndrome
- Hepatic dysfunction and cholestatic jaundice
- Clostridioides difficile-associated diarrhea
- Crystalluria and interstitial nephritis after overdose
- The following are discussed in more detail in other sections of the labeling: Anaphylactic reactions [see Warnings and Precautions (5.1)] Severe Cutaneous Adverse Reactions [see Warnings and Precautions (5.2)] Drug-Induced Enterocolitis Syndrom (DIES) [see Warnings and Precautions (5.3)] Hepatic Dysfunction [see Warnings and Precautions (5.4] Clostridioides difficile Associated Diarrhea (CDAD) [see Warnings and Precautions (5.5] 5.4 The most frequently reported adverse effects were diarrhea/loose stools (9%), nausea (3%), skin rashes and urticaria (3%), vomiting (1%) and vaginitis (1%). (6.1)
- To report SUSPECTED ADVERSE REACTIONS, contact Allegis Holdings, LLC at 1-866-633-9033 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
6.1 Clinical Trial Experience
6.1 Clinical Trial Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The most frequently reported adverse reactions were diarrhea/loose stools (9%), nausea (3%), skin rashes and urticaria (3%), vomiting (1%) and vaginitis (1%).
Less than 3% of patients discontinued therapy because of drug‑related adverse reactions. The overall incidence of adverse reactions, and in particular diarrhea, increased with the higher recommended dose. Other less frequently reported adverse reactions (less than 1%) include: Abdominal discomfort, flatulence, and headache.
In pediatric patients (aged 2 months to 12 years), 1 US/Canadian clinical trial was conducted which compared 45/6.4 mg/kg/day (divided every 12 hours) of Amoxicillin and Clavulanate Potassium for 10 days versus 40/10 mg/kg/day (divided every 8 hours) of Amoxicillin and Clavulanate Potassium for 10 days in the treatment of acute otitis media. A total of 575 patients were enrolled, and only the suspension formulations were used in this trial.
Overall, the adverse reactions seen were comparable to that noted above; however, there were differences in the rates of diarrhea, skin rashes/urticaria, and diaper area rashes. [see Clinical Studies (14.2)].
6.2 Postmarketing Experience
6.2 Postmarketing Experience In addition to adverse reactions reported from clinical trials, the following have been identified during postmarketing use of AUGMENTIN. Because they are reported voluntarily from a population of unknown size, estimates of frequency cannot be made. These events have been chosen for inclusion due to a combination of their seriousness, frequency of reporting, or potential causal connection to Amoxicillin and Clavulanate Potassium.
Gastrointestinal: Drug-induced enterocolitis syndrome (DIES), indigestion, gastritis, stomatitis, glossitis, black “hairy” tongue, mucocutaneous candidiasis, enterocolitis, and hemorrhagic/pseudomembranous colitis. Onset of pseudomembranous colitis symptoms may occur during or after antibacterial treatment. [see Warnings and Precautions (5.5].
Immune: Hypersensitivity reactions, anaphylactic/anaphylactoid reactions (including shock), angioedema, serum sickness-like reactions (urticaria or skin rash accompanied by arthritis, arthralgia, myalgia, and frequently fever), hypersensitivity vasculitis [see Warnings and Precautions (5.1)]. Skin and Appendages: Rashes, pruritus, urticaria, erythema multiforme, SJS, TEN, DRESS, AGEP, exfoliative dermatitis, and linear IgA dermatosis.
Liver: Hepatic dysfunction, including hepatitis and cholestatic jaundice, increases in serum transaminases (AST and/or ALT), serum bilirubin, and/or alkaline phosphatase, has been reported with Amoxicillin and Clavulanate Potassium. It has been reported more commonly in the elderly, in males, or in patients on prolonged treatment.
The histologic findings on liver biopsy have consisted of predominantly cholestatic, hepatocellular, or mixed cholestatic hepatocellular changes. The onset of signs/symptoms of hepatic dysfunction may occur during or several weeks after therapy has been discontinued. The hepatic dysfunction, which may be severe, is usually reversible.
Deaths have been reported [see Contraindications (4.2), Warnings and Precautions (5.4)]. Renal: Interstitial nephritis, hematuria, and crystalluria have been reported [see Overdosage (10)]. Hemic and Lymphatic Systems: Anemia, including hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, and agranulocytosis have been reported.
These reactions are usually reversible on discontinuation of therapy and are believed to be hypersensitivity phenomena. Thrombocytosis was noted in less than 1% of the patients treated with AUGMENTIN. There have been reports of increased prothrombin time in patients receiving AUGMENTIN and anticoagulant therapy concomitantly [see Drug Interactions (7.2)].
Central Nervous System: Agitation, anxiety, behavioral changes, aseptic meningitis, confusion, convulsions, dizziness, insomnia, and reversible hyperactivity have been reported. Miscellaneous: Tooth discoloration (brown, yellow, or gray staining) has been reported. Most reports occurred in pediatric patients. Discoloration was reduced or eliminated with brushing or dental cleaning in most cases.
Monitoring parameters
- Kidney function for dose; liver tests in hepatic impairment; rash; diarrhea (CDAD); INR with oral anticoagulants (label). Keep fluid intake up at high doses (crystalluria with overdose). Kidney
- Kidney function for dose
- Liver tests in hepatic impairment
- INR with oral anticoagulants
Pregnancy considerations
Pregnancy (US label) US FDA label
8.1 Pregnancy Teratogenic Effects: Pregnancy Category B. Reproduction studies performed in pregnant rats and mice given AUGMENTIN (2:1 ratio formulation of amoxicillin:clavulanate) at oral doses up to 1200 mg/kg/day revealed no evidence of harm to the fetus due to AUGMENTIN. The amoxicillin doses in rats and mice (based on body surface area) were approximately 4 and 2 times the maximum recommended adult human oral dose (875 mg every 12 hours).
For clavulanate, these dose multiples were approximately 9 and 4 times the maximum recommended adult human oral dose (125 mg every 8 hours). There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
Breastfeeding considerations
Lactation (US label) US FDA label
8.3 Nursing Mothers Amoxicillin has been shown to be excreted in human milk. Amoxicillin and clavulanate potassium use by nursing mothers may lead to sensitization of infants. Caution should be exercised when amoxicillin and clavulanate potassium is administered to a nursing woman.
Mechanism of action
12.1 Mechanism of Action AUGMENTIN is an antibacterial drug [see Microbiology (12.4)].
US FDA labelPharmacokinetics
Key PK parameters
| Half-life | Amoxicillin 1.3 hours; clavulanate 1 hour |
|---|---|
| Protein binding | Amoxicillin about 18%; clavulanate about 25% |
| Renal excretion kidney | Amoxicillin 50% to 70% and clavulanate 25% to 40% unchanged in urine in 6 hours |
| Dialyzability kidney | Yes (hemodialysis; label) |
Metabolism and Excretion : The half‑life of amoxicillin after the oral administration of AUGMENTIN is 1.3 hours and that of clavulanic acid is 1 hour.
Approximately 50% to 70% of the amoxicillin and approximately 25% to 40% of the clavulanic acid are excreted unchanged in urine during the first 6 hours after administration of a single 250 mg/125 mg or 500 mg/125 mg tablet of AUGMENTIN.
Pharmacokinetics (US label) US FDA label
12.3 Pharmacokinetics Mean amoxicillin and clavulanate potassium pharmacokinetic parameters in normal adults following administration of Amoxicillin and Clavulanate Potassium Tablets are shown in Table 6 and following administration of Amoxicillin and Clavulanate Potassium for Oral Suspension and Chewable Tablets are shown in Table 7. Table 6: Mean (±S.D.) Amoxicillin and Clavulanate Potassium Pharmacokinetic Parameters a,b with Amoxicillin and Clavulanate Potassium Tablets Table 7: Mean (±S.D.) Amoxicillin and Clavulanate Potassium Pharmacokinetic Parameters a,b with Amoxicillin and Clavulanate Potassium for Oral Suspension and Chewable Tablets Oral administration of 5 mL of the 250 mg/62.5 mg suspension of Amoxicillin and Clavulanate Potassium or the equivalent dose of 10 mL of the 125 mg/31.25 mg suspension of Amoxicillin and Clavulanate Potassium provides average peak serum concentrations approximately 1 hour after dosing of 6.9 mcg/mL for amoxicillin and 1.6 mcg/mL for clavulanic acid.
The areas under the serum concentration curves obtained during the first 4 hours after dosing were 12.6 mcg*h/mL for amoxicillin and 2.9 mcg*h/mL for clavulanic acid when 5 mL of the 250 mg/62.5 mg suspension of Amoxicillin and Clavulanate Potassium or equivalent dose of 10 mL of the 125 mg/31.25 mg suspension of Amoxicillin and Clavulanate Potassium were administered to normal adults. One 250 mg/62.5 mg chewable tablet of Amoxicillin and Clavulanate Potassium or two 125 mg/31.25 mg chewable tablets of Amoxicillin and Clavulanate Potassium are equivalent to 5 mL of the 250 mg/62.5 mg suspension of Amoxicillin and Clavulanate Potassium and provide similar serum concentrations of amoxicillin and clavulanic acid.
Amoxicillin serum concentrations achieved with Amoxicillin and Clavulanate Potassium are similar to those produced by the oral administration of equivalent doses of amoxicillin alone. Time above the minimum inhibitory concentration of 1 mcg/mL for amoxicillin has been shown to be similar after corresponding every 12 hour and every 8-hour dosing regimens of Amoxicillin and Clavulanate Potassium in adults and children.
Absorption: Dosing in the fasted or fed state has minimal effect on the pharmacokinetics of amoxicillin. While AUGMENTIN can be given without regard to meals, absorption of clavulanate potassium when taken with food is greater relative to the fasted state. In one study, the relative bioavailability of clavulanate was reduced when AUGMENTIN was dosed at 30 and 150 minutes after the start of a high‑fat breakfast.
Distribution: Neither component in AUGMENTIN is highly protein‑bound; clavulanic acid is approximately 25% bound to human serum and amoxicillin approximately 18% bound Amoxicillin diffuses readily into most body tissues and fluids with the exception of the brain and spinal fluid. Two hours after oral administration of a single 35 mg/kg dose of suspension of AUGMENTIN to fasting children, average concentrations of 3 mcg/mL of amoxicillin and 0.5 mcg/mL of clavulanic acid were detected in middle ear effusions.
Metabolism and Excretion: The half‑life of amoxicillin after the oral administration of AUGMENTIN is 1.3 hours and that of clavulanic acid is 1 hour. Approximately 50% to 70% of the amoxicillin and approximately 25% to 40% of the clavulanic acid are excreted unchanged in urine during the first 6 hours after administration of a single 250 mg/125 mg or 500 mg/125 mg tablet of AUGMENTIN.
Table Table
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Co-Amoxiclav (Amoxicillin + Potassium Clavulanate) 200 mg + 28.5 mg/5 mL, 70 mL Suspension | ₱110.00–₱205.00Reference ₱115.76 | per unit | DPRI procurement range |
| Co-Amoxiclav (Amoxicillin + Potassium Clavulanate) 400 mg + 57 mg/5 mL, 70 mL Suspension | ₱127.00–₱321.50Reference ₱168.37 | per unit | DPRI procurement range |
| Co-Amoxiclav (Amoxicillin + Potassium Clavulanate) 500 mg + 125 mg Tablet | ₱5.99–₱14.36Reference ₱7.00 | per tablet | DPRI procurement range |
| Co-Amoxiclav (Amoxicillin + Potassium Clavulanate) 875 mg + 125 mg Tablet | ₱9.90–₱11.00Reference ₱10.99 | per tablet | DPRI procurement range |
| 200 mg (as trihydrate) + 28.5 mg (as potassium clavulanate) per 5 mL granules/powder for suspension in 70 mL | ₱244.50 | per unit | PhilHealth GAMOT fixed fee |
| 400 mg (as trihydrate) + 57 mg (as potassium clavulanate) per 5 mL granules/powder for suspension in 70 mL | ₱312.00 | per unit | PhilHealth GAMOT fixed fee |
| 500 mg (as trihydrate) + 125 mg (as potassium clavulanate) tablet | ₱25.75 | per tablet | PhilHealth GAMOT fixed fee |
| 600 mg (as trihydrate) + 42.9 mg (as potassium clavulanate) per 5 mL granules/powder for suspension in 70 mL | ₱230.00 | per unit | PhilHealth GAMOT fixed fee |
| 875 mg (as trihydrate) + 125 mg (as potassium clavulanate) tablet | ₱41.25 | per tablet | PhilHealth GAMOT fixed fee |
PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf, as of October 13, 2026
Formulary and coverage
| Philippine National Formulary | Listed as Co-Amoxiclav (amoxicillin + potassium clavulanate) |
| PNF listing | Oral: 500 mg amoxicillin (as trihydrate) + 125 mg potassium clavulanate per tablet |
| PNF listing | Oral: 875 mg amoxicillin (as trihydrate) + 125 mg potassium clavulanate per tablet |
| PNF listing | Oral: 200 mg amoxicillin (as trihydrate) + 28.5 mg potassium clavulanate per 5 mL granules/powder for suspension, 70 mL |
| PNF listing | Oral: 400 mg amoxicillin (as trihydrate) + 57 mg potassium clavulanate per 5 mL granules/powder for suspension, 70 mL |
| PNF listing | Oral: 600 mg amoxicillin (as trihydrate) + 42.9 mg potassium clavulanate per 5 mL granules/powder for suspension |
| PhilHealth GAMOT | Yes (listed since July 28, 2025) |
| PhilHealth YAKAP (formerly Konsulta) | Yes |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Augmentin · Allegis Holdings, LLC [US FDA-approved label, version 5, October 26, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=04a31a42-d79e-bbb4-e063-6394a90a63ee
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
- Allegis Holdings, LLC. (2026). AUGMENTIN (amoxicillin/clavulanate potassium) for oral suspension and tablets [Prescribing information; US FDA-approved label, NDA050575, set ID 04a31a42-d79e-bbb4-e063-6394a90a63ee, version effective October 26, 2026]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=04a31a42-d79e-bbb4-e063-6394a90a63ee
renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.
Last updated: .

